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Abstract 
Streptococcus agalactiae is a pathogen of multiple hosts. The bacterium, an aetiological 
agent of septicaemia and meningo-encephalitis in freshwater and saltwater fish species, is 
considered a major threat to the aquaculture industry, particularly for tilapia. Cattle and 
humans are however the main known reservoirs for S. agalactiae. In humans, the bacterium 
(commonly referred to as Group B Streptococcus or GBS) is a member of the commensal 
microflora of the intestinal and genito-urinary tracts, but it is also a major cause of neonatal 
invasive disease and an emerging pathogen in adults. In cattle, S. agalactiae is a well-
recognized causative agent of mastitis. Numerous studies focusing on S. agalactiae from 
human and bovine origins have provided insight into the population structure of the 
bacterium, as well as the genome content and pathogenic mechanisms through identification 
of virulence determinants. Concerning S. agalactiae from aquatic origins, scientific 
information mainly focused on case reporting and/or experimental challenges, with a limited 
or absence of information in terms of pathogenesis, virulence determinants and genotypes of 
the strains involved. The objective of this study was to enhance our understanding of the 
molecular epidemiology, host-adaptation and pathogenicity of S. agalactiae in aquatic 
species, with particular emphasis on tilapia. 
Firstly, a collection of 33 piscine, amphibian and sea mammal isolates originating from 
several countries and continents was assembled, with the aim of exploring the population 
structure and potential host specificity of aquatic S. agalactiae. Isolates were characterised 
using pulsed-field gel electrophoresis (PFGE), multi-locus sequence typing (MLST), and a 
standardised 3-set genotyping system comprising molecular serotypes, surface protein gene 
profiles and mobile genetic element profiles. Two major subpopulations were identified in 
fish. The first subpopulation consisted of non-haemolytic isolates that belonged to sequence 
type (ST) 260 or 261, which are STs that have been reported only from teleosts. These 
isolates exhibited a low level of genetic diversity by PFGE and clustered with other STs that 
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have been reported only in fish. Another common feature was the absence of all surface 
protein genes or mobile genetic elements targeted as part of the 3-set genotyping and that 
are usually found in human or bovine isolates. The second subpopulation consisted of β-
haemolytic isolates recovered from fish, frogs and sea mammals, and that exhibited medium 
to high genetic diversity by PFGE. STs identified among these isolates have previously been 
identified from strains associated with asymptomatic carriage and invasive disease in 
humans. The human pathogenic strain ST7 serotype Ia was detected in fish from Asia. 
Moreover, ST283 serotype III-4 and its novel single locus variant ST491 detected in fish 
from Southeast Asia shared a 3-set genotype identical to that of an emerging ST283 clone 
associated with invasive disease of adult humans in Asia. These observations suggested that 
some strains of aquatic S. agalactiae may present a zoonotic or anthroponotic hazard. STs 
found among the seal isolates (ST23) have also been reported from humans and numerous 
other host species, but never from teleosts. This work provided an excellent basis for 
exploration of the virulence of selected strains in experimental challenges. 
The virulence of two strains of S. agalactiae was experimentally investigated by intra-
peritoneal infection of Nile tilapia (Oreochromis niloticus), using an isolate originally 
recovered from fish and belonging to ST260, and an isolate originating from a grey seal and 
belonging to ST23. The clinical signs, the in vivo distribution of viable bacteria and 
bacterial antigens, and the gross and histopathological lesions that developed during the 
time course of the infection were investigated. The ST260 strain was highly virulent, 
whereas no major clinical sign or mortalities occurred in the fish challenged with the ST23 
strain. After injection, both strains however gained access to the bloodstream and viable 
bacteria were recovered from all organs under investigation. During the early stages of 
infection, bacteria were mostly found within the reticulo-endothelial system of the spleen 
and kidney. Thereafter, the ST260 demonstrated a particular tropism for the brain and the 
heart, but granulomatous inflammation and associated necrotic lesions were observed in all 
organs. ST23 was responsible for a mixed inflammatory response associated with the 
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presence of bacteria in the choroid rete and in the pancreatic tissue only. After 7 days post-
challenge and for both strain, the formation or containment of bacteria within granulomata 
or other encapsulated structures appeared to be a major component of the fish response. 
However, the load of viable bacteria remained high within organs of fish infected with 
ST260, suggesting that, unlike ST23, this strain is able to survive within macrophages 
and/or to evade the immune system of the fish. This work demonstrates that the lack of 
report of ST23 strains in fish is possibly not due to a lack of exposure but to a lack of 
virulence in this host. The two strains, which differ in prevalence and virulence in fish, 
provide an excellent basis to investigate genomic differences underlying the host-
association of distinct S. agalactiae subpopulations. 
The genome of the ST260 strain used in challenge studies was sequenced. We therefore 
provided the first description for the genome sequence of a non-haemolytic S. agalactiae 
isolated from tilapia (strain STIR-CD-17) and that belongs by multi-locus sequence typing 
(MLST) to clonal complex (CC) 552, which corresponds to a presumptive fish-adapted 
subgroup of S. agalactiae. The genome was compared to 13 S. agalactiae genomes of 
human (n=7), bovine (n=2), fish (n=3) and unknown (n=1) origins. Phylogenetic analysis 
based on the core genome identified isolates of CC552 as the most diverged of all S. 
agalactiae studied. Conversely, genomes from β-haemolytic isolates of CC7 recovered from 
fish were found to cluster with human isolates of CC7, further supporting the possibility that 
some strains may represent a zoonotic or anthroponotic hazard. Comparative analysis of the 
accessory genome enabled the identification of a cluster of genes uniquely shared between 
CC7 and CC552, which encode proteins that may provide enhanced fitness in specific 
niches. Other genes identified were specific to STIR-CD-17 or to CC552 based on genomic 
comparisons; however the extension of this analysis through the PCR screening of a larger 
population of S. agalactiae suggested that some of these genes may occasionally be present 
in isolates belonging to CC7. Some of these genes, occurring in clusters, exhibited typical 
signatures of mobile genetic elements, suggesting their acquisition through horizontal gene 
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transfer. It is not possible to date to determine whether these genes were acquired through 
intraspecies transfer or through interspecies transfer from the aquatic environment. Finally, 
general features of STIR-CD-17 highlighted a distinctive genome characterised by an 
absence of well conserved insertion sequences, an abundance of pseudogenes, a smaller 
genomic size than normally observed among human or bovine S. agalactiae, and an 
apparent loss of metabolic functions considered conserved within the bacterial species, 
indicating that the fish-adapted subgroup of isolates (CC552) has undergone niche 
restriction. 
Finally, genes encoding recognised virulence factors in human S. agalactiae were selected 
and their presence and structural conservation was evaluated within the genome of STIR-
CD-17. Numerous genes were absent in STIR-CD-17, while the cyl operon responsible for 
the β-haemolysin production was found to be only partially present, indicating that their 
encoded proteins are not important contributors to pathogenecity of S. agalactiae in fish. 
The gene encoding an immunogenic bacterial adhesin in certain human S. agalactiae 
(gbs2018) was identified as a distinct variant, unique to fish isolates of CC552, which 
possibly reflects differences or adaptations in the function of the protein. Finally, a limited 
set of genes were found to be well-conserved in STIR-CD-17 and included fbsA, pavA, srr1, 
cfb, hylB, ponA and sodA. The cspA gene was also found to be well conserved, but a 
deletion responsible for a frameshift suggested that, if the gene is expressed, the protein 
would be secreted and not cell-wall anchored. The cps genes were also found to be well-
conserved, with the exception of cpsK, but whether the variations in cpsK affect the 
biosynthesis of the capsule is unknown. 
In conclusion this study used a multidisciplinary and sequential approach in order to 
enhance our understanding of the molecular epidemiology, host-adaptation and virulence of 
S. agalactiae in tilapia. This thesis has laid a firm foundation for further studies that should 
address the questions of epidemio-surveillance for assessment of transmission of S. 
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agalactiae between humans and fish and the evaluation of the role of putative virulence 
determinants, with a view to effective control of the disease in fish through prevention or 
vaccine development. 
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1 CHAPTER 1 
Streptococcus agalactiae, a pathogen of major significance in 
tilapia culture. A general introduction. 
 
1.1 Streptococcus agalactiae and its relevance as bacterial 
pathogen 
Bacteria belonging to the genus Streptococcus (from the Greek streptos, meaning pliant or 
chain, and coccos, meaning a grain or berry) are non-motile, non-sporulating Gram-positive 
spherical cells of 0.5-2 μm in diameter that occur in pairs or chains when grown in liquid 
media (Holt et al., 1994). They are facultatively anaerobic, catalase-negative and require 
nutritionally rich media for growth (Holt et al., 1994). Streptococci may produce complete 
or partial lysis of red blood cells when inoculated onto blood agars, leading to a greenish 
discoloration (α-haemolysis) or complete clearing (β-haemolysis) around colonies (Holt et 
al., 1994). A serological classification pioneered by Rebecca Lancefield has proved useful 
in differentiating streptococci based on the detection of different versions of the major cell-
wall polysaccharide (Lancefield group A, B, C, etc.), with the S. agalactiae species placed 
into the Lancefield group B (Lancefield, 1933), leading to its common designation as group 
B streptococcus (GBS). Lancefield group B solely comprises S. agalactiae, and conversely 
all members of the species present on their surface the group B polysaccharide. 
Streptococcus agalactiae (from the latin agalactia, no milk) was initially described in 
bovids in 1887 as a causative agent of mastitis (Nocard and Mollereau, 1887); the bacterium 
remains to-date a significant cause of subclinical, clinical or chronic mastitis in many herds, 
affecting milk quality and causing significant economic impact in the dairy sector (Keefe, 
1997). In the early 20
th
 century, group B streptococci (GBS) were recognized in humans as 
commensals of the upper-respiratory, gastro-intestinal and genito-urinary tracts (Lancefield, 
1933 and 1935), leading some authors to assign these bacteria as S. opportunus (Brown, 
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1947). At this time, the bacterium was rarely associated with disease in humans (Rantz, 
1942), but from the 1960s GBS emerged as a major cause of human neonatal diseases, 
causing infections such as pneumonia, septicemia and meningitis (Dermer et al., 2004). 
Moreover, clinical manifestations caused by GBS, including sepsis, soft tissue infection, 
peri- and endocarditis, pneumonia and urosepsis (Schuchat, 1999; Farley, 1993), have been 
reported increasingly in human adults over the last decades, with elderly and immuno-
compromised adults being at higher risk of infection (Farley and Strasbaugh, 2001).  
Streptococcus agalactiae has been isolated from various other mammals, including camels, 
monkeys, pigs, nutrias, rats, rabbits, horses, cats, dogs, and dolphins, occasionally in 
association with local or systemic pathological processes (Wibawan et al., 1993; Lämmler et 
al., 1998; Bekele and Molla, 2001; Yildirim et al., 2002; Hetzel et al., 2003; Zappulli et al., 
2005; Ren et al., 2013; Shuster et al., 2013). In addition, S. agalactiae infections of 
poikilothermic animals have been well-documented (Table 1.1). 
1.2 Geographical and host-species distribution of piscine S. 
agalactiae 
The geographic distribution of S. agalactiae infections in fish is primarily confined to sub-
tropical and tropical regions, but S. agalactiae may also occur in temperate regions, either 
naturally during warm seasons (e.g, the natural outbreak in Chesapeake Bay on East coast of 
the USA; Baya et al., 1990), or through the import of aquatic animals (e.g. doctor fish 
imported into the UK for spa use; Verner-Jeffreys et al., 2012). The bacterium has been 
reported to affect poikilotherms in all continents except Antarctica and Africa (Table 1.1). 
If the absence of the S. agalactiae in Antarctica is understandably linked to the temperature, 
the absence of the bacterium from Africa is surprising and might be due to the absence of 
published reports, inadequate identification techniques, or non-susceptible species. 
Evidence, however, suggests that the bacterium occurs in tilapia farms in Africa but further 
investigation is required (David Rodgers, personal communication). 
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Table 1.1 Reports of natural Streptococcus agalactiae infections in fish and other 
poikilothermic animals. The geographic origin and host species are presented along with the 
outbreak type. W., Wild animal; F., Farmed animal; A, Aquarium fish; NA, Non Available. 
 
Common name Scientific name Country Type References
Atlantic croaker Micropogon undulatus USA W Plumb et al., 1974
Bluefish Pomatomus saltatrix USA W Baya et al., 1990
Golden shiners Notemigonus crysoleucas USA F Robinson and Meyer, 1966
Gulf killifish Fundulus grandis USA NA  Garcia et al., 2008; Olivares-Fuster et al., 2008
Hybrid striped bass Morone saxatilis x Morone 
chrysops
USA NA  Garcia et al., 2008; Olivares-Fuster et al., 2008
Menhaden Brevoortia patronus USA W Plumb et al., 1974
Pinfish Lagodon rhomboides USA W Plumb et al., 1974
Sea catfish Arius felis USA W Plumb et al., 1974
Sea trout Cynoscion regalis USA W Baya et al., 1990
Spot Leiostomus xanthurus USA W Plumb et al., 1974
Stingray Dasyatis  sp. USA W Plumb et al., 1974
Striped bass Morone saxatilis USA W Baya et al., 1990
Striped mullet Mugil cephalus USA W Plumb et al., 1974
Tilapia Oreochromis sp. USA NA Berridge et al, 2001; Garcia et al., 2008; Olivares-Fuster et 
al., 2008
Honduras NA Berridge et al, 2001; Garcia et al., 2008; Olivares-Fuster et 
al., 2008
Bullfrog Rana catesbeiana Brazil F Amborski et al., 1983
Tilapia Oreochromis sp. Brazil F/NA Salvador et al., 2005; Evans et al., 2008; Garcia et al., 
2008; Olivares-Fuster et al., 2008; Mian et al., 2009
Colombia F Hernandez et al., 2009; Delannoy et al., 2013
Costa Rica F Delannoy et al., 2013
Honduras F Delannoy et al., 2013
Whiteleg shrimp Litopenaeus vannamei NA F Hasson et al., 2009
Bartail flathead Platycephalus indicus Kuwait W Jafar et al., 2009
Bullfrog Rana rugurosa Thailand F Delannoy et al., 2013
Catfish Arius thalassinus Kuwait W Jafar et al., 2009
Doctor fish Garra rufa UK A Verner-Jeffreys et al., 2012
Golden pompano Trachinotus blochii Malaysia F Amal et al., 2012
Grey mullet Mugus cephalus Israel NA Eldar et al., 1994
Hybrid striped bass Morone saxatilis x Morone 
chrysops
Israel NA Evans et al., 2008; Olivares-Fuster et al., 2008
Klunzinger's mullet Liza klunzingeri Kuwait W Evans et al. 2002; Gilbert et al., 2002; Jafar et al., 2009
Seabream Sparus auratus Kuwait F Evans et al. 2002; Gilbert et al., 2002; Jafar et al., 2009
Silver croaker Otolithes argenteus Kuwait W Jafar et al., 2009
Silver grunt Pomaddasys stidens Kuwait NA Jafar et al., 2009
Silver pomfret Pampus argenteus Kuwait F Duremdez et al., 2004;  Jafar et al., 2009
Tilapia Oreochromis sp. Belgium F Delannoy et al., 2013
China F Ye et al., 2011
Indonesia F Lusiastuti et al., 2012
Israel NA Eldar et al., 1994
Malaysia F Musa et al., 2009; Abuseliana et al., 2010; Zamri-Saad et 
al., 2010
Thailand F Suanyuk et al., 2008
Vietnam F Delannoy et al., 2013
Ya fish Schizothorax prenanti China F Geng et al., 2012
Yellowtail Seriola quinqueradiata Japan NA Eldar et al., 1994
Australia
Crocodile Crocodylus porosus Australia F Bishop et al., 2007
Estuary stingray Dasyatis fluviorum Australia W Bowater et al., 2012
Giant grouper Epinephelus lanceolatus Australia W Bowater et al., 2012
Giant sea catfish Arius thalassinus Australia W Bowater et al., 2012
Golden ram Mikrogeophagus ramirezi Australia A Delannoy et al., 2013
Javelin grunter
 Pomadasys kaakan Australia W Bowater et al., 2012
Rosy Barb Puntius conchonius Australia A Delannoy et al., 2013
Shovelnose ray Aptychotrema rostrata Australia W Bowater et al., 2012
Mangrove whipray Himantura granulata Australia W Bowater et al., 2012
North America
South America
Eurasia
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Natural infections have occasionally been reported in shrimps, frogs, and crocodiles but 
most reports concern fish species. A total of 34 naturally-infected fish species have been 
reported thus far, including freshwater, marine and estuarine species, and involving both 
cultured and wild populations (Table 1.1). Four major epizootics affecting estuarine and 
marine wild fish have been described: one off the South-East Coast of the USA (Gulf of 
Mexico) in 1972 (Plumb et al., 1974), one in the North-East coast of the USA (Chesapeake 
Bay) in 1988 (Baya et al., 1988), one off the Kuwait Bay (Persian Gulf) in 2001 (Evans et 
al., 2002), and finally one in Australia (Northern Queensland) that occurred sporadically and 
continuously from 2007 to 2011 (Bowater at al., 2012). Other infections due to S. agalactiae 
mostly refer to the aquaculture industry. Initially, S. agalactiae was responsible for a disease 
outbreak in cultured freshwater golden shiners in the USA (Robinson and Meyer, 1966); 
however it is now considered a major threat to the aquaculture industry with most recent 
outbreak reports involving fish species of economic importance (Table 1.1). 
1.3 Importance of aquaculture and tilapia farming 
Fish are a vital foodstuff and over three billion people are nutritionally dependent upon fish 
(FAO, 1997). In 2010, aquaculture accounted for 46 percent of total food fish supply for 
human consumption (FAO, 2010b), with tilapia (Oreochromis sp.) one of the most 
productive and internationally traded farmed species. 
Tilapia is a major source of protein in numerous developing countries (FAO, 2003-2013). It 
presents excellent culture characteristics, such as easy reproduction in captivity, tolerance to 
a wide range of environmental conditions, efficient use of low protein diets, fast growth and 
relative resistance to stress and infection (Hassanien et al., 2005). Although native to Africa 
and the Middle East, tilapia has become a globally-important aquatic species, produced in 
nearly 100 countries worldwide (FAO, 2010b). In view of the increasing commercialization 
and continuing growth of the tilapia industry, the commodity is now among the most 
important farmed fish globally, second only to carp but surpassing the salmonid group 
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(FAO, 2010a). World tilapia production is led by China, followed quite distantly by Egypt, 
Indonesia and Thailand (FAO, 2010a). Diseases have however become a primary constraint 
to tilapia culture growth. In China, the main streptococcal pathogen has been considered to 
be S. iniae, but a shift towards a predominance of S. agalactiae infections has been 
described in recent years (Wang et al., 2013). In some Latin American countries, S. 
agalactiae has thus far been the only streptococcal species isolated from natural outbreaks 
of disease in tilapia (Jiménez et al., 2011). 
1.4 Streptococcus agalactiae infections in tilapia 
Streptococcal infections, which have increased in number during the last decade as a 
consequence of the intensification of aquaculture, are responsible for significant economic 
losses in the farmed fish industry. Streptococcosis of fish, from a clinical point of view, is a 
generic term used to designate similar clinical manifestations in which different species of 
Gram-positive cocci are involved (Becovier et al., 1997). Among the main pathogenic 
species responsible for these streptococcal infections is S. agalactiae. Recorded losses in 
natural outbreaks of S. agalactiae in farmed tilapia are variable, with mortalities as high as 
83.4% reported in some Malaysian farms (Zamri-Saad et al., 2010). 
1.4.1 Route of transmission 
Despite the significance of S. agalactiae disease in farmed tilapia, relatively little is known 
about the route of transmission of this pathogen. Vertical transmission of the disease is 
considered to be unlikely, as Hernández et al. (2009) and Jiménez et al. (2011) were unable 
to detect the bacterium from a batch of infected broodstock-derived larvae and juvenile 
tilapia; it is therefore generally accepted that the transmission of the disease predominantly 
occurs through horizontal transfer between congeners. This hypothesis is further supported 
by successful experimental challenges via cohabitation (Mian et al., 2009), even so it is 
unclear whether horizontal transfer occurs by ingestion, through the water, or by direct 
contacts between congeners. 
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The oral route of pathogen transmission in fish has been well described, including for S. 
iniae (Bromage and Owens, 2002). It can occur through ingestion of feces from infected 
fish (fecal-oral route), through ingestion of contaminated water, or through cannibalism and 
ingestion of infected animal tissues. Rasheed et al. (1984), however, demonstrated that the 
administration of 8 x 10
6
 colony forming unit (cfu) of pathogenic S. agalactiae directly into 
the stomach of Gulf killifish resulted in an absence of death and bacterial recovery from 
internal organs 24h post-infection, suggesting that an oral route of disease transmission in 
this fish species is unlikely. To our knowledge, the oral route of transmission has not been 
evaluated further using different S. agalactiae strains, neither has it been tested in tilapia. 
Unlike other fish pathogens, no study on the survival of S. agalactiae in the water has been 
reported and it is therefore not known whether the water represents an important vehicle for 
the transmission of the disease. Pasnik et al. (2009) recovered S. agalactiae from the 
intestine of intra-peritoneally infected tilapia and suggested a possible shedding of the 
pathogen into the environment and feco-oral transmission of the bacterium. However, the 
presence of S. agalactiae in the feces themselves has not been evaluated and the sampling of 
water, mud or sediment surrounding infected farms resulted in an absence (Hernández et al., 
2009) or rare (Amal et al., 2013) recovery of S. agalactiae. In theory, however, the 
transmission of S. agalactiae can occur through the water, as exemplified by numerous 
challenges successfully reproducing the disease by immersion or gill inoculation (Mian et 
al., 2009; Rasheed et al., 1984; Pereira et al., 2009). The gills and the skin (with or without 
injury) have been suggested to represent an important route of entry (Mian et al., 2009; 
Rasheed et al., 1984). Direct contact with infected congeners is also considered an important 
factor of transmission of the disease (Mian et al., 2009), but this has not been assessed as it 
is not possible to exclude the possibility of transmission through the water in experimental 
challenges. 
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In conclusion, the existing evidence suggests that the disease is transmitted horizontally 
between congeners but much more work is required to elucidate the route of transmission 
and to accurately identify the natural portal(s) of entry.  
1.4.2 Pathophysiology 
Streptococcus agalactiae disease has been extensively described in both natural and 
experimental infections of fish. The intensity and progression of the disease is somewhat 
variable and possibly depends on the virulence of the strain. For example, Mian et al. (2009) 
infected tilapia (40g) intra-peritoneally with non-haemolytic isolates recovered from natural 
infections in fish farms in Brazil and observed mortalities up to 100% with only 10 cfu per 
fish. In contrast, β-haemolytic isolates recovered from natural infections in wild mullet 
appeared to be less virulent, with a determined median lethal dose (LD50) of 1.9 x 10
3.3 
cfu 
per fish after intra-peritoneal infection of 30g tilapia (Evans et al., 2002). Other factors 
influencing infection outcome may be the specific host-susceptibility and environmental 
factors involving water quality. For example, different tilapia species demonstrate different 
levels of resistance to S. agalactiae (Huang et al., 2013) and low dissolved oxygen levels 
have been associated with higher mortalities in S. agalactiae infected tilapia (Evans et al., 
2003).  
Most experimental and natural infections share a number of common features which are 
similar to aquatic infections caused by S. agalactiae or S. iniae (Agnew et al., 2007). In its 
per-acute form, the disease is characterized by rapid and sudden death with no expression of 
clinical changes (Eldar et al., 1995). In the sub-acute or chronic forms, the clinical or 
external signs classically reported refer to behavioral manifestations and eye lesions. All 
studies reported an abnormal swimming behavior of infected tilapia such as spiraling, 
spinning, whirling at the surface, head up or tail down swimming, upside down swimming, 
and serpentine or exaggerated movements, whereas eye lesions corresponded to unilateral or 
bilateral exophthalmia, corneal opacity and periorbital or intra-ocular hemorrhages (Evans 
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et al., 2002; Suanyuk et al., 2005; Hernández et al., 2009; Inocente Filho et al., 2009; Zamri-
Saad et al., 2010). Other clinical signs may comprise anorexia, lethargy, C-shaped curvature 
of the spine or other skeletal deformities, hemorrhages on the mouth, fins or vent, darkening 
of the skin and abdominal distension (Evans et al., 2002; Pasnik et al., 2005; Hernández et 
al., 2009; Zamri-Saad et al., 2010). 
Internally, a consistent finding is the presence of intracranial oedema accompanied with 
brain softening or haemorrhages (Zamri-Saad et al., 2010). In addition to the eye lesions, 
gross pathological changes may consist of hepatomegaly, pale-colored liver, splenomegaly, 
and congestion of the kidney (Suanyuk et al., 2008; Inocente Filho et al., 2009; Zamri-Saad 
et al., 2010). The presence of white fibrinous exudate covering the heart or epicardial 
opacity has also been noticed in a few studies (Hernández et al., 2009; Inocente Filho et al., 
2009), as well as visceral adherence and ascites (Eldar et al., 1995). 
The main histopathological findings are located in the brain and in the eyes, but since S. 
agalactiae causes systemic disease, other organs may be affected including the kidney, 
liver, spleen and heart. It consists generally of focal to multifocal granulomatous 
inflammation and eventual granuloma formation, accompanied by multifocal necrotic 
inflammatory lesions (Hernández et al., 2009). Degenerative changes of endothelial cells, 
marked congestion and formation of thrombi associated with tissue infarction have also 
been reported in numerous organs (Zamri-Saad et al., 2010). The pathological and 
histopathological findings in the brain and in the eyes correlate with the clinical signs 
observed: the resulting meningo-encephalitis explains the behavioural manifestations, 
whereas the infiltration of inflammatory cells and exudates in the periorbital tissues and in 
the cornea explain the exophthalmia and corneal opacity. 
The pathogenesis of S. agalactiae in fish is not understood fully yet. No study has focused 
on elucidating the progression of the bacterium and associated lesions during the time-
course of an infection. To-date, all studies of experimentally or naturally-infected tilapia 
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have only evaluated the lesions or the presence of bacteria as observed at a specific 
sampling point or in moribund fish. It is believed that the bacterium primarily causes a 
septicaemic state, and that the presence of bacteria or toxins within the blood vessels causes 
degenerative changes of endothelial cells, thrombi formation and associated tissue 
infarction, which promote rapid bacterial dissemination and subsequent colonization of 
numerous internal organs (Zamri-Saad et al., 2010). The primary target organ for S. 
agalactiae have been found to be the brain, followed the eye and the heart (Hernández et al., 
2009). The identification of numerous putatively viable bacteria within macrophages has led 
researchers to hypothesize that S. agalactiae may use macrophages as a vehicle to cross the 
blood brain barrier (Hernández et al., 2009). This phenomenon is well-accepted for S. iniae, 
which has been shown to withstand the bactericidal activity of macrophages and to trigger 
their apoptosis (Zlotkin et al., 2003). However, the ability of S. agalactiae to evade the 
immune system of fish has not been experimentally evaluated thus far. 
1.4.3 Detection and identification 
Detection methods are generally based upon culture of the bacterium, whereas presumptive 
identification is traditionally performed using routine phenotypic tests, which may include 
biochemical tests (Evans et al., 2002). However, the phenotypic profiles of S. agalactiae 
strains are quite heterogeneous and may lead to misidentifications. In humans, pathogenic S. 
agalactiae are usually β-haemolytic, and their growth, phenotypic characteristics and 
metabolic capabilities have been well-characterized (Holt et al., 1994). Assuming the same 
to be true of S. agalactiae from other species has led to misidentification of isolates from 
fish which differ from “classic” S. agalactiae by an absence of growth at 37°C, slow growth 
on Brain Heart Infusion agar plates at 30°C (1mm colonies after 48h incubation), restricted 
metabolic capabilities (as assessed by biochemical tests), and an absence of β-haemolysis 
(Eldar et al., 1994). However, phenotypic tests based on Lancefield sero-grouping may also 
be performed, which allows accurate identification of the bacterium as belonging to 
Lancefield group B.  
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In addition to culture and phenotypic tests, molecular methods for the detection and 
definitive identification of S. agalactiae have been described and may be performed using 
DNA extracted directly from tissues of infected animals or bacteria propagated in the 
laboratory. Researchers have designed species-specific oligonucleotide primers to amplify 
by Polymerase Chain Reaction (PCR) the intergenic spacer region between the 16S and 23S 
ribosomal gene (Berridge et al., 2001; Phuektes et al., 2001), the 16S ribosomal gene 
(Abdulmawjood and  Lämmler, 1999), the 23S ribosomal gene (Kawata et al., 2004), and 
the CAMP factor encoding gene cfb (Kong et al., 2002). Most of these primers have been 
designed for human or bovine S. agalactiae isolates and successfully used for identification 
of piscine S. agalactiae isolates from laboratory cultures or tissues (Suanyuk et al., 2008; 
Evans et al., 2008; Duremdez et al., 2004; Jiménez et al., 2011). In addition, an alternative 
more sensitive and rapid approach for nucleotide amplification, called Loop-Mediated 
Isothermal amplification (LAMP), has recently been developed for detection and 
identification of S. agalactiae from fish, using primers targeting the fbsB gene (Wang et al., 
2012).  
In the field, the presence of typical clinical signs and demonstration of Gram-positive cocci 
from internal organs constitutes a presumptive diagnostic of streptococcosis (Amal. and 
Zamri-Saad, 2011). Recovery and culture of the organism, followed by phenotypic and/or 
genotypic tests may then be used to consolidate or confirm the diagnosis. However, these 
techniques are time-consuming and may delay the initiation of an appropriate treatment. For 
a more rapid identification, DNA extraction from tissues followed by amplification of target 
bacterial sequences may be performed, but this would still require laboratory work. 
Interestingly, an optical immunoassay for detection of the Lancefield group B antigen was 
recently shown to be an interesting tool for the rapid in-field identification of S. agalactiae 
using nare and brain swabs (Evans et al., 2010). 
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1.4.4 Prevention and therapy 
The strategy commonly adopted to control bacterial disease outbreaks in aquaculture 
consists of the use of antibiotic-medicated food. Antibiotic usage must be approved for a 
specific purpose depending on each country’s legislation. Antibiotics like florfenicol are 
commercially available for the control of fish pathogens, including S. agalactiae, after its 
incorporation into feed pellets (Aquaflor
®
, MERK Animal Health). However, although the 
control of in-farm or experimental S. iniae infections by the use of oral antibiotics is well-
documented in the literature (Stoffregen et al., 1996; Darwish et al., 2005), no such 
information is available for S. agalactiae. It is well known that diseased fish stop feeding, 
and any in-feed treatment therefore requires the identification of the outbreak at an early 
stage. Moreover, as for any antibiotherapy in farmed animals, the choice of the antibiotic 
should be based on or refined following the isolation of the pathogen and antibiogram 
testing, thus providing a targeted therapeutic treatment to assure efficacy and avoid the 
development of antibiotic resistance. Following treatment, a withdrawal period should be 
respected to avoid antibiotic residues in fish intended for human consumption. Because of 
the possible development of resistance to antibiotics, the limitations of antibiotic-medicated 
food, and the absence of antibiotics registered for use in aquaculture in some countries like 
Australia (Agnew and Barnes, 2007), efforts to control the disease have focused on the 
development of a commercial vaccine. 
Despite the industry-preference for a vaccine, there are however few published studies on 
vaccination trials against S. agalactiae infections in tilapia. Eldar et al. (1995) and Evans 
and colleagues (Evans et al., 2004; Pasnik et al., 2005) developed injectable S. agalactiae 
vaccines, and presented those as highly efficacious against both homologous and 
heterologous strains. The vaccines developed by Eldar et al (1995) were composed of 
formalin-killed bacteria or protein extracts, using as master-seed a non-haemolytic S. 
agalactiae isolate. Vaccinated fish were challenged with the vaccine master-seed isolate and 
other non-haemolytic isolates originating from distinct outbreaks. Vaccination of 165±15g 
General introduction 
1-12 
tilapia provided a long lasting protection with a relative percent of survival (RPS) close to 
100%; however, no indication was provided as to whether the challenge isolates were 
genetically distinct. Furthermore, protection against β-haemolytic S. agalactiae was not 
evaluated. Evans and colleagues (Evans et al., 2004; Pasnik et al., 2005) developed a 
vaccine composed of concentrated extracellular products and formalin-killed whole-cells, 
using a β-haemolytic strain originating from the 2001 Kuwait outbreak. Vaccination of 30g 
tilapia provided a long-lasting protection with a RPS of 80%; however, the challenge 
isolates all appeared to originate from the 2001 Kuwait outbreak after retrieval of the 
bacterial identification name from another publication (Garcia et al., 2008). Thus, it is 
unknown whether the vaccine provides cross-protection against epidemiologically unrelated 
β-haemolytic strains or against non-haemolytic strains. In an elegant study by Cheng et al. 
(2012), vaccine candidates were screened using both single and genetically-distinct strains 
chosen after PFGE typing. Formalin-killed vaccines were developed, and vaccinated 51±8g 
tilapia were experimentally-infected using single strains or a mixture of distinct strains. 
Their results demonstrated that an efficient vaccine could not be obtained using a single 
strain as master-seed. Therefore, it is likely that, as described for S. agalactiae in humans 
(Maione et al., 2005), a single commercially-available vaccine will only be possible through 
the appropriate combination of strains or antigens. 
Autogenous vaccines have been produced and used in response to S. agalactiae outbreaks in 
individual farms, but there are no scientific publications on the efficacy or cross-protection 
against other strains afforded by these vaccines. Moreover, an inactivated oil-adjuvanted 
injection vaccine called AquaVac
®
 STREP Sa (MSD Animal Health) is commercially-
available in some countries, including Brazil, Costa Rica and Indonesia, to aid in the 
protection against a specific S. agalactiae biotype. The biotype nomenclature is not 
commonly used in scientific publications; biotype 1 corresponds to “classical” β-
haemolotyic isolates, whereas biotype 2 corresponds to the non-haemolytic isolates 
previously called S. difficile. The AquaVac
®
 STREP Sa is described as safe and effective 
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against S. agalactiae biotype 2 in both laboratory and field trials; however, it does not 
provide any protection against S. agalactiae biotype 1. 
1.5 Typing and molecular epidemiology  
In addition to biotyping, S. agalactiae typing is traditionaly based on the identification of 
distinct capsular polysaccharides, which may be achieved using phenotypic or genotypic 
methods, although phenotypic capsule typing has lower typeability and discriminatory 
power than genotypic alternatives (Lancefield, 1934; Kong et al., 2008; Yao et al., 2013). A 
total of 10 capsular serotypes have been identified thus far (Ia, Ib, II to IX), with serotype III 
further subdivided into 4 sero-subtypes (Kong et al., 2002; Slotved et al., 2007). Only 3 
serotypes have been reported among piscine isolates (Ia, Ib and III), with serotypes Ia and 
III corresponding to β-haemolytic isolates predominantly found in Asian countries, and 
serotype Ib corresponding to non-haemolytic isolates predominantly found in American 
countries (Evans et al., 2008; Suanyuk et al., 2008).  
Numerous comparative typing methods have been developed in the past and are widely used 
in studies of S. agalactiae associated with humans or bovids. Techniques such as random 
amplification of polymorphic DNA (RAPD) or pulsed-field gel electrophoresis (PFGE) are 
useful tools for outbreak investigations. Two studies have successfully applied RAPD for 
investigation of piscine S. agalactiae outbreaks; Amal et al. (2013) used the RAPD to 
demonstrate that infection of tilapia in Malaysian farms originated from the acquisition of 
juveniles from a single contaminated hatchery. Jafar et al (2009) demonstrated using RAPD 
that S. agalactiae isolates from sewage samples had similar banding patterns to those 
isolated from infected fish during the Kuwait outbreak of 2001, suggesting a human source 
of contamination of the fish. Finally, PFGE has also been used with piscine S. agalactiae in 
order to identify different genotypes for rational selection of strain candidates to be used in 
challenge studies and vaccine development (Pereira et al., 2009; Chen et al., 2012). 
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For global population studies of S. agalactiae, approaches using markers that are part of the 
core genome are preferred since these markers are presumed to evolve slowly by the 
random accumulation of neutral variations, providing much more reliable data for both 
accurate typing and phylogeny estimation. For this, multi-locus sequence typing (MLST) is 
generally accepted as the standard method (Urwin and Maiden, 2003). Using MLST, 
isolates were found to cluster into well-defined clonal complexes (CCs), with some of those 
corresponding to sub-populations associated with specific host-species or clinical 
manifestations. Among the different clonal complexes identified, CC17 corresponds to a 
very homogenous group adapted to humans, which is over-represented among isolates 
responsible for invasive infections in neonates (Brochet et al., 2006). In comparison, CC67 
is considered to constitute a bovine-adapted subpopulation (Bisharat et al., 2004), but many 
other CCs are commonly found in cattle (Zadoks, 2011). Using MLST, Evans et al. (2008) 
showed that the genotype of β-haemolytic isolates responsible for the 2001 Kuwait outbreak 
has also been associated with human neonatal infections, further supporting that humans 
may have been the source of the Kuwait epizootic. In addition, Evans et al. (2008) as well as 
Brochet et al (2006) identified a number of new STs among several fish species, particularly 
in tilapia. 
To enhance the discriminatory power of S. agalactiae typing methods, a typing scheme 
based on the accessory genome, also called 3-set genotyping, has been developed. It 
consists of the identification of the molecular serotype, plus the determination of the 
presence or absence of 7 surface protein encoding genes and 7 mobile genetic elements 
(Kong et al., 2003). This typing scheme was further extended into a 4-set genotyping system 
through the additional detection of 7 antibiotic resistance genes (Suanyuk et al., 2008). The 
advantage of this technique is that it is portable and allows for further differentiation of 
isolates following MLST (Sun et al., 2005). This genotyping method has been successfully 
applied to isolates recovered from affected tilapia in Thailand, leading to the identification 
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of a genotype previously reported among invasive human S. agalactiae (Suanyuk et al., 
2008). 
1.6 Project aims and hypotheses 
This study, jointly funded by the University of Stirling and the Moredun Research Institute, 
aimed to enhance our understanding of the molecular epidemiology, host-adaptation and 
virulence of S. agalactiae in tilapia. Hypotheses addressed throughout this work are 
presented below, with the aim of addressing each hypothesis within 1 year of the PhD. 
The first hypothesis is that S. agalactiae infections in fish may be caused by a subset of 
strains that are found in humans, whereas other strains may be unique to fish. This 
hypothesis is based on 2 previous studies using either MLST (Evans et al. 2008) or 3-set 
genotyping (Suanyuk et al., 2008) on piscine S. agalactiae isolates. In this thesis, a global 
collection of S. agalactiae from multiple aquatic host species will be collected and subjected 
to a combination of typing methods (Chapter 2), including the joint use of the 2 portable 
genotyping methods previously mentioned. In order to answer our hypothesis, the 
prevalence of specific genotypes obtained will be compared to previous typing reports of 
strains isolated from humans, bovines and fish.  
The second hypothesis is that the epidemiological distribution observed (i.e. only a subset of 
the human S. agalactiae population is found in fish) is due to differences in virulence as 
opposed to differences in exposure.  To assess this hypothesis, an injectable model of tilapia 
infection will be used in order to compare the virulence of two S. agalactiae strains, one 
belonging to a subpopulation never encountered in fish, and another one belonging to a 
subpopulation uniquely recovered from fish (Chapter 3). Differences will be measured 
through comparison of mortalities, bacterial load within organs and histopathology. 
Comparisons of mortalities with previous publications using similar in-vivo models will 
further allow the grading of virulence of specific strains within fish. 
The final hypothesis is that host-adaptation and virulence of S. agalactiae strains in fish is 
driven at the genomic level by regions of gene loss, gene gain, or diversification, as 
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previously reported among S. agalactiae strains infecting bovines (Richards et al., 2011). 
For this, a piscine S. agalactiae strain will be selected based on previous in vitro (Chapter 
2) and in vivo (Chapter 3) studies and its genome will be fully sequenced. Comparative 
genomic analyses between S. agalactiae genomes from different host species (human, 
bovine and fish) will be performed in order to identify and describe genomic differences 
(Chapter 4). Furthermore, the conservation or diversification of genes encoding well 
recognised virulence determinants in S. agalactiae of human origin will be assessed within 
the S. agalactiae genome of fish origin (Chapter 5). 
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2.1 ABSTRACT  
Streptococcus agalactiae is a well-recognized pathogen affecting both terrestrial and aquatic 
species. Whilst human and bovine isolates have been widely studied, the population 
structure of S. agalactiae infecting aquatic species remains to be investigated further. A 
collection of 33 piscine, amphibian and sea mammal isolates originating from several 
countries and continents was assembled, with the aim of exploring the population structure 
and potential host-specificity of aquatic S. agalactiae. Isolates were characterised using 
pulsed-field gel electrophoresis (PFGE), multi-locus sequence typing (MLST), and a 
standardised 3-set genotyping system comprising molecular serotypes, surface protein gene 
profiles and mobile genetic element profiles. Two major subpopulations were identified. 
The first subpopulation consisted of non-haemolytic isolates that belonged to sequence type 
(ST) 260 or 261, which are STs that have been reported only from teleosts. These isolates 
exhibited a low level of genetic diversity by PFGE and clustered with other STs that have 
been reported only in fish. Another common feature was the absence of surface protein 
genes or mobile genetic elements usually found in human or bovine isolates. The second 
subpopulation consisted of β-haemolytic isolates recovered from fish, frogs and sea 
mammals, and that exhibited medium to high genetic diversity by PFGE. STs identified 
among these isolates have previously been identified in strains associated with 
asymptomatic carriage and invasive disease in humans. Moreover, ST283 serotype III-4 and 
its novel single locus variant ST491 detected in fish from Southeast Asia shared a 3-set 
genotype identical to that of an emerging ST283 clone associated with invasive disease of 
adult humans in Asia. These observations suggest that some strains of aquatic S. agalactiae 
may present a zoonotic or anthroponotic hazard. STs found among the seal isolates (ST23) 
have also been reported from humans and numerous other host species, but never from 
teleosts. This work provides a rational framework for exploration of pathogenesis and host-
associated genome content of S. agalactiae strains. 
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2.2 INTRODUCTION 
Streptococcus agalactiae has been documented as a cause of epizootics in fish from as early 
as 1966 (Robinson and Meyer, 1966). The bacterium, identified as an aetiological agent of 
septicaemia and meningo-encephalitis in freshwater and saltwater fish species, is now 
considered a major threat to the aquaculture industry, particularly for tilapia (Oreochromis 
sp.) (Hernández et al., 2009; Mian et al., 2009; Suanyuk et al., 2008; Ye et al., 2011). 
Streptococcus agalactiae has also been reported from other aquatic or semi-aquatic species, 
including those that are poikilothermic (ectothermic), such as frogs and crocodiles (Bishop 
et al., 2007; Kawamura et al., 2005), and those that are homeothermic, such as dolphins 
(Evans et al., 2006; Zappulli et al., 2005). 
Cattle and humans are the main known reservoirs for S. agalactiae. In humans, the 
bacterium (commonly referred to as Group B Streptococcus or GBS) is a member of the 
commensal microflora of the intestinal and genito-urinary tracts, but it is also considered a 
major cause of neonatal invasive disease and an emerging pathogen in adults (Ip et al., 
2006; van der Mee-Marquet et al., 2008). In cattle, S. agalactiae is a well-recognized 
causative agent of mastitis (Duarte et al., 2005; Sukhnanand et al., 2005). Numerous typing 
methods including randomly amplified polymorphic DNA (RAPD) typing, pulsed-field gel 
electrophoresis (PFGE) and ribotyping have been used for typing of bovine and human S. 
agalactiae (Duarte et al., 2005; Martinez et al., 2000; Sukhnanand et al., 2005). These 
comparative typing methods, although very useful for outbreak investigations, are not 
always sufficiently standardized and reproducible for comparison of results between distinct 
studies. Surveillance systems monitoring clonal spread and prevalence in populations over 
extended areas or periods of time require the use of definitive or library typing schemes with 
exchangeable databases (Van Belkum et al., 2007). Validated or promising library typing 
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methods for S. agalactiae include multi-locus sequence typing (MLST) and profiling of 
other genetic markers such as those implemented in the so-called 3-set genotyping sheme 
and comprising molecular serotypes (MS), surface protein genes (SPGs) and mobile genetic 
elements (MGEs) (Gilbert et al., 2006; Jones et al., 2003; Sun et al., 2005).  
MLST is expected to be replaced by whole genome sequencing in the future, but it remains 
an important tool for molecular epidemiology because the MLST databases for individual 
pathogen species currently cover far more isolates than have been characterized based on 
whole genome sequencing (Spratt, 2012). Similarly, isolates that have been characterized by 
3-set genotyping still outnumber isolates that have been characterized by whole genome 
sequencing, thus providing a less detailed but broader frame of reference than offered by 
whole genome sequences. MLST is used to define sequence types (STs) and clonal 
complexes (CCs). Most human isolates can be assigned to a limited number of clonal 
complexes, referred to as CC1, CC17, CC19 and CC23 (Jones et al., 2003; Sørensen et al., 
2010). In contrast, most bovine isolates belong to another distinct CC, named CC67 
(Bisharat et al., 2004). Members of predominantly host-associated CCs are occasionally 
identified in other host-species; for example, members of the human-associated CC23 have 
been reported in crocodiles and cattle (Bisharat et al., 2004; Bishop et al., 2007). The three-
set genotyping allows for further differentiation of isolates belonging to the same ST (Sun et 
al., 2005). For example, ST283 isolates with molecular serotype III-4, C-α protein and C-α 
protein repeating units and the MGEs IS1381, ISSag1, and ISSag2 are associated with the 
emergence of GBS meningitis in adults in Southeast Asia (Ip et al., 2006). 
A limited number of DNA-based typing methods have been used to analyse the genomic 
diversity of S. agalactiae isolates from fish (Olivares-Fuster et al., 2008; Pereira et al., 2010; 
Suanyuk et al., 2008). Evans et al. (2008) demonstrated that S. agalactiae epizootics in fish 
can be caused by at least 2 distinct subpopulations, of which only one is also associated with 
infections in humans. Control measures for aquatic species may therefore need to target 
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epidemiologically or genetically distinct subpopulations, which need to be defined further. 
To that aim, we characterized a collection of S. agalactiae isolated from aquatic host 
species, with the emphasis on tilapia, using PFGE, MLST and the 3-set genotyping system. 
Results were compared with those from aquatic and terrestrial species, in order to evaluate 
whether specific genotypes are associated exclusively with piscine or aquatic hosts or are 
shared between piscine, aquatic and terrestrial species. 
2.3 MATERIALS & METHODS 
2.3.1 Isolate collection and identification 
A collection of 33 aquatic S. agalactiae isolates was assembled, including isolates from 
poikilothermic and homeothermic host species originating from multiple countries and 
continents (Table 2.2; table in appendix). Of 33 isolates, 13 represented 3 separate disease 
outbreaks (5, 4 and 4 isolates from outbreaks in Kuwait, Honduras and Colombia, 
respectively) with the remaining 20 isolates each representing a single, unrelated outbreak 
or death. Most fish isolates (n=18) originated from infections in farmed tilapia 
(Oreochromis sp.) from Honduras, Colombia, Costa Rica, Belgium, Thailand and Vietnam, 
whereas other fish isolates originated from infections in wild Klunzinger’s mullets (n=5; 
Liza klunzinger) from Kuwait and ornamental fish (n=3; rosy barb, Puntius conchonius; 
golden ram, Mikrogeophagus ramirezi; and an undetermined fish species) from Australia. 
Sea mammal isolates (n=6) were recovered at post-mortem from lung swabs of 1 bottlenose 
dolphin (Tursiops truncatus) and 5 grey seals (Halichoerus grypus) that had stranded at 
various sites around the coast of Scotland. Finally, one amphibian isolate originating from 
an infected farmed frog (Rana rugurosa) in Thailand was made available for molecular 
characterisation. 
Bacterial isolates were streaked onto 5% sheep blood agar plates (SBA; E&O Laboratories, 
Bonnybridge, United Kingdom) and grown aerobically at 28°C for 48h in order to assess 
purity and haemolysis properties. Isolates were Gram-stained and confirmed to belong to 
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Lancefield Group B by a group B-specific latex agglutination test (Slidex Strepto Plus
 
B; 
bioMérieux, Marcy L'Étoile, France). Single colonies were then selected, used to inoculate 
Brain Heart Infusion (BHI) broth (Oxoid, Basingstoke, United Kingdom) and incubated 
with gentle shaking at 28°C for 12h (ß-haemolytic bacteria, fast growing) or 48h (non-
haemolytic bacteria, slow growing). Chromosomal DNA was prepared using lysozyme and 
proteinase K (Furrer et al., 1991) and used to confirm species identity of S. agalactiae by 
polymerase chain reaction (PCR) using forward primer STRA-AgI (5’-
AAGGAAACCTGCCATTTG-‘3) and reverse primer STRA-AgII (5’-
TTAACCTAGTTTCTTTAAAACTAGAA-3’), which target the 16S to 23S rRNA 
intergenic spacer region (Phuektes et al., 2001). PCR reactions were performed in a final 
25μl volume containing 12.5μl of GoTaq Green Master Mix (Promega, Madison, USA), 
0.25 μM of each primer and 2 μl of DNA template. The thermal cycling was conducted as 
follows: denaturation of DNA at 94°C for 5 min followed by 35 cycles of 94°C for 1 min, 
58°C for 45 sec and 72°C for 30 sec, with a final step at 72°C for 7 min. The PCR products 
for all reactions were visualized following electrophoresis through a 1.5% (w/v) agarose 
gels containing Gel Red (Cambridge Bioscience, Cambridge, UK). 
2.3.2 Comparative typing: PFGE 
Bacterial cells were pelleted by centrifugation of 1ml of incubated BHI, re-suspended in 
0.5ml of TE buffer (10mM Tris-HCl, 1mM EDTA), warmed to 56°C and mixed with 0.5ml 
of 2% (w/v) low-melting point agarose (Incert agarose; Lonza, Berkshire, United Kingdom) 
in TE buffer. The mixture was then pipetted into plug moulds. Each solidified plug was 
placed into 2ml of TE buffer containing 4mg of lysosyme (Sigma Aldrich, Dorset, United 
Kingdom) (2mg/ml) and incubated overnight at 37°C with gentle shaking. The buffer was 
then replaced with 2ml of ES buffer (0.5M EDTA–1% (w/v) N-lauroyl sarcosine [pH 8.0 to 
9.3]) supplemented with 4mg of proteinase K (Promega, Southampton, United Kingdom) 
(2mg/ml) and incubated at 56°C for a minimum of 48h. Plugs were washed 6 times for 1h in 
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TE buffer at room temperature and with gentle shaking. A 1mm thick slice (4x4mm
2
) from 
each plug was exposed to digestion with restriction endonuclease SmaI (20U in 100μl of 
fresh reaction buffer; New England Biolabs, Hitchin, United Kingdom) at 25°C overnight. 
PFGE was performed with a CHEF-mapper system (BioRad Laboratories, Hertfordshire, 
United Kingdom) in 0.5x TBE using 1% (w/v) agarose gel (Pulsed Field Certified Agarose, 
BioRad Laboratories, Hertfordshire, United Kingdom), a run time of 24h and switch time of 
3-55 s (linear ramp) at 14°C. Patterns were observed by UV transillumination after SYBR 
Gold staining (Invitrogen, Paisley, United Kingdom). Computer-assisted data analysis and 
dendogram construction were
 
performed with Phoretix 1D Pro software (TotalLab Ltd, 
Newcastle upon Tyne, United Kingdom). Similarities between PFGE patterns were also 
assessed visually using standard criteria (Van Belkum et al., 2007). 
2.3.3 Library typing 
2.3.3.1 Multilocus sequence typing 
MLST consisted of the amplification by PCR and sequencing
 
of seven housekeeping genes, 
namely adhP, atr, glcK,
 
glnA, pheS, sdhA, and tkt, and using primers designed by Jones et 
al. (2003). PCRs were conducted as previously described (section 2.3.1), with exception of 
annealing temperature adjusted for each primer set. The PCR products were purified with 
the QIAquick PCR purification kit (Qiagen, Crowley, UK) and then sent to Eurofins MWG 
operon (Ebersberg, Germany) for sequencing using the cycle sequencing technology, which 
is a modification of the traditional Sanger sequencing method. Consensus
 
sequences were 
trimmed in SeqMan (DNAStar, London, United Kingdom), and
 
the S. agalactiae database 
(shttp://pubmlst.org/sa-galactiae/, Jolley et al., 2004) was used
 
for allele and sequence type 
(ST) assignments. Sequences of novel alleles were submitted to the database curator for 
allocation of new allele numbers and STs; these are now available in the database. The 
unweighted pair group method in Phylodendron was used to visualize the relationship 
between allelic profiles (http://pubmlst.org/sagalactiae/). Analysis using the most up-to-date 
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complete allelic profile list (last accessed 20 September 2011) was carried out using 
eBURST version 3 (http://eburst.mlst.net/) in order to define relationships between STs. 
Finally, single locus variants (SLVs), double locus variants (DLVs) and triple locus variants 
(TLVs) were explored via ST query for STs that did not form part of a clonal complex in the 
eBURST analysis (http://pubmlst.org/sagalactiae/). 
2.3.3.2 Three-set genotyping system 
A 3-set genotyping system, comprising MS, SPG profiles and MGE profiles, was used. 
Serotyping was performed using multiplex-PCR assays (Poyart et al., 2007), with 
modifications as described by Evans et al. (2008). Non-typeable (NT) isolates were further 
investigated using other primer sets (Kong et al., 2005) and the serosubtyping of MS III 
isolates was performed as previously described (Kong et al., 2002). Surface-protein genes 
were determined by PCR and sequencing of PCR products, using primers targeting the bca, 
bac, alp1, alp2, alp3 and alp4 genes (Zhao et al., 2006). Finally, the prevalence of 7 MGEs, 
corresponding to 1 group II intron (GBSi1) and 6 insertion sequences (IS1381, IS861, 
IS1548, ISSa4, ISSag1 and ISSag2) was evaluated by PCR and amplicon identity was 
confirmed by sequencing of PCR products, using published primers (Kong et al., 2003; 
Suanyuk et al., 2008). PCRs and sequencing of products were conducted as previously 
described (sections 2.3.2 and 2.3.3.1). Primers used are listed in Table 2.1. 
2.4 RESULTS 
2.4.1 Isolate collection and identification 
All isolates were Lancefield Group B, Gram-positive cocci appearing in pairs and chains. 
They were either β-haemolytic or non-haemolytic on SBA (Table 2.2). All were confirmed 
as S. agalactiae by species-specific PCR. 
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2.4.2 PFGE analysis  
All isolates were typeable by SmaI macrorestriction and 13 pulsotypes were produced 
(Table 2.2). Pulsotypes were identical when multiple isolates from a single outbreak were 
analysed. In some cases pulsotypes were also identical between isolates from distinct 
outbreaks, countries or host species (e.g. tilapia isolates from Honduras, Colombia and 
Costa Rica; bullfrog and tilapia isolates from Thailand; Table 2.2). Despite efforts to 
identify potential epidemiological relationships between farms sharing the same pulsotype, 
e.g. through shared broodstock or feed companies, no such links could be identified and 
each outbreak is considered to be epidemiologically independent. 
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Table 2.1 List of primers used for the 3-set genotyping of Streptococcus agalactiae. 
 
∆
Numbers represent the base positions at which primer sequences start and finish 
(numbering refers to the GenBank accession numbers for the corresponding genes). 
Target Primer name Primer sequence∆ Genbank  no. Tm (˚C) Reference
Molecular serotypes (n=9) - First set
Ia (cpsH ) cps1aHS 7943 GGTCAGACTGGATTAATGGTATGC 7966 AB028896 61.00 Poyart et al., 2007
cps1aHA 8463 GTAGAAATAGCCTATATACGTTGAATGC 8436 AB028896 60.70 Poyart et al., 2007
Ib (cpsJ-K ) cps1bJS 5627 TAAACGAGAATGGAATATCACAAACC 5652 AB050723 58.50 Poyart et al., 2007
cpsIbKA 6396 GAATTAACTTCAATCCCTAAACAATATCG 6368 AB050723 59.60 Poyart et al., 2007
II (cpsK ) cps2KS 7449 GCTTCAGTAAGTATTGTAAGACGATAG 7475 AY375362 60.40 Poyart et al., 2007
cps2KA 7845 TTCTCTAGGAAATCAAATAATTCTATAGGG 7816 AY375362 59.90 Poyart et al., 2007
III (cpsI-J ) cps1a/2/3IS 8273 TCCGTACTACAACAGACTCATCC 8295 AF163833 60.60 Poyart et al., 2007
cps1a/2/3JA 10098 AGTAACCGTCCATACATTCTATAAGC 10073 AF163833 60.10 Poyart et al., 2007
IV (cpsN ) cps4NS 8991 GGTGGTAATCCTAAGAGTGAACTGT 9015 AF355776 61.30 Poyart et al., 2007
cps4NA 9568 CCTCCCCAATTTCGTCCATAATGGT 9544 AF355776 63.00 Poyart et al., 2007
V (cpsO ) cps5OS 9852 GAGGCCAATCAGTTGCACGTAA 9873 AF349539 60.30 Poyart et al., 2007
cps5OA 10552 AACCTTCTCCTTCACACTAATCCT 10529 AF349539 59.30 Poyart et al., 2007
VI (cpsI ) cps6IS 8276 GGACTTGAGATGGCAGAAGGTGAA 8299 AF337958 62.70 Poyart et al., 2007
cps6IA 8762 CTGTCGGACTATCCTGATGAATCTC 8738 AF337958 63.00 Poyart et al., 2007
VII (cpsM ) cps7MS 5089 CCTGGAGAGAACAATGTCCAGAT 5111 AY376403 60.60 Poyart et al., 2007
cps7MA 5459 GCTGGTCGTGATTTCTACACA 5439 AY376403 57.90 Poyart et al., 2007
VIII (cpsJ ) cps8JS 7016 AGGTCAACCACTATATAGCGA 7035 AY375363 55.90 Poyart et al., 2007
cps8JA 7297 TCTTCAAATTCCGCTGACTT 7278 AY375363 53.20 Poyart et al., 2007
Molecular serotypes (n=9) - Second set
Ia (cpsH ) IacpsHS 8176 ATACAGTTGTCGTAAAGAAGAAAAC 8200 AB028896 58.42 Kong et al., 2005
IacpsHA 8536 TGTTTAGCTTTCCTACCAATATTAG 8512 AB028896 58.46 Kong et al., 2005
Ib (cpsH ) IbcpsHS 2986 TTTAGAAGTCCAGAATTTCATAGAGTC 3012 AB050723 60.82 Kong et al., 2005
IbcpsHA 3265 CAAAGAAAGCCATTGCTCTCTG 3244 AB050723 64.91 Kong et al., 2005
II (cpsK ) IIcpsKS 7269 CTCCAGATGGTCTTTGTGAC 7288 AY375362 59.68 Kong et al., 2005
IIcpsKA 7700 AAAATTGGTATATTTCCTCTTGAC 7677 AY375362 58.08 Kong et al., 2005
III (cpsH ) IIIcpsHS 7509 CCACATATGAGAATAAGACTTGC 7531 AF163833 59.15 Kong et al., 2005
IIIcpsHA 7874 CCTAGTGATAGTACTTTGGTTTCTG 7850 AF163833 58.86 Kong et al., 2005
IV (cpsH ) IVcpsHS 7634 ATAGCCTTTTGACAGGTAGGTT 7655 AF355776 59.56 Kong et al., 2005
IVcpsHA 7958 TGTAAATCATCTACACCCCC 7939 AF355776 58.67 Kong et al., 2005
V (cpsH ) VcpsHS 7616 GATGTTCTTTTAACAGGTAGATTACAC 7642 AF349539 59.04 Kong et al., 2005
VcpsHA 7945 CTTTTTTATAGGTTCGATACCATC 7922 AF349539 58.56 Kong et al., 2005
VI (cpsH ) VIcpsHS 7648 TGTTTTTCTTACAAAGTGGAGTC 7670 AF337958 58.83 Kong et al., 2005
VIcpsHA 7926 CCTGTTTTGTTTGATAGCTTCTC 7904 AF337958 60.66 Kong et al., 2005
VII (cpsM ) VIIcpsMS 5359 GTGCAATTAGAGGACAAAAATTTA 5382 AY376403 59.92 Kong et al., 2005
VIIcpsMA 5651 CATCGAATCAGGAAAAATAGAT 5630 AY376403 58.56 Kong et al., 2005
VIII (cpsJ ) VIIIcpsJS 5687 ATCTCATGGCATGTCTGG 5704 AY375363 59.56 Kong et al., 2005
VIIIcpsJA 5998 CATTCGAATAAACAATCTTATTGC 5975 AY375363 60.23 Kong et al., 2005
Molecular sero-subtypes (n=1)  
cpsE-G cpsES3 6020 GTTAGATGTTCAATATATCAATGAATGGTCTATTTGGTCAG 6060  AF163833 66.40 Kong et al., 2002
cpsGA1 6809 GTGTGTGATAACAATCTCAGCTTC 6781  AF163833 59.30 Kong et al., 2002
Surface protein genes (n=7)
Protein Cα (bca ) bcaS 313 GCTTACATAGATTTATATGATGTAAAATTAGG 344 M97256 59.20 Zhao et al., 2006
bcaA 637 CAGTACGACTTTCTTCCGTC 618 M97256 57.30 Zhao et al., 2006
Cα-like protein 2 (alp2 ) alp23S 1254 CATGGAAGTGACAATTATGAAAG 1276 AF208158 55.30 Zhao et al., 2006
alp2A 1603 CCACTGTAACTTTTACAGGAACTTC 1579 AF208158 59.70 Zhao et al., 2006
Cα-like protein 3 (alp3 ) alp23S 1254 CATGGAAGTGACAATTATGAAAG 1276 AF208158 55.30 Zhao et al., 2006
alp3A 1847 CTTTTGAACCATCTGGGTAAG 1827 AF208158 55.90 Zhao et al., 2006
Protein R (rib ) ribS 219 AGATACTGTGTTTGCAGCTGAAGTAA 244 U58333 60.10 Zhao et al., 2006
ribA 577 CTATTTTATCTCTCAAAGCTGAAG 554 U58334 55.90 Zhao et al., 2006
Cα-like protein 4 (alp4 ) alp4S 158 TGTTAGCAGCTGAAGTAGTTGAAG 181 AJ488912 59.30 Zhao et al., 2006
alp4A 350 GCATAAACTTTTGAACCTTGTG 329 AJ488912 54.70 Zhao et al., 2006
Protein epsilon (alp1 ) epsS 304 CTGTGTTTGCAGCTGAGGTG 323 U33554 58.80 Zhao et al., 2006
epsA 719 CAGTACATCTTTTCGACTATCATCG 695 U33554 59.70 Zhao et al., 2006
Protein Cβ (bac ) bacS 1337 AAGGCTATGAGTGAGAGCTTGGAG 1360 X59771 62.70 Zhao et al., 2006
bacA 1960 CTGCTCTGGTGTTTTAGGAACTTG 1937 X59772 61.00 Zhao et al., 2006
Mobile genetic elements (n=7)
IS1548 IS1548S 143 CTATTGATGATTGCGCAGTTGAATTGGATAGTCGTC 178 Y14270 68.30 Kong et al., 2003
IS1548A3 930 CGTGTTACGAGTCATCCCAATACCACGTAACTTATGCC 893 Y14270 71.60 Kong et al., 2003
IS1381 IS1381S1 272/818 CTTATGAACAAATTGCGGCTGATTTTGGCATTCACG 307/853 AF064785/AF367974 68.30 Kong et al., 2003
IS1381A 881/1424 CTAAAATCCTAGTTCACGGTTGATCATTCCAGC 849/1392 AF064785/AF367974 67.00 Kong et al., 2003
ISSa4 ISSa4S 326 CGTATCTGTCACTTATTTCCCTGCGGGTGTCTCC 359 AF165983 71.90 Kong et al., 2003
ISSa4A2 780 CGTAAAGGAGTCCAAAGATGATAGCCTTTTTGAACC 745 AF165983 68.30 Kong et al., 2003
IS861 IS861S 445 GAGAAAACAAGAGGGAGACCGAGTAAAATGGGACG 479 M22449 70.60 Kong et al., 2003
IS861A2 1020 CAAACTCCGTCACATCGGTATAGCACTTCTCATAGG 985 M22449 70.60 Kong et al., 2003
GBSi1 GBSi1S1 721 CATCTCGGAACAATATGCTCGAAGCTTACAAGCAAGTG 758 AJ292930 70.50 Kong et al., 2003
GBSi1A2 1161 CCAGGGACATCAATCTGTCTTGCGGAACAGTATCG 1127 AJ292930 71.80 Kong et al., 2003
ISSag1 ISSag1S 449 GGCGACTGGTCGTTTAATCTCTGTTGAATTCTAGTTTC 486 AF329276 69.50 Suanyuk et al., 2008
SSag1A 792 CTATCTCAGATTGTCAGGACACGGATTTTGTACTAGAC 755 AF329276 69.50 Suanyuk et al., 2008
ISSag2 ISSag2S 1910 CAAATTCAATTTTGAAAGCACGATACGTACTTTCAGC 1946 AF329276 66.10 Suanyuk et al., 2008
ISSag2A 2289 CCCTATTCCCAACCACTTAGACAGGCAATTTAAGC 2255 AF329276 69.50 Suanyuk et al., 2008
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Table 2.2 Overview of S. agalactiae origin, isolate number (n) and results of phenotypic and genotypic characterization 
 
Results include analysis of haemolysis (Haem), multilocus sequence typing (MLST), pulsed-field gel electrophoresis (PFGE), molecular serotyping (MS), and profiling of 
surface protein genes and mobile genetic elements. Trees for MLST and PFGE results were constructed using unweighted pair group method analysis (UPGMA). Boxes 
enclose major clonal complexes (CCs) or sequence types (STs). STs shown in bold were first identified in the current study. ND: not determined. 
 
MLST UPGMA               
tree
PFGE patterns
b
ac
  
  
b
ca
 
al
p
1
al
p
2
al
p
3
al
p
4
ri
b
IS
1
3
8
1
IS
8
6
1
IS
1
5
4
8
IS
S
a4
IS
S
ag
1
IS
S
ag
2
G
B
S
i1
Dolphin (1) UK 1995 β 399 Ib + + + - - + - + + - - + + +
Bullfrog (1) Thailand 2009 β 7 Ia + + - - - - - + + - - - + +
Tilapia (1) Thailand 2009 β 7 Ia + + - - - - - + + - - - + +
Mullet (5) Kuwait 2001 β 7 Ia + + - - - - - + + - - + + +
Tilapia (1) Thailand ND β 7 Ia + + - - - - - + + - - - + +
Tilapia (1) Thailand ND β 7 Ia + + - - - - - + + - - - + +
Tilapia (1) Thailand ND β 7 Ia + + - - - - - + + - - - + +
Tilapia (1) Thailand ND β 500 Ia + + - - - - - + + - - - + +
Tilapia (1) Thailand ND β 500 Ia + + - - - - - + + - - - + +
Tilapia (1) Thailand ND β 283 III-4 - + - - - - - + - - - + + -
Tilapia (1) Vietnam 2006 β 491 III-4 - + - - - - - + - - - + + -
Seal (1) UK 2003 β 23 Ia - - + - - - - + - - - + + -
Seal (1) UK 2010 β 23 Ia - - + - - - - + - - - + + -
Seal (1) UK 2003 β 23 Ia - - - - - - - + - - - + + -
Seal (1) UK 2002 β 23 Ia - - - - - - - + - - - + + -
Seal (1) UK 2002 β 23 Ia - - - - - - - + - - - + + -
Tilapia (4) Honduras 2008 - 260 Ib - - - - - - - - - - - - - -
T ilapia (4) Colombia 2008 - 260 Ib - - - - - - - - - - - - - -
T ilapia (1) Costa Rica 2008 - 260 Ib - - - - - - - - - - - - - -
Rosy barb (1) Australia 2004 - 261 Ib - - - - - - - - - - - - - -
Golden ram (1) Australia 1996 - 261 Ib - - - - - - - - - - - - - -
Unspecied fish (1) Australia 1997 - 261 Ib - - - - - - - - - - - - - -
T ilapia (1) Belgium 2007 - 261 Ib - - - - - - - - - - - - - -
Country Haem.Host (n) Year ST Mobile  genetic elementsMS Surface protein genesPFGE UPGMA tree
CC 7
CC 283
CC 23
DISTANCE:
0.00.1
0.00.2
Distance:
0.00.2
Distance:
CC 552
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2.4.3 MLST and eBURST analysis 
Among the 33 S. agalactiae isolates, 8 STs were observed (Table 2.2), including 2 new STs 
(ST491 and ST500) that differed from existing STs through the presence of a novel allele. 
The new STs were single locus variants of known STs and resulted from single nucleotide 
changes. 
STs were identical when multiple isolates from a single outbreak were analysed. In several 
cases, STs were also identical between isolates from epidemiologically unrelated animal 
deaths, outbreaks, countries or host species (e.g. ST261 was associated with three 
epidemiologically unrelated cases from Australia; ST260 was found in tilapia from 
Honduras, Colombia and Costa Rica; ST7 was found in bullfrog and tilapia from Thailand 
and mullet from Kuwait; Table 2.2).  
E-burst analysis (Figure 2.1) showed that piscine isolates from Asia and the Middle-East 
(ST7 and its SLV ST500; ST283 and its SLV ST491) belonged to 2 related subgroups, CC7 
and CC283. The amphibian isolate from Asia (ST7) and the bottlenose dolphin isolate from 
the UK (ST399) also belonged to CC7. All grey seal isolates from the UK belonged to 
ST23, which is not related to ST7 or ST283. Piscine isolates from Latin America (ST260) 
were part of the previously unreported CC552, which also includes ST257, ST259, ST552 
and ST553. Based on analysis of DLVs and TLVs, ST261 and its SLV, ST246, may also be 
related to CC552, whilst ST258 is a TLV of C552 (Figure 2.2). STs in this cluster (CC552, 
ST246 and ST261, ST258) have only been reported from fish (Brochet et al., 2006; Evans et 
al., 2008; Figueiredo et al., 2011; this study). None of the STs in this cluster share SLVs, 
DLVs or TLVs with isolates of human, bovine or other non-piscine origin. 
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Figure 2.1 Population snapshot of Streptococcus agalactiae. All sequence types (STs) from the public MLST database (http://pubmlst.org/sagalactiae/; last accessed 20 
September 2011; updated version available in Delannoy et al., 2013) are displayed as a single eBURST diagram. Burst groups and major clonal complexes (CCs) are 
identified. STs identified in the current study are shown (framed numbers). CC8 and related STs are enlarged for clarity (inset).  
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Figure 2.2 Relations between clonal complex 552 and other sequence types (STs) that have 
only been identified in fish. Continuous, dashed and dotted lines represent single, dual and triple 
locus variants, respectively, i.e. STs that differ at one, two or three of seven loci. STs in this cluster 
differ from all other STs in the database by more than 3 alleles.  
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2.4.4 Three-set genotyping system 
Using primers from Poyart et al. (2007), isolates were identified as serotype Ia, Ib or NT. 
Further investigation of NT isolates with additional primer sets (Kong et al., 2002 and 2005) 
showed that the NT isolates belonged to serotype III sero-subtype 4. Based on the 
combination of MS, SPGs and MGEs, seven 3-set genotypes were distinguished (Table 
2.2). Three set genotypes were identical when multiple isolates from a single outbreak were 
analysed. Piscine and amphibian isolates from Asia and the Middle-East and all mammalian 
isolates were positive for MGE IS1381 and ISSag2. IS861 was always found in combination 
with GBSiI and vice versa but rarely in combination with ISSag1, which was found in all 
mammalian isolates tested but only 7 of 27 non-mammalian isolates. When the Cβ protein 
gene (bac) was present, it was always found in association with the Cα protein gene (bca) 
and only in CC7 but bca was present in the absence of bac in CC283 (Table 2.2). Piscine 
isolates from Latin America (n=6), Australia (n=3) and Europe (n=1), all shared serotype Ib 
(Table 2.2) but none of the surface protein genes and mobile genetic elements investigated 
in this study was detected in any of these isolates.  
2.4.5 Comparison across typing methods 
All -haemolytic isolates belonged to CCs that are also found in humans and carried at least 
1 SPG or MGE (Tables 2.2 and 2.3). By contrast, all non-haemolytic isolates belonged to 
STs that are unique to fish and did not carry any of the SPGs and MGEs examined in this 
study (Tables 2.2 and 2.3). Each CC correlated with a PFGE cluster, although MLST could 
be more discriminatory than PFGE and vice versa. Concordance between PFGE and MLST 
was good. Within -haemolytic isolates, PFGE clusters matched CCs and within non-
haemolytic isolates, PFGE clusters matched STs. In some instances, PFGE was more 
discriminatory than MLST. For example, ST261 contained a PFGE type and subtype that 
differed from each other by 3 bands and ST23 comprised as many as 5 PFGE patterns. In 
other instances, MLST was more discriminatory than PFGE, e.g. in differentiation of 
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isolates in CC283. The number of PFGE types (Table 2.2) appeared to correlate with 
bacterial population size and host range of the corresponding ST or CC: the largest number 
of PFGE patterns were found in ST23 which is a very common ST and associated with a 
wide host range; an intermediate number of PFGE patterns were found in CC7, which 
encompasses less commonly found STs and is associated with a narrower range of host 
species; and the lowest number of PFGE patterns was found in ST260 and ST261, which 
have been reported in a limited number of isolates, all of which originate from teleosts 
(Table 2.3). Results from 3-set genotyping were also in agreement with origin, 
phenotyping, MLST and PFGE results. For example, the two closely related PFGE clusters 
within CC23 were associated with two closely related virulence gene profiles (Table 2.2). 
Within CC7, the dolphin isolate was the most divergent isolate based on PFGE typing, 
number of virulence genes and serotype. Within CC7, fish isolates from Kuwait had an 
extra MGE compared to the remainder of the fish isolates from Thailand (Table 2.2). 
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Table 2.3 Number of epidemiologically unrelated S. agalactiae reports in aquatic, mixed or terrestrial host species for STs identified in the current study. 
 
° Amph, Amphibians; Rep, aquatic Reptiles; Mam, sea Mammals; Bov, Bovines; Hum, Humans 
* The numerous isolates recovered from the 2001 fish kill of Kuwait bay are accounted as 1 single epidemiological event. The sea mammal isolate 
originated from a dolphin found dead during this outbreak. 
Key references
CC ST Aquatic
Fish Amph Rep Mam Bov Hum 
7    10* 1 -  1* 1 19 Jones et al. (2003); Hery-Arnaud et al. (2007); Evans et al. (2008); Ye et al., 2011 
500 2 - - - - -        /
399 - - - 1 - 1 Lartigue et al. (2009) 
283 1 - - - - 9 Ip et al. (2006); Salloum et al. (2010) 
491 1 - - - - -        / 
23 23 - - 1 4 7 >500 Bisharat et al. (2004); Brochet et al. (2006); Bishop et al. (2007); Hery-Arnaud et al., 2007
552 260 4 - - - - - Evans et al. (2008) 
NA 261 5 - - - - - Evans et al. (2008) 
7
Mixed Terrestrial
MLST Host species ° 
283
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2.5 DISCUSSION 
Within the piscine S. agalactiae assessed in this study, 2 major subgroups were 
distinguished: the first one comprised β-haemolytic strains, with STs commonly associated 
with humans; the second one comprised non-haemolytic strains, with STs that appear to be 
unique to fish (Table 2.2).  
Non-haemolytic S. agalactiae have previously been isolated from fish and frogs and have 
temporarily been misclassified as a new species, Streptococcus difficile (Kawamura et al., 
2005). It is now widely recognized as a cause of disease in fish and has been reported from 
the USA, Honduras, Brazil and Israel (Evans et al., 2008; Mian et al., 2009; Robinson and 
Meyer, 1966). In our study, non-haemolytic piscine S. agalactiae were recovered from 
epizootics in Latin America (Honduras, Colombia, and Costa Rica), from an outbreak in 
Europe (Belgium) and from 3 unrelated ornamental fish in Australia. All our isolates from 
Latin America were of ST260 and serotype Ib, showing a wide dissemination of this 
specific clone in the region. The Belgian and Australian isolates were triple locus variants of 
ST260, namely ST261, and also of serotype Ib. ST260 and ST261 were first identified in 
non-haemolytic piscine S. agalactiae from Honduras and Israel, respectively (Evans et al., 
2008). Like ST552, ST553, ST246, ST257, ST258 and ST259, they have never been 
reported from animals other than teleost fish (Table 2.3). These 8 piscine STs are 
genetically related and differ from all known STs associated with terrestrial animals at more 
than 3 loci, suggesting the existence of a fish-adapted CC of S. agalactiae (Figure 2). In the 
laboratory, members of the group that includes ST260 and ST261 do not grow well at 37°C, 
which may explain their current absence from homeothermic species. Among the ST260 
and ST261 isolates from our study, we identified none of the SPGs and MGEs that are 
commonly found in human or bovine isolates (Table 1), providing additional evidence to 
support the idea that these strains are genetically distinct from human and bovine S. 
agalactiae. It is unknown whether fish-specific SPGs and MGEs exist in S. agalactiae. 
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The other isolates recovered in this study from fish, amphibians and sea mammals were all 
β-haemolytic. Our piscine isolates from the 2001 Kuwait bay outbreak belonged to ST7, as 
previously reported by Evans et al. (2008) based on analysis of other isolates from that 
outbreak. The ST7 strain from Kuwait is closely related to CC7 isolates from Thailand, with 
PFGE patterns and 3-set genotypes differing by 1 band and 1 MGE, respectively. PFGE and 
3-set genotyping results showed that all ST7 and ST500 isolates from Thailand, which 
originated from tilapia and a bullfrog, share two closely related PFGE patterns and a single 
3-set genotype (Ia-bca-bac-IS1381-IS861-ISSag2-GBSi1). This 3-set genotype has 
previously been detected among tilapia isolates from Thailand (Suanyuk et al., 2008) but we 
could find no reports of its occurrence among human or bovine isolates. 
Sequence type 7 is part of a large group of human-associated clonal complexes, which 
includes CC1 and CC10 (Figure 2.1), but ST7 itself is relatively rare among isolates 
associated with colonization or infection in humans. By contrast, ST7 appears to be one of 
the major S. agalactiae clones associated with disease in fish (Table 2.3). Human ST7 can 
cause disease and death in fish, as shown by experimental challenge of tilapia with an ST7, 
serotype Ia isolate from a case of human neonatal meningitis (Evans et al., 2009). Fish-to-
human transmission of S. agalactiae has never been documented, but does occur with 
Streptococcus iniae, a bacterial fish pathogen that is closely related to S. agalactiae 
(Facklam et al., 2005). It remains to be established if and how human-to-fish or fish-to-
human transmission of S. agalactiae occurs under natural conditions. 
Sequence type 283 and its SLV ST491, found among isolates from Thailand and Vietnam 
respectively, share a single PFGE pattern and 3-set genotype (III-bca-IS1381-ISSag1-
ISSag2). ST283 and ST491 have not previously been reported from fish, but isolates with 
this 3-set genotype were recently found among piscine isolates from Thailand (Suanyuk et 
al., 2008). In humans, ST283 has been associated with meningitis and with skin, soft tissue 
and osteo-articular infections in adults (Ip et al., 2006; Salloum et al., 2010). Our piscine 
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ST283 isolates share the same 3-set genotype as ST283 isolates associated with invasive 
disease in human adults in Hong Kong (Ip et al., 2006). ST283 has evident invasive 
potential in human adults and in fish but it has not been identified among human-colonizing 
strains (Ip et al., 2006; van der Mee-Marquet et al., 2008). Ip et al. (2006) postulated that the 
emergence of the ST283 clone might be due to a process similar to the emergence of human 
ST17, which is a neonatal hyper-invasive clone that has been suggested to have evolved 
from the bovine-associated ST67 (Bisharat et al., 2004). The evolutionary linkage between 
ST17 and ST67 is controversial, however, as other authors argue that the common ancestor 
is more closely related to ST17 than to ST67 (Brochet et al., 2006), or even that the two STs 
are not closely related at all (Sørensen et al., 2010). Based on the population snapshot for S. 
agalactiae, ST283 belongs to a cluster of human-adapted CCs (Figure 2.1), making direct 
inter-species transmission, similar to that described for ST7 more likely than a long term 
evolutionary linkage between human and fish isolates of ST283. 
The distinction between human-associated and fish-specific subpopulations of S. agalactiae 
in aquatic species is important for several reasons, including the assessment of the risk of 
zoonotic or anthroponotic transmission, investigation of biological mechanisms of host-
adaptation, and development of disease control measures. The haemolotyic, human-
associated and non-haemolytic, fish-specific subpopulations described in our study are 
compatible with biotypes 1 and 2, respectively. The biotype nomenclature is not commonly 
used in scientific publications, but a commercial vaccine against biotype 2 S. agalactiae in 
tilapia (AquaVac
®
 STREP Sa, MSD Animal Health) has recently become available. This 
vaccine does not provide cross-protection against biotype 1 strains of S. agalactiae, 
providing further evidence that fish are affected by two distinct subpopulations of the 
pathogen. 
Isolates from aquatic mammals in our study belonged either to ST399, which is part of CC7, 
or to ST23 (Figure 2.1). Unlike the dolphin isolate described by Evans et al. (2006), our 
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isolate was not associated with a fish kill but was obtained from a single stranding. It was 
recovered in the same geographic area as the seal isolates, all of which belonged to ST23. 
The number of isolates from aquatic mammals is too small to determine whether the 
association of dolphin isolates with CC7 and seal isolates with ST23 is due to coincidence 
or to the biology of aquatic mammals or S. agalactiae. ST399 has been reported once 
before, from a human isolate (Lartigue et al., 2009). The dolphin ST399 isolate had serotype 
Ib, whereas the rest of our isolates from CC7 as well as the human ST399 isolate shared 
serotype Ia. This suggests that capsular serotype switching may have occurred within this 
CC. ST23, which was found in seals, is the founder of a major CC mostly human-associated 
(Figure 2.1) that has however been identified in numerous aquatic and terrestrial hosts, 
including cattle, dogs and crocodiles (Brochet et al., 2006; Bishop et al., 2007) (Table 2.3). 
Within ST23, molecular serotypes Ia and III predominate, with serotype Ia linked to humans 
and serotype III primarily found in dairy cattle (Brochet et al., 2006; Sørensen et al., 2010). 
All seal isolates included in the current study had serotype Ia, suggesting a human origin. 
Among ST23 isolates in our study, two 3-set genotypes were distinguished (Table 1). One 
of these genotypes, Ia-alp1-IS1381-ISSag1-ISSag2, has previously been reported from ST23 
isolates associated with necrotizing fasciitis in crocodiles (Bishop et al., 2007). Based on the 
screening of a subset of elements from the 3-set genotyping system (ISSag1 and 2 not 
screened) Ia-alp1-IS1381 also appears to be the most common profile found amongst human 
ST23. Despite its occurrence in a wide range of host species, ST23 has not been described 
in fish. It is unknown whether this is due to the limited number of fish isolates characterized 
to date or to host or pathogen biology.  
 2.6 CONCLUSION 
Within aquatic S. agalactiae, 3 subgroups were distinguished. The first subgroup comprises 
non-haemolytic isolates that belonged to ST260 or ST261. Those STs have been reported 
only from teleosts and exhibited a low level of genetic diversity as detected by PFGE. A 
common feature is the absence of surface protein genes or mobile genetic elements 
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commonly found in human or bovine isolates. Although only ST260 is currently defined as 
a member of CC552, both ST260 and ST261 appear to be part of a fish-specific cluster of S. 
agalactiae strains. The second subgroup, which was found in fish, amphibia and sea 
mammals, comprises β-haemolytic isolates that exhibit medium to high genetic diversity by 
PFGE and 3-set genotyping. Their corresponding STs, together with some of the 3-set 
genotyping profiles, have been reported to cause disease in humans which raises the 
possibility of inter-species transmissions. The third group consists of ST23 isolates, which 
were found in all seals that were investigated. ST23 has been found in numerous terrestrial 
and aquatic species, including homeothermic and poikilothermic species, but to date it has 
never been reported from fish. This work provides a rational framework for exploration of 
pathogenesis and host-associated genome content of S. agalactiae strains. 
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3.1 ABSTRACT 
Streptococcus agalactiae, a causative agent of septicaemia and meningo-encephalitis in fish, 
is recognised as a major threat for tilapia culture worldwide. In this study, the virulence of 
two strains of S. agalactiae was experimentally investigated by intra-peritoneal infection of 
Nile tilapia (Oreochromis niloticus), using an isolate originally recovered from fish and 
belonging to sequence type (ST) 260, and an isolate originating from a grey seal and 
belonging to ST23. Isolates of ST260 have only been reported from poikilotermic hosts, 
whereas isolates of ST23 have been recovered from numerous host species but never from 
teleosts. The clinical signs, the in vivo distribution of viable bacteria and bacterial antigens, 
and the gross and histopathological lesions that develop during the time course of the 
infection were investigated. The ST260 strain was highly virulent, whereas no major clinical 
sign or mortalities occurred in the fish challenged with the ST23. After injection, both 
strains however gained access to the bloodstream and viable bacteria were recovered from 
all organs under investigation. During the early stages of infection, bacteria were mostly 
found within the reticulo-endothelial system of the spleen and kidney. Thereafter, the ST260 
demonstrated a particular tropism for the brain and the heart, but granulomatous 
inflammation and associated necrotic lesions were observed in all organs. ST23 was 
responsible for a mixed inflammatory response associated with the presence of bacteria in 
the choroid rete and in the pancreatic tissue mainly. After 7 days post-challenge and for both 
strain, the formation or containment of bacteria within granulomata or other encapsulated 
structures in various organs appeared to be a major component of the fish response. 
However, the load of viable bacteria remained high within organs of fish infected with 
ST260, suggesting that, unlike ST23, this strain is able to survive within macrophages 
and/or to evade the immune system of the fish. This work demonstrates that the lack of 
report of ST23 strains in fish is possibly not due to a lack of exposure (e.g. absence from the 
aquatic environment) but to a lack of virulence. The two strains, which differ in prevalence 
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and virulence in fish, provide an excellent basis to investigate genomic differences 
underlying the host-association of distinct S. agalactiae subpopulations. 
Keywords: Challenge, Streptococcus agalactiae, tilapia, ST260, ST23 
3.2 INTRODUCTION 
Streptococcus agalactiae is a pathogenic bacterium affecting cultured and wild fish 
worldwide in a wide range of habitats including freshwater, estuarine and marine 
environments (Robinson et al, 1966; Eldar et al, 1994; Evans et al, 2008; Suanyuk et al, 
2008; Musa et al, 2009; Mian et al, 2009). The bacterium is a cause of septicaemia and 
meningo-encephalitis in fish and associated pathological lesions have been described in both 
naturally acquired (Bowater et al., 2012; Baya et al., 1990; Zamri-Saad et al., 2010; 
Hernández et al., 2009) and experimental infections (Eldar et al., 1995; Rasheed et al., 1985; 
Suanyuk et al., 2008). Streptococcus agalactiae-associated lesions of necrotising fasciitis 
have also been reported in other aquatic or semi-aquatic hosts such as sea mammals and 
crocodiles, respectively (Bishop et al, 2007; Zappulli et al, 2005). 
As well as aquatic animal species, S. agalactiae is also a significant pathogen in terrestrial 
species. Initially it was described in bovids in 1887 as a causative agent of mastitis (Nocard 
and Mollereau, 1887). However, in humans, the bacterium has highly variable roles from 
being a commensal organism of the intestinal and genito-urinary tracts to a pathogen 
responsible for invasive and often fatal infections in neonates (Yang et al., 2010). The 
genomic diversity of S. agalactiae isolates from human and bovine origins has been 
investigated using a broad range of molecular typing techniques. Library typing methods 
have recently been applied to isolates recovered from aquatic species with the aim of 
studying population structure and potential transmission between aquatic and terrestrial 
animal species. Studies were based on a housekeeping gene-based typing method, i.e. multi-
locus sequence typing (MLST; Ye et al., 2011, Evans et al., 2008), or methods of typing 
genes from the accessory genome referred to as “3-set genotyping”. The latter approach 
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consists of the identification of molecular serotypes and the profiling of surface protein 
genes and mobile genetic elements (Suanyuk et al, 2008). More recently, both techniques 
were simultaneously used to characterise isolates from a wide range of aquatic species 
(Chapter 2). This work showed that fish can be infected with 2 major and distinct bacterial 
subpopulations; the first was comprised of isolates with genotypes previously reported 
among humans and the second of isolates with genotypes that have, thus far, been recovered 
only from poikilotherms, primarily teleosts.  
Isolates with genotypes found in both humans and fish species are beta-haemolytic, of 
serotype Ia or III-4, and by MLST classification belong to the human-adapted clonal 
complexes (CCs) 7 (ST7 and ST500) or 283 (ST283 and ST491). These strains have been 
responsible for major clinical disease outbreaks in wild mullet in Kuwait (ST7) and in 
farmed tilapia (Oreochromis sp.) in China (ST7), Thailand (ST7, ST500 and ST283) and 
Vietnam (ST491) (Chapter 2; Ye et al., 2011; Evans et al., 2008). Isolates of ST7 have also 
been recovered from a bottlenose dolphin (Tursiops truncatus) found dead during a fish 
epidemic in Kuwait (Evans et al., 2008). In experimental challenge studies, ST7 isolates 
recovered from either human, fish or dolphin sources can cause clinical disease and death in 
tilapia after intra-peritoneal injection, suggesting that ST7 strains are virulent in tilapia 
independent of their original host (Evans et al., 2002, 2006 and 2009).  Evans et al. (2002 
and 2006) used isolates recovered either from mullet, seabream or a dolphin recovered 
during a natural outbreak to experimentally infect 30-40g tilapia intra-peritoneally. This 
research determined that inoculation of 10
7 
colony forming units (cfu) per fish of these 
strains later confirmed as ST7 (Evans et al., 2008) would cause 60 to 100% mortalities. In 
comparison, infection of tilapia using different doses (10
2
 to 10
7
 cfu per fish) of a ST7 of 
human origin caused clinical signs and mortalities ranging from 0 to 50% mortalities but a 
linear dose response was not seen (Evans et al., 2009). 
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Isolates with genotypes found exclusively in fish species are non-haemolytic, of serotype Ib, 
and belong by MLST classification to CC552 (ST246, 257, 258, 259, 260, 261). ST261 
strains have been isolated from ornamental fish in Australia and from tilapia cultured in 
Belgium, Israel and Indonesia (Chapter 2; Evans et al., 2008; Lusiastuti et al., 2012). Using 
a strain originally named S. difficile and later found to be a non-haemolytic S. agalactiae of 
genotype ST261 (Kawamura et al., 2005; Evans et al., 2008), clinical disease has been 
reproduced experimentally in tilapia (Eldar et al., 1995). Other STs belonging to CC552 
have been reported from outbreaks of clinical disease in tilapia in Latin American countries 
(Honduras, Colombia, Costa Rica, and Brazil) and in hybrid striped bass in Israel (Chapter 
2; Evans et al., 2008). No experimental challenge has been reported with other STs 
belonging to CC552 such as ST260. 
In a recent study, another ST (ST23) more frequently associated with human and cattle was 
repeatedly isolated from the lungs of Scottish grey seals (Chapter 2). Isolates belonging to 
ST23 have also been associated with an outbreak of necrotizing fasciitis in crocodiles 
(Bishop et al, 2007) and they have been isolated from dogs (Brochet et al., 2006). It would 
appear, therefore, that ST23 may be able to infect or colonise a wide variety of host species 
including aquatic animals, but unlike the ST7, it has never been reported in clinical disease 
of teleosts. It is unknown whether this is due to the relatively low number of fish isolates 
characterised by MLST to date, to lack of exposure of fish to ST23, or to biological 
constrains, i.e. the inability of ST23 to cause disease in fish even when exposure occurs. 
Although the pathology of S. agalactiae infection in fish has been described previously, 
there are no reports of the development and progression of lesions during the course of the 
disease. Moreover, most pathological studies provided limited or no information on the 
genotype of the strain involved. The aims of this study were (1) to investigate the in vivo 
virulence of 2 different strains of S. agalactiae that differ in term of prevalence in tilapia 
(Oreochromis niloticus), one a strain belonging to a subpopulation that has uniquely been 
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associated with fish and the other a strain corresponding to a subpopulation never 
encountered in fish, and (2) to describe the clinical signs, the in vivo bacterial distribution, 
and the gross and histopathological lesions that develop during the time course of the 
experimental infection. Additionally, the tissue distribution of the bacterium during the 
challenge study was visualised by immunohistochemistry (IHC).  
3.3 MATERIALS & METHODS 
3.3.1 Bacterial strains 
3.3.1.1 Bacterial strain selection 
The S. agalactiae strains STIR-CD-17 and MRI Z1-201 used in this study were isolated 
from aquatic animals and selected based on previous epidemiological, phenotypic and 
genotypic characterisation (Chapter 2). STIR-CD-17 was isolated in 2008 during a clinical 
disease outbreak affecting farmed tilapia (Oreochromis sp.) in Honduras, whereas MRI Z1-
201 was recovered by lung swab from a grey seal (Halichoerus grypus) found dead in 2003 
in Scottish coastal waters. Post-mortem examination of the seal identified a systemic 
infectious process as the cause of death, but it is not certain whether the strain recovered and 
used in this study was directly involved. These strains are phenotypically and genotypically 
distinct. STIR-CD-17 is non-haemolytic, of serotype Ib and, based on multi-locus sequence 
typing (MLST), belongs to ST260 and clonal complex (CC) 552, which corresponds to a 
cluster of strains associated exclusively with disease in poikilotherms. MRI Z1-201 is beta-
haemolytic, of serotype Ia, and belongs to ST23 and CC23, representing a subpopulation of 
S. agalactiae that has been reported from many host species but never from teleosts. Based 
on the standardized 3-set genotyping, STIR-CD-17 was negative for all surface protein 
genes and mobile genetic elements screened, whereas MRI Z1-201 contains genes encoding 
an alpha-like protein (alp1) and 3 insertion sequences (IS1381, ISSag1and ISSag2). MRI 
Z1-201 has the same genotype as a strain previously reported as a cause of necrotizing 
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fasciitis in crocodiles (Bishop et al, 2007). Both STIR-CD-17 and MRI Z1-201 will be 
referred to as ST260 and ST23 respectively in the remaining chapter. 
3.3.1.2 Bacterial identification  
Bacteria were recovered from frozen glycerol stocks onto 5% sheep blood agar plates (SBA; 
blood agar base [Oxoid Ltd, Basingstoke, UK] containing 5% [v/v] of defibrinated sheep 
blood [E&O laboratories Ltd, Bonnybridge, UK]) and grown aerobically at 28˚C for 72h to 
assess purity and haemolytic properties. Upon recovery, strain identity was further 
confirmed as Gram positive by a standard Gram staining protocol and as Lancefield Group 
B by a group B-specific latex agglutination test (Slidex Strepto Plus
 
B; bioMérieux, Marcy 
L'Étoile, France). Isolates were further confirmed as S. agalactiae by polymerase chain 
reaction (PCR) based on amplification of the 16S to 23S rRNA intergenic spacer region 
using primers from Phuektes et al. (2001). Briefly, sample templates were prepared by 
suspending a single 48h growth colony into 50μl of TE buffer (10mM Tris-HCl, 1mM 
EDTA). PCR reactions were then performed as previously described (Chapter 2, section 
2.3.1) with exception of the initial denaturation step which lasted for 15min for optimal cell 
lysis. 
3.3.1.3 Inocula preparation for experimental infections 
Single colonies from a pure culture were selected and aseptically inoculated into 4 ml of 
tryptone soya broth (TSB; Oxoid Ltd, Basingstoke, UK) and incubated aerobically for 8h 
(the ST23 strain, fast growing) or 24h (the ST260 strain, slow growing) at 28˚C with gentle 
shaking (140 rpm). A 36 ml volume of TSB was then seeded with 4 ml of each culture and 
incubated overnight (16h, 28
°
C, 140 rpm). The bacterial suspensions were then centrifuged 
at 3,500 rpm for 15 min and the supernatant was removed; this process had to be repeated 
numerous times to enhance bacterial concentration for ST260 strain since this bacterium 
produced a fragile cell pellet. The cell pellets were resuspended in sterile 0.85% saline and 
the OD600nm adjusted to give an OD value of 1 corresponding to approximately 10
9
 viable 
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colony forming units (cfu) per ml for the ST260 strain and 10
8
 viable cfu/ml for the ST23 
strain, as determined using the method of Miles and Misra, (1938). Serial 10-fold dilutions 
were eventually performed using sterile 0.85% saline to obtain the desired bacterial 
concentrations for the challenge study. The exact concentration for all inocula was 
confirmed using the viable cell method of Miles and Misra, (1938).  
3.3.2 The fish 
3.3.2.1 Origin and screening of the fish 
Nile tilapia (Oreochromis niloticus) were reared in the Tropical Aquarium at the Institute of 
Aquaculture (University of Stirling, UK) and maintained in a re-circulating water system in 
aquaria at 28±2°C under constant aeration and filtration. The fish were fed twice daily with 
commercial pellets (Skretting Trout Nutra 25) and kept on a 12h light: 12h dark cycle. Prior 
to use for bacterial challenge, a subset of the fish (n=3) were sampled randomly for bacterial 
recovery. Bacterial recovery was performed as previously described (Crumlish et al., 2010) 
and consisted of the insertion of a sterile plastic bacteriological loop (Fisher Scientific, 
Loughborough, UK) into the kidney followed by the inoculation of a tryptone soya agar 
plate (TSA; Oxoid Ltd, Basingstoke, United Kingdom). Plates were incubated at 28˚C for 
72h and then examined for the presence of bacterial colonies. No growth was observed and 
apparently healthy animals weighing 40±5 g were used for the subsequent challenge study. 
3.3.2.2 General live animal procedures and maintenance of infected fish 
Apparently healthy fish were transferred to the Aquatic Research Challenge Facility 
(Institute of Aquaculture, University of Stirling, UK) where they were subjected to bacterial 
challenge by intra-peritoneal (i.p.) injection. For this, the fish were first lightly anaesthetized 
by immersion in a benzocaine bath (Sigma-Aldrich, Irvine, UK) and then each fish received 
the required inoculum by i.p. injection. For i.p. injection, the needle mounted on a 1ml 
syringe was inserted cephalad into the midline of the abdomen just posterior to the pectoral 
fins and 0.1ml of the inoculum was injected intra-peritoneally. Fish were fasted for 24h 
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prior to injection and for 12h following the injection, at which time daily feeding was 
resumed. 
All fish from different experimental groups were kept in separate 10L aquaria with separate 
flow-through water systems, a temperature of 28 ± 2˚C and a 12h light: 12h dark cycle. Fish 
were monitored at least 3 times daily for signs of disease and death. All moribund and dead 
fish were removed and moribund fish were euthanized with an overdose of benzocaine. All 
animal experiments were conducted at the Institute of Aquaculture (University of Stirling, 
UK) in accordance with the Animals (Scientific Procedures) Act 1986. 
3.3.3 Experimental challenge studies 
3.3.3.1 Bacterial isolates passages 
Each strain was passaged through fish prior to challenge in order to enhance their virulence 
post-storage (Eldar et al., 1995). Inocula prepared as previously described and containing a 
high concentration of bacteria were injected into a single fish. This procedure was 
performed once with ST260 as the fish died within 3 days post-inoculation (p.i.). Fish 
challenged with ST23 had no mortality and the procedure was successively repeated 3 times 
with the fish euthanized after 3 days p.i. These fish were sampled for bacterial recovery 
from a range of organs including the brain, eyes, spleen, heart, kidney and liver onto 
tryptone soya agar (TSA; Oxoid Ltd, Basingstoke, UK). One colony isolated from the brain 
after the 1
st
 passage (ST260) or the 3
rd
 passage (ST23) was sub-cultured onto SBA and used 
for further experimental infections after its identity was confirmed as previously described 
(section 3.3.1.2.).  
3.3.3.2 Pre-challenge studies 
Two pre-challenge studies were performed; in one, fish were challenged with ST260 and in 
the other, fish were challenged with ST23. 
Experimental bacterial challenges 
3-58 
A dose-dependent experimental challenge was performed using strain ST260 to compare 
survival rates of tilapia infected with different bacterial doses and to provide a description of 
the clinical signs. For this, 3 different doses (10
2
, 10
5
 and 10
7
 cfu per fish) were used to 
challenge 10 fish per dose and 10 further fish were administered 0.85% sterile saline 
solution as negative controls. Each treatment group consisted of 10 fish per tank. The 
experiment lasted 16 days, and during this time moribund fish were euthanized as well as 
the fish remaining at day 16 p.i. Euthanized fish were aseptically sampled for bacterial 
recovery from the kidney (Crumlish et al. 2010). For statistical analysis, Kaplan-Meier 
curves were used to compare survival rates of tilapia challenged with different bacterial 
doses; differences between doses were compared using a log rank test in Graph Pad Prism 
version 5 (Graph Pad Software, San Diego, California, USA). 
For ST23, the objectives were to evaluate the development of morbidity or mortality and 
successful bacterial recovery from tilapia challenged with a single high bacterial dose. 
Based on results from the passages (section 3.3.3.1), a dose-dependent challenge study was 
not considered necessary for this strain. In this study, 20 fish were injected with a single 
bacterial concentration (1 x 10
7
 cfu per fish) and allocated in 2 groups (10 fish per tank). 
Additionally, 10 negative control fish received 0.1ml of 0.85% sterile saline by i.p. injection 
and were allocated to a separate tank. For the fish receiving ST23, 1 group of fish (n=10) 
was sampled as described previously at day 7 p.i., while the second group of fish (n=10) and 
negative control fish (n=10) were sampled at day 16 p.i.  
The identity of bacterial isolates recovered from both studies was confirmed as S. agalactiae 
based on previously described methods (section 3.3.1.2.). 
3.3.3.3 Challenge studies 
3.3.3.3.1 Challenge study design 
After the pre-challenge studies, 2 further challenge studies were performed: in one, fish 
were challenged with ST260 and in the other, fish were challenged with ST23. A total of 
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135 fish were used per challenge study, with 120 fish administered the appropriate bacterial 
strain and 15 fish injected with 0.85% sterile saline solution as negative controls. The fish 
receiving ST260 were injected with 10
5
 cfu/fish, whereas the fish receiving ST23 were 
injected with 10
7
 cfu/fish. The fish density was 10 fish per tank for the challenged animals 
and 15 fish per tank for the negative controls. A total of 13 tanks were therefore used for 
each challenge study. Each study was terminated 14 days after bacterial challenge. 
During the challenge studies, moribund fish were euthanized and examined grossly. At 
necropsy, selected tissues were sampled from brain, heart, liver, spleen, kidney and eye and 
preserved in 10% buffered formalin for histopathology. To study the progression of 
infection and pathology, all fish from 3 tanks, plus 3 negative control fish, were sacrificed at 
day 1, 3, 7 and 14 p.i. Sacrificed fish were processed in the same manner as moribund fish 
to obtain pathological information and histopathology material. In addition, 3 fish were 
randomly selected from each tank for viable bacterial counts from the blood (0.1ml/fish 
collected with heparinised syringes [Sigma Aldrich, Dorset, UK]), brain, heart, liver, spleen, 
kidney and eye. 
3.3.3.3.2 Bacterial counts from organs 
Samples of aseptically harvested blood, brain, heart, liver, spleen, kidney and eye were 
placed in sterile tubes, weighed and stored on ice until all samples had been collected at any 
one time-point. Organs were then manually homogenized using disposable pestles (VWR 
International Inc., Poole, UK) and diluted 1:10 with sterile 0.85% saline solution (w/v). The 
homogenates were further diluted serially in 10-fold steps to 10
-6. Triplicate samples (20μl) 
from each serial dilution (10
-6
 to 10
-1
) were dropped onto TSA plates, allowed to dry at 
room temperature and then incubated aerobically at 28˚C for 48h. Total viable bacterial 
counts were performed using a dilution level giving, when possible, a range of 10 to 50 
colonies per spot and the bacterial load per gram of tissue or per millilitre of blood was 
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calculated for each organ from each fish. This was then used to determine the mean and 
standard deviation (SD) for each organ at each of the sampling time points.  
For statistical analysis, all viable colony counts data were log10 transformed. A linear mixed 
model was built using the 12th Edition of the GenStat statistical package (Payne et al., 
2009). In this model, tanks and fish within tanks were used as random effects whereas day, 
organs and treatments (ST260 and ST23) were used as fixed effects. To evaluate the mean 
difference of bacterial counts (1) between organs at each time point of the same treatment, 
(2) between time points for a specified organ and treatment, or (3) between treatments for 
the same organs at the same time point, t-test were conducted. The P-values obtained from 
the t-tests were adjusted using a false discovery rate (FDR) approach to take into account 
multiple comparisons of treatment means. 
3.3.3.3.3 Isolates identity confirmation and strain typing 
The identity of bacterial isolates recovered was confirmed as S. agalactiae based on 
previously described methods (section 3.3.1.2.). Colonies confirmed as non-S. agalactiae 
were further identified to the genus level using standard Gram-staining protocol and 
biochemical tests (API 20E; bioMerieux, Marcy l'Etoile, France), followed by partial 16s 
rDNA sequencing of PCR product. For PCRs, sample templates were prepared by 
suspending a single 48h growth colony into 50μl of TE buffer (10mM Tris-HCl, 1mM 
EDTA). PCR amplification of a 700 base segment from the 16s rDNA region was then 
performed. Reactions were performed in a final 25 μl volume containing 12.5μl of GoTaq 
Green Master Mix (Promega, Madison, USA), 0.25 μM of primers PEU7 (5’-GCAAACA-
GGATTAGATACCC-3’) (Rothman et al., 2002) and DG74 (5’-AGGAGGTGATCCAA-
CCGCA-3’) (Greisen et al., 1994) and 2 μl of the sample template, with the rest of the 
volume made up of DNA-free water. The cycling conditions were as follows: cell lysis and 
initial denaturation of DNA at 94°C for 15min followed by 30 cycles of 94°C for 1min, 
50°C for 1min and 72°C for 1.5min, with a final step at 72°C for 7min. The PCR products 
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were visualized on a 1.5% (w/v) agarose gel containing gel red (Cambridge Bioscience, 
Cambridge, UK), purified with the QIAquick PCR purification kit (Qiagen, Crowley, UK) 
and then sent to Eurofins MWG operon (Ebersberg, Germany) for sequencing using primers 
PEU7 and P3SH (5’-CTACGGTTA-CCTTGTTACGACTT-3’) (Ralyea et al., 1998). 
Microbial identification was accomplished through Basic Local Alignment Search Tool 
(BLASTN; available from: http://www.ncbi.nlm.ni-h.gov/BLAST; accessed 25 Nov. 2012) 
analysis to compare the obtained sequence data with 16s rDNA sequence data stored in 
GenBank (Altschul et al., 1990). 
The original challenge strains (ST260 and ST23) and a subset of confirmed S. agalactiae 
colonies recovered during the challenge studies (39 colonies from the ST260-challenged 
fish; 21 colonies from for the ST23-challenged fish) were further typed by pulsed field gel 
electrophoresis (PFGE) as described in Chapter 2 (section 2.4.2).  
3.3.3.3.4 Histopathology  
Samples were fixed for a minimum of 24h in 10% neutral buffered formalin and routinely 
processed prior to being embedded in paraffin wax by a maximum of 4 days post-fixation 
This maximum fixation time was deliberately chosen to avoid interferences with antigen 
recognition by immunohistochemistry (IHC; Ramos-Vara, 2005). Formalin-fixed paraffin-
wax-embedded (FFPE) tissue sections (4 μm thick) were mounted on glass microscope 
slides, dried overnight at 37˚C, dewaxed in xylene and rehydrated through graded alcohols. 
Sections were stained with haematoxylin and eosin (H&E). Duplicate sections were 
subjected to Gram staining and IHC to aid in the localisation of the bacteria in the tissues. 
3.3.3.3.5 Immunohistochemistry  
Semi-serial tissue sections from all samples were mounted on Superfrost
TM
 Plus slides 
(Menzel-Gläser, Braunschweig, Germany), dewaxed and rehydrated as previously described 
(section 3.3.3.3.4), and subjected to IHC to determine the presence and distribution of S. 
agalactiae. For antigen retrieval, slides were placed in 0.2% citrate buffer pH 6.0 and 
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autoclaved at 121˚C for 10 min, allowed to cool to 50˚C and then washed in water for 5 
min. Sections were then treated with 3% hydrogen peroxide in methanol (v/v) for 20 min to 
block endogenous peroxidase activity and washed in phosphate-buffered saline (PBS).  
Non-specific binding of the secondary antibody was blocked by incubation with 25% 
normal goat serum (Vector Laboratories, Peterborough, UK) diluted in PBS for 30 min at 
room temperature. Subsequently to this, rabbit anti-S. agalactiae polyclonal antibody (code 
AB53584; Batch No. GR56848-1; Abcam, Cambridge, UK) diluted 1/200 in PBS was 
applied to all slides and incubated for 18h at 4°C. Slides were then washed 3 times for 5 min 
in PBS prior to adding 100 μl of goat anti-rabbit antibody conjugated to horseradish 
peroxidase (HRP) (Dako UK Ltd., Cambridgeshire, UK) for 30 min at room temperature. 
Slides were washed as above and then incubated with Nova Red chromagen (Vector 
Laboratories, Peterborough, UK) for 12 min. Finally, slides were washed in water, 
counterstained with haematoxylin Z (Cellpath, Newton, UK), “blued” with Scott’s tap water 
substitute (Cellpath, Newton, UK), dehydrated in graded alcohols, cleared and mounted. 
Negative controls were prepared by substituting the primary antibody with normal rabbit 
serum produced locally at the Moredun Research Institute (Penicuik, UK) at the same 
dilution.  
3.4 RESULTS 
3.4.1 Pre-challenge studies  
Fish challenged with ST260 had a dose-dependent mortality response (Figure 3.1). Most 
deaths occurred between days 1 and 7 p.i. and at termination of the experiment, only 1 fish 
remained. No clinical signs of disease were observed from the fish that died within 48h. The 
first clinical signs appeared 2 to 5 days p.i. depending on the dose administered and 
consisted of lethargy and anorexia, which were always followed by signs of ataxia 24 to 48h 
prior to death. Most fish remaining after day 7 (fish groups receiving 10
2
 and 10
5
 cfu/fish) 
exhibited uni- or bilateral exophthalmia together with corneal opacity and peri-ocular 
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haemorrhage. Streptococcus agalactiae was recovered from the kidney of 100% of 
euthanized tilapia.  
 
Figure 3.1 Kaplan-Meier curves comparing survival of tilapia following intra-peritoneal 
injection of S. agalactiae strain ST260 at doses corresponding to 10
2
, 10
5
 and 10
7
 cfu/fish. No 
mortality was observed for the negative control fish (sham dose). Curves are significantly different 
as shown by the log rank (Mantel-Cox) test (P < 0.05). 
 
Among fish challenged with ST23, no mortality or clinical signs were observed after 7 days 
p.i. and 10 fish were then sacrificed. Bacteria were recovered from the kidneys of 30% of 
these fish. After day 7, one dead fish was observed but this was attributed to fighting 
behaviour within this tank. Due to cannibalism leading to an absence of carcass, sampling 
for bacterial recovery was not possible for the later fish.  No bacteria were recovered from 
the kidneys of the remaining fish sacrificed at 16 days p.i.  
No mortalities or morbidity were recorded in the control animals which did not display any 
clinical signs nor were any bacteria recovered from these fish. 
 
Survival of Three groups:Survival proportions
0 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16
0
20
40
60
80
100
102 cfu/fish
105 cfu/fish
107 cfu/fish
Sham dose
Days post-infection
P
e
rc
e
n
t 
s
u
rv
iv
a
l
Experimental bacterial challenges 
3-64 
3.4.2 Challenge studies  
3.4.2.1 Isolates confirmation and strain typing  
All bacterial isolates recovered were confirmed as S. agalactiae, with one exception. One of 
the ST260-infected fish sacrificed at day 14 p.i. and selected for colony counts was found to 
be co-infected with another bacterial species. These bacteria were present in most organs 
investigated at a concentration of 10
4 
to 10
8
 cfu/g of tissue, with the exception of the eye and 
the heart where they were under the limit of detection. After 24h incubation on TSA, 
corresponding colonies were white cream and larger (5mm) than those expected for S. 
agalactiae ST260. These bacteria were found to be Gram-negative rods with a 16S rDNA 
sequence identical to numerous Aeromonas species (Aeromonas hydrophila, Aeromonas 
sobria, Aeromonas veronii, etc.). Biochemical tests were in agreement with the sequencing 
result, with the closest profile corresponding to an Aeromonas hydrophila (Buller, 2004).  
Among the confirmed S. agalactiae isolates recovered and selected for PFGE, pulsotypes 
identical to those of the respective challenge strains were obtained (Figure 3.2). 
 
Figure 3.2 Representative PFGE patterns of S. agalactiae isolates from fish challenged with 
strain ST23 (lanes 1 and 2) or strain ST260 (lanes 5 and 6). The original strains ST23 and ST260 
used for the challenge experiment were also analyzed and used as comparison (lane 3 and lane 7 
respectively). Streptococcus agalactiae strain STIR CD-25 was run as marker (lane 4 and lane 8). 
MW, molecular weight marker (MidRange II PFG Marker, New England Biolabs, Herts, UK).  
1        2         3        4        5         6        7        8     MW
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3.4.2.2 Bacterial counts from organs  
Bacterial load of organs and number of fish for which bacterial numbers were above the 
limit of detection for the specified organ are represented in Figure 3.3 and Figure 3.4. All 
calculations with regard to bacterial counts refer to all organs at a single time-point, 
including some organs that may have been culture negative. Detection limit for the count 
was of 167 cfu/ml of blood and varied between 417-1670 cfu/g for the organs depending of 
their weight (from 0.4g to 0.01g). 
3.4.2.2.1 Fish challenged with ST260 
The i.p. injection resulted in systemic dissemination into most internal organs and 24h p.i. 
all fish sampled had a bacterial load above the limit of detection in the spleen, kidney, liver 
and blood. The total viable bacterial count in the spleen, as expressed by a general mean of 
3.3 x 10
9
 cfu per gram of tissue, was significantly higher than the mean bacterial load of 
other organs (p < 0.05) and surpassed these by 1.5 to 4 logs (Figure 3.3A). In some fish, 
streptococci were not detected in the brain or the eye (Figure 3.4A2, B2). From day 1 to 
day 3, the number of bacteria increased significantly (2 to 4 logs; p < 0.01) in the brain, eye 
and heart (Figure 3.3A and Figure 3.4A1, B1, F1). At day 3, all organs from all fish 
contained bacteria above the limit of detection (Figure 3.4A2 to G2), with the highest load 
in the brain and the heart (Figure 3.3A). From day 3 to day 7, the number of viable bacteria 
remained high, but with a general tendency towards a slight decrease in bacterial 
concentration. A significant decrease of viable bacteria was, however, observed in the 
spleen (p < 0.01) (Figure 3.3A and Figure 3.4C1). The highest concentration of bacteria at 
day 7 was found, as in day 3, in brain and heart, but this difference was statistically 
significant only at day 7 (p < 0.01). Finally, between day 7 and day 14, the bacterial load 
remained high for brain and heart and increased significantly (p < 0.05) in all other organs 
with the exception of blood (Figure 3.3A and Figure 3.4B1 to E1). The eye was the organ 
with the most variability at day 14, with results spanning from 0 to 10
10
 cfu per gram of 
tissue (Figure 3.4B1, B2). 
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3.4.2.2.2 Fish infected with ST23 
The i.p. injection of strain ST23 resulted in systemic dissemination into most internal organs 
and at 24h p.i. all fish sampled had bacterial loads above the limit of detection in spleen, 
kidney and liver (Figure 3.3B). Bacterial counts in spleen and kidney, as expressed by a 
general mean of 0.42 and 0.11 x 10
9
 of cfu per gram of tissue, were significantly higher than 
the mean bacterial load of all other organs (p < 0.01), except the liver which also contained 
a high bacterial concentration. From day 1 to day 3, the mean viable bacterial count 
significantly decreased (p < 0.05) in all organs of the sampled fish but not in the blood 
(Figure 3.3B). At day 3, the lowest mean count was found in the eye where only 1 fish out 
of 9 sampled had recoverable bacteria above the limit of detection (Figure 3.4B2). The 
highest mean bacterial counts were recorded in the heart, spleen and kidney (Figure 3.3B), 
although the number of positive livers (8 of 9) was higher than the number of positive hearts 
or other organs (Figure 3.4 E2). From day 3 to day 7, the mean bacterial counts 
significantly decreased in most organs except brain, heart and eye. At day 7, recovery of 
bacteria was lower and varied considerably between fish: out of the 9 fish sampled, 5 fish 
had bacteria below the limit of detection in all organs, 1 fish had bacterial load above the 
limit of detection in all organs except brain and eye, 1 fish had bacterial load above the limit 
of detection in the brain and the eye only, 1 fish had bacterial load above the limit of 
detection in the heart and kidney only, and 1 fish had bacterial load above the limit of 
detection in the eye only. Finally, at day 14, viable bacteria were recovered from eye or 
kidney from 2 fish only (Figure 3.4B2, D2). 
3.4.2.2.3 Comparison between strains 
At day 1 p.i., bacterial concentrations were significantly different between the blood 
samples of fish infected with ST260 and ST23 (p < 0.01), whereas no statistical differences 
were observed when comparing bacterial concentrations within other organs between 
challenge strains. At day 3 p.i., bacterial concentrations were significantly different between 
challenge strains for all organs (p < 0.05) except for the kidney (Figure 3.4A2 to G2). 
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Finally, at day 7 and day 14 p.i., most organs of fish challenged with ST23 were cleared of 
bacteria and therefore had significantly lower means of bacterial loads in all organs (Figure 
3.4A2 to G2). 
 
 
Figure 3.3 Bacterial load of Streptococcus agalactiae strains ST260 (A) and ST23 (B) in selected 
organs of Nile tilapia (Oreochromis niloticus) intra-peritoneally infected. Mean counts (Log10) 
and standard deviation from fish sampled at days 1, 3, 7 and 14 post-infection are presented in the 
form of cfu per g of tissue or cfu per ml of blood. 
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Figure 3.4 (A1 to G1) Bacterial load of 
Streptococcus agalactiae strains ST260 (red) 
and ST23 (blue) in selected organs of Nile 
tilapia (Oreochromis niloticus) intra-
peritoneally infected. Mean counts and 
standard deviation from 8 to 9 fish sampled at 
days 1, 3, 7 and 14 post-infection are presented 
in the form of cfu per g of tissue or cfu per ml 
of blood. (A2 to G2) Number of fish sampled 
for colony counts and for which bacteria were 
higher (full bars) or lower (empty bars) than 
the limit of detection, for both ST260 (red) and 
ST23 (blue). *P<0.05 compared to the 
bacterial concentration in organs from fish 
infected with ST23. 
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3.4.2.3 Gross pathological changes 
The number of fish with gross lesions in the selected organs and for each time point is 
presented in Table 3.1. 
Table 3.1 Number of fish with apparent gross pathological changes in selected organs observed 
at each sampling point.  
 
a
 The number of fish listed refers to live fish that could be sacrificed for examination. 
 
3.4.2.3.1 Fish infected with ST260 
No gross lesion was observed in any fish at day 1 p.i. From day 3 onwards, organs most 
frequently affected were brain and heart (Table 3.1). Affected brains were oedematous and 
occasionally haemorrhagic, with numerous cases of marked brain softening and liquefaction 
among the moribund fish and in the fish sampled at day 7 and day 14 p.i. (Figure 3.5a). 
Heart lesions consisted of focal zones of epicardial opacity at day 3, whereas most affected 
hearts at day 7 and day 14 appeared hypertrophic with the epicardium and the tunica 
adventitia of the bulbus arteriosus covered by a layer of fibrino-purulent exudate (Figure 
3.5b). Two fish at day 14 also presented with severe pyo-pericadium, while another fish had 
milder lesions similar to those observed in fish at day 3. Eye lesions were occasional (Table 
3.1) and consisted of mild (day 7) to severe (day 14) exophthalmia, which was associated at 
day 14 with corneal opacity (Figure 3.5c) and peri-ocular haemorrhage (Figure 3.5d). No 
lesion of the liver was observed with the exception of sub-capsular petechial haemorrhage in 
Brain Eye Spleen Kidney Liver Heart
        ST260
Day 1 30 0/30 0/30 0/30 0/30 0/30 0/30
Day 3 30 15/30 2/30 2/30 0/30 2/30 10/30
Day 7 18 14/18 5/18 2/18 0/18 0/18 10/18
  Day 14 11 9/11 2/11 1/11 0/11 2/11 10/11
        ST23
Day 1 30 0/30 0/30 0/30 0/30 0/30 0/30
Day 3 30 0/30 0/30 0/30 0/30 0/30 0/30
Day 7 30 0/30 0/30 0/30 0/30 0/30 0/30
  Day 14 30 0/30 0/30 0/30 0/30 0/30 0/30
Number of fish with gross lesions
Time post-inoculation Fish no.a
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2 fish at day 3 and a mottled appearance in 1 fish at day 14. One fish also presented at day 
14 with a liver broken down in pieces possibly due to the extreme ascites and abdominal 
distension. No gross changes of the spleen were observed with the exception of occasional 
splenomegaly. 
Most fish that died or were sacrificed after day 7 had a mild to severe peritonitis (Figure 
3.5d), which was associated with ascitic fluid ranging from translucid to purulent (Figure 
3.5e). In the case of 2 fish sacrificed at day 14, the swimming capabilities of the fish were 
severely impaired possibly due to the abdominal distension caused by the ascites. Finally, an 
unusual finding in 2 fish sampled at day 14 was the presence of abscess-like lesions of 2 to 
5 mm on the oral commissure, the base of the fins, or on the jaws. No gross lesions were 
observed in the control fish. 
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Figure 3.5 Gross external and internal pathological changes as observed in fish experimentally 
infected with S. agalactiae ST260. (a) Brain of negative control fish (left) and infected fish (right) 
at sampling day 7. The brain from the infected fish is highly haemorrhagic and it appears liquefied 
with loss of structure. (b) Apparently normal heart from control group (b1) and infected fish at day 3 
(b2) and day 7 (b3) p.i. In the fish at day 3 p.i., a focal zone of epicardial opacity can be observed 
(arrow), whereas the heart is hypertrophic and covered by fibrino-purulent material in the fish at day 
7. (c) Unilateral exophthalmia and corneal opacity as observed in a fish sampled at day 7 p.i.  
  
(c)
(a) (b1)
(b3)
(b2)
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Figure 3.5 (continued). Gross external and internal pathological changes as observed in fish 
experimentally infected with S. agalactiae ST260. (d) Fish sampled at day 14 showing severe 
peritonitis. Note the eye that is exophthalmic and accompanied by corneal opacity and peri-ocular 
haemorrhages. (e) Fish sampled at day 14 showing the presence of fibrino-purulent material on the 
surface of the heart and the presence of translucent ascitic fluid within the abdominal cavity.  
(d)
(e)
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3.4.2.3.2 Fish challenged with ST23 
No gross pathological change was observed in any of the fish and at any of the time points 
in the group of fish receiving strain ST23 (Table 3.1). The only exception was the presence 
of abscess-like lesions of approximately 2 to 5 mm diameter on the oral commissure, on the 
jaws or at the base of the fins in 2 fish sampled at day 7 p.i. and 8 fish sampled at day 14 p.i. 
(Figure 3.6). 
 
Figure 3.6 Abscess-like lesion at the base of the pectoral fin as observed in a fish 
experimentally infected with S. agalactiae ST23. 
 
3.4.2.4 Histopathology and immunohistochemistry 
3.4.2.4.1 Fish challenged with ST260 
Brain. Granulomatous meningitis ranged from minimal at day 1 to mild at day 3 (Figure 
3.7a). At day 7 and onwards the meningitis was severe and associated with haemorrhage 
and vasculitis (Figure 3.7b). Granulomatous ventriculitis (Figure 3.7c) was also observed 
as were extensive areas of malacia extending through the cortex from the meninges (Figure 
3.7b). Some barely encapsulated aggregates of yellow-pigmented macrophages were present 
scattered through the meningitis and ventriculatis. These were considered to be melano-
macrophage centres (MMCs), MMC-like structures, or early granulomata (Figure 3.7d). At 
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the last sampling day, identical lesions were found with additional septic thrombi within the 
meninges of 4 fish out of 11 (Figure 7e). Two fish at day 14 however showed milder 
lesions similar to those observed at day 3 p.i. 
With IHC, no bacteria were found at day 1 p.i. Macrophages within the meninges and 
meningal blood vessels were laden with bacteria from day 3 onwards. Bacteria were also 
observed within macrophages present in the ventricle of fish from day 7 onwards. At day 14 
p.i., labelling of bacterial antigens was predominantly but not uniquely found within the 
MMC-like structures. 
 
Eye. No histopathological change was observed at day 1 p.i.  From day 3 onward, a marked 
granulomatous inflammation of the choroid of all fish was noted (Figure 3.8a). This 
observation was usually accompanied by a mild to severe inflammation of the scleral 
connective tissue, retrobulbar adipose tissue, optic nerve sheaths and occulo-motor muscles 
(Figure 3.8b). In some cases and more predominantly toward the end of the follow-up 
period, these lesions further evolved toward a pan-ophthalmitis with inflammatory reaction 
also involving the retina, iris, cornea and chambers, which led to a disruption of the internal 
structure (Figure 3.8c). Macrophage aggregates within the choroid rete appeared yellow 
pigmented. Occasionally these aggregates were loosely encapsulated at day 7 and 14 
suggesting the formation of granulomata or MMC-like structures (Figure 3.8d). 
Using IHC, no bacteria were observed at day 1 p.i. However, at day 3 bacteria were present 
in high number within the macrophages. At day 7 and day 14 p.i., bacteria were still present 
in high numbers but bacterial load was predominantly within MMC-like structures within 
the rete (Figure 8e). Numerous free bacteria were also seen within heavily infected eyes. 
 
Spleen. The spleen exhibited major changes from day 1 and onwards. At day 1, the 
ellipsoids increased in size due to an accumulation of macrophages within and surrounding 
the Schweigger-Seidel sheaths, and there was, therefore, an apparent shift from a 
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predominance of red pulp in healthy fish (Figure 3.9a) towards a predominance of white 
pulp in infected animals (Figure 3.9b). Between day 3 and day 7, however, ellipsoidal 
diameter decreased to a size closer to normal, while numerous newly forming melano-
macrophage aggregates were observed adjacent to the ellipsoids (Figure 3.9c and d). At 
day 14 p.i., numerous MMCs were additionally observed. These were well organized, 
encapsulated and surrounded by lymphoid cells (Figure 3.9e). Finally, blood vessels from 1 
fish at day 7 and 1 fish at day 14 contained septic thrombi showing an early degree of 
organization and associated with areas of local tissue infarction.  
Using IHC, bacterial antigens were detected from day 1 when they were apparently 
associated with the endothelial lining of the ellipsoidal axial vessel (Figure 3.9b, inset). At 
day 3 and day 7, bacteria were observed associated with the endothelial lining of the 
arteriole but also within most reticular macrophages surrounding the ellipsoids and within 
newly forming MMCs (Figure 3.9d, inset). Bacteria at day 14 were found mostly within 
forming and well defined MMCs. Finally, at day 7 and day 14, numerous bacteria (free and 
within macrophages) were observed within septic thrombi and associated infarcted tissue. 
 
Hepato-pancreas. No major change of hepatic tissue was observed microscopically at day 
1 with the exception of discrete vasculitis in most fish. Fish sampled at day 3, 7 and 14 p.i, 
all had mild to severe vasculitis (Figure 3.10a). Moreover, blood vessels from 4 fish out of 
the 11 still alive at day 14 contained septic thrombi showing early degree of organization, 
and which were associated with areas of local tissue infarction (Figure 3.10b).  Finally, a 
mild infiltration of mononuclear cells within and surrounding the pancreatic tissue was 
present in all fish and at all sampling points (Figure 3.10c). 
With IHC, a few S. agalactiae-laden phagocytic cells were present in the lumen of the 
vascular system at all time points. At day 14, numerous extracellular and phagocytosed 
bacteria were found within septic thrombi and infarcted tissues. Moreover, at all time points 
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and for most fish, a concentration of bacterial antigens was found to be within and 
surrounding pancreatic tissue (Figure 3.10c, inset). 
 
Kidney. No particular lesion was found in the kidney of any fish at any of the time points. 
With IHC, bacteria were visible on rare occasions at day 1, day 3 and day 7 p.i. These were 
localized within peritubular vessels and mostly appeared endocytosed by macrophages or 
endothelial cells (Figure 3.11a). Additionally, in some cases at day 7 p.i., positive antigen 
labelling was also observed in MMCs. Finally, at day 14 a large number of free and 
endocytosed bacteria were observed scattered within peritubular portal vessels but no 
MMCs were found (Figure 3.11b). 
 
Heart. No pathological change was observed at day 1 p.i., with the exception of minimal to 
moderate infiltration of inflammatory cells within the connective tissue at the base of the 
ventricle (Figure 3.12a). At day 3, lesions had progressed, and mild to severe pericarditis of 
the bulbus and at the base of the ventricle was observed, whereas pericarditis was minimal 
to mild for the rest of the ventricle. Moreover from day 3 onwards, mild to severe 
endocarditis of the bulbus arteriosus was observed, whereas at the level of the ventricle the 
endocarditis was always minimal. At day 7 and day 14, the epicarditis was severe, affecting 
the bulbus, atrium and ventricle (Figure 3.12b). Within the ventricle, fibrinoid necrosis of 
the compact layer of the myocardium was observed in all fish, while in some cases (5 fish at 
day 7; 6 fish at day 14) a layer of proteinaceous/purulent exudate was also seen external to 
the layer of inflammatory cells (Figure 3.12c). In the case of moribund fish that were 
euthanized between day 7 and day 14, large mats of bacteria were observed penetrating 
through the bulbus arteriosus (Figure 3.12d). Lesions at day 14 additionnally showed the 
presence of vasculitis of coronary arteries (Figure 3.12e) and numerous early granulomata 
within the epicardium (Figure 3.12f). 
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Using IHC, small numbers of phagocyted S. agalactiae were seen, but in only one of the 
fish sampled at day 1, localized within the connective tissue at the base of the ventricle. 
From day 3 onwards, large numbers of bacteria-laden macrophages and extracellular 
bacteria were seen within the pericardial sac. Streptococcus agalactiae was detected rarely 
from the endocardium or myocardium. At day 7 and day 14, high bacterial loads were seen 
occupying the inflammatory layer (mostly within macrophages) and the proteinacious layer 
(mostly free bacteria) of the pericardial cavity. At day 14, however, positive labeling was 
mostly concentrated within granulomata (Figure 3.12g).  
 
Other. Abscess-like lesions of the skin were sampled for histopathological examination. 
These appeared to be large granulomatous lesions containing mixed inflammatory cells 
(macrophages predominantly) and including multinucleated giant cells. These structures 
were well delimited by epithelioid cells and fibroblasts and surrounded by lymphoid cells. 
Mononuclear inflammatory cells had also invaded the muscles tissues adjacent to the 
granulomata.  
In IHC, positive labelling within macrophages was present focally at the periphery of the 
granulomata (externally and internally)  
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Figure 3.7 Histopathological changes in brain of fish experimentally infected with S. agalactiae 
ST260. (a) Optic tectum of a fish at day 3 p.i. with mild granulomatous meningitis (arrows). (b) 
Optic tectum of a fish at day 7 p.i. with severe meningitis. Note the loss of substance (malacia) in the 
stratum fibrosum marginale (*).  
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Figure 3.7 (continued). Histopathological changes in brain of fish experimentally infected with 
S. agalactiae ST260. (c) Macrophages (arrows) as observed within the ventricle of a fish at day 7 
p.i. Note the presence of numerous bacteria (pale blue dots) engulfed within the macrophages (d) 
Aggregate of yellow pigmented macrophages (delimited by arrows) were observed at day 14 within 
the meninges of this fish, suggesting the formation of MMC-like structures. Labelling by IHC was 
more preponderant within these structures (data not shown). (e) Large thrombus as observed in the 
meninges of a fish sampled at day 14 p.i.   
(c)
(d) (e)
(c) 
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Figure 3.8 Histopathological changes in eye of fish experimentally infected with S. agalactiae 
ST260. (a) Fish at day 3 p.i. with severe granulomatous inflammation of the choroid rete and 
connective tissue surrounding the sheaths of the optic nerves. (b) Fish at day 3 p.i. with severe 
granulomatous inflammation surrounding the scleral cartilage and also infiltrating the external 
oculo-motor muscles. ON, optic nerve; SC, scleral cartilage; M, oculo-motor muscles; CR, choroid 
rete.  
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Figure 3.8 (continued). Histopathological changes in eye of fish experimentally infected with S. 
agalactiae ST260. (c) Iridocorneal angle in a fish at day 14 p.i. High infiltration of inflammatory 
cells is observed surrounding the scleral cartilage and appearing to progress within the cornea (*). 
This will lead to corneal opacity as observed clinically. Note the presence of severe inflammation 
involving the iris. (d) Fish at day 14 p.i. with severe granulomatous inflammation of the choroid 
rete. Note the presence of yellow pigmented macrophages in aggregates within the choroid rete 
(arrows). ON, optic nerve; SC, scleral cartilage;  M, oculo-motor muscles; CR, choroid rete; C, 
cornea; IR, iris; AL, annular ligament.  
SC
AL
C
*
IR
CR
ON
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(c)
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Figure 3.8 (continued). Histopathological changes in eye of fish experimentally infected with S. 
agalactiae ST260. (d) Labelling of bacterial antigens (red) by IHC as seen within the melano-
macrophage aggregate presented in (d).   
(e)
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Figure 3.9 Histopathological changes in spleen of fish experimentally infected with S. 
agalactiae ST260. (a) The red pulp, consisting mainly of erythrocytes and thrombocytes within 
splenic cord and sinusoids, comprises the majority of the splenic parenchyma in negative control 
fish, whereas the white pulp is present in small clusters. The white pulp consists of lymphoid cells 
surrounding arterial vessels, melano-macrophage centres (MMCs) and ellipsoids. (b) At day 1 p.i. 
the ellipsoids increased in size due to an accumulation of macrophages within and surrounding the 
Schweigger-Seidel sheaths of the ellipsoids. Bacteria (red) can be seen trapped within the first layer 
of the ellipsoids by IHC (inset). (c) At day 3, however, ellipsoidal diameter decreased to a size closer 
to normal, while numerous macrophages appeared yellow pigmented. (d) Numerous newly forming 
melano-macrophage aggregates were observed adjacent to the ellipsoids at day 7 PI. These 
structures contain lots of bacterial antigen, as seen by IHC (inset). (e) At day 14 p.i, numerous large 
MMCs were observed. These were well organized, encapsulated and surrounded by lymphoid cells. 
E, ellipsoid; MMC, melano-macrophage centre.  
E
MMC
(d) 
(e) 
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Figure 3.10 Histopathological changes in hepato-pancreas of fish experimentally infected with 
S. agalactiae ST260. (a) The hepatic central vein (v) is lined by a thin endothelium and erythrocytes 
can occasionally been seen in the lumen, whereas sinusoids (arrows) lined by endothelial cells can 
be observed running into the central vein. The central vein is perfectly normal in negative control 
fish (a1), but in most fish at day 1 p.i., discrete infiltration of mononuclear cells within the 
endothelium was observed, indicating the presence of discrete vasculitis (a2). The severity of the 
vasculitis evolved to mild (a3) and severe (a4) in the fish sampled at day 3 and onwards. (b) Hepatic 
blood vessels from fish still alive at day 14 p.i. contained septic thrombi showing early degree of 
organization (1) and which were associated with areas of local tissue infarction (2) adjacent to 
normal hepatic tissue (3). (c) Pancreatic tissue of all challenged fish was mildly infiltrated by 
mononuclear cells (arrow) and to a lesser extent by eosinophilic granular cells. Pancreatic tissue 
constituted a “hot spot” for the detection of bacterial antigen (inset; IHC).  
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Figure 3.11 IHC of kidney of fish experimentally infected with S. agalactiae ST260. (a) 
Minimal positive labelling can be observed within the peritubular capillaries in a fish at day 
1 p.i. In this case bacteria (red) are in clusters suggesting they are endocytosed within cells 
associated with the endothelial lining (renal portal macrophages). (b) Positive labelling is 
more pronounced in this fish at day 14 p.i.  
(a)
(b)
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Figure 3.12 Histopathological changes in heart of fish experimentally infected with S. 
agalactiae ST260. (a) Fish at day 1 p.i. showing minimal infiltration of mononuclear cells and 
eosinophilic granular cells in the connective tissue at the base of the ventricle. (b) Severe pericarditis 
is seen at the base of the ventricle in a fish at day 7 p.i. (c) Extreme pericarditis in a fish at day 14 
p.i. Adjacent to normal spongy myocardium (1), eosinophilic necrosis of the compact myocardium 
can be observed (2). The pericardial cavity is filled by a layer of inflammatory cells (3) followed by 
a layer of proteinaceous exudate (4). B, Bulbus; V, Ventricle.  
(a) (b)
(c)
1
2
3
4
B B
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Figure 3.12 (continued). Histopathological changes in heart of fish experimentally infected 
with S. agalactiae ST260. (d) Bacterial mats (arrow) penetrating through bulbus arteriosus in a 
moribund fish sacrificed between day 7 and day 14 p.i. (e) Severe vasculitis of coronary vessels at 
the atrio-ventricular junction in a fish at 14 p.i. (f) At day 14 p.i., some aggregates of yellow 
pigmented macrophages (arrows delimitation) can be observed within the inflamed pericardial 
cavity, suggesting the formation of MMC-like structures or granulomata. (g) IHC showing large 
amounts of bacterial antigen (red; arrows delimitation) within the granulomata presented in (f).  
(e)
B
(d) (e)
(f) (g)
B
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3.4.2.4.2 Fish infected with ST23 
Brain. No major changes were observed in any fish and at any of the time points, nor were 
any bacterial antigens seen in IHC.  
 
Eye. A discrete to mild infiltration of mononuclear cells in the choroid rete was observed at 
day 1 and day 3 (Figure 3.13a1). These lesions persisted at day 7 and day 14 with some 
macrophages appearing yellow pigmented and in aggregates, suggesting the formation of 
MMC-like structures or granulomata (Figure 3.13b1).  
By IHC, bacterial antigens were found only within the choroid rete. From day 1 to day 7, 
this was observed occasionally and confined within macrophages (Figure 3.13a2). At day 7 
but more predominantly at day 14, positive labelling was significant but observed only 
within the MMC-like structures (Figure 3.13b2). 
 
Spleen. No major changes of splenic tissue were observed microscopically in H&E stained 
sections at any time point in any fish sampled. 
 By IHC, a small number of bacteria were observed either in small clusters within 
macrophages scattered within the interstitium (Figure 3.14a), or to a lesser extent within 
macrophages surrounding the ellipsoids in fish sampled at day 1 and day 3. At day 7, only a 
few bacteria were observed and localised as in previous time points, but minimal labelling 
was also observed in the MMCs centres. Finally, at day 14, labelling of bacterial antigens 
was more pronounced but concentrated within MMCs only (Figure 3.14b). 
 
Kidney. No major changes were observed at day 1 and day 3, but at day 7 and more 
predominantly at day 14, higher numbers of melano-macrophage aggregates and MMCs 
were seen scattered throughout the renal interstitium.  
Using IHC, in all fish at day 1 and day 3, a small number of bacteria were occasionally 
observed within peritubular vessels, and due to their clustering, presumably within renal 
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portal macrophages (Figure 3.15a). At day 7 p.i., a small number of bacteria were still 
visible in most fish and as previously described, but a minimal labelling was also observed 
in melano-macrophage aggregates and MMCs. Finally, at day 14 p.i., labelling of bacterial 
antigens is more predominant and mostly concentrated within MMCs (Figure 3.15b). 
 
Hepato-pancreas. No major changes were observed microscopically within the hepatic 
tissue at any of the time points using H&E-stained sections or IHC. The pancreatic tissue, 
however, had numerous changes. At day 1 and day 3, a mild infiltration of mixed 
inflammatory cells was observed within and surrounding the pancreatic cells in all fish 
sampled at these time points (Figure 3.16a). These lesions often evolved towards the 
formation of pyogranulomata-like structures at day 7, consisting of a core of macrophages 
and necrotic tissue surrounded by mixed inflammatory cells (Figure 3.16b and c). Well-
organised pyogranulomata were observed at day 14 and in lesser extent at day 7, consisting 
of a core of necrotic material and macrophages surrounded by epithelioid cells, fibroblasts 
and mixed inflammatory cells (Figure 3.16d and e). 
No bacteria were detected within the hepatic tissue using IHC. However, a “hot spot” for the 
presence of bacterial antigens was within and surrounding pancreatic tissue where bacteria 
mostly appeared within macrophages. Bacteria-laden macrophages were all concentrated 
within the early pyogranulomata at day 7 and day14 p.i. (Figure 3.16c and f, insets). 
 
Heart. No major changes were observed in any of the fish and at any of the time points. No 
bacterial antigens were observed by IHC. 
 
Other. Abscess-like lesions of the skin as previously described grossly (Figure 3.6) were 
sampled for histopathological examination. These appeared to be large granulomatous 
lesions (Figure 3.17a) containing mixed inflammatory cells (macrophages predominantly) 
including multinucleated giant cells (Figure 3.17b). These structures were well delimited by 
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epithelioid cells and fibroblasts and surrounded by a lymphoid cuff. Mononuclear 
inflammatory cells also invaded the muscle tissues adjacent to the granuloma (Figure 
3.17d).  
Positive staining within macrophages was present focally at the periphery of the 
granulomata through IHC (external and internal to the granuloma) (Figure 3.17c).   
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Figure 3.13 Histopathological changes in eye of fish experimentally infected with S. agalactiae 
ST23. (a) Fish at day 1 showing mild infiltration of mononuclear cells and eosinophilic granular 
cells within the choroid rete. The infiltrated region appears more basophilic (a1).  At higher 
magnification, IHC demonstrates the presence of bacterial antigens (arrows) within macrophages in 
the choroid rete (a2).  
(a1)
(a2)
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Figure 3.13 (continued). Histopathological changes in eye of fish experimentally infected with 
S. agalactiae ST23. (b) Presence of MMC-like structure in the choroid rete of a fish sampled at day 
7. This structure is loosely encapsulated by epithelioid cells and fibroblasts (b1) and the IHC reveals 
the presence of numerous bacterial antigens within these structures.  
(b1)
(b2)
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Figure 3.14 IHC of spleen of fish experimentally infected with S. agalactiae ST23. (a) Positive 
labelling of bacterial antigen is an occasional finding in fish at day 1; bacteria are located within a 
macrophage located in the splenic pulp. (b) Positive labelling is more obvious at day 14 and by now 
is concentrated within MMCs. E, ellipsoid; MMC, melano-macrophage centre. 
 
 
 
 
 
Figure 3.15 IHC of kidney of fish experimentally infected with S. agalactiae ST23. (a) Presence 
of bacterial antigens (arrow) within the peritubular vessel of a fish sampled at day 1. (b) Marked 
labelling of bacterial antigens concentrated within a MMC in a fish sampled at day 14. G., 
glomerulus; T, tubule; MMC, melano-macrophage centre. 
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Figure 3.16 Histopathological changes in the hepato-pancreas of fish experimentally infected 
with S. agalactiae ST23. (a) Tissue surrounding the pancreas is infiltrated by mixed inflammatory 
cells in fish at day 3 p.i. (b and c) Inflammatory reaction surrounding the pancreas is more 
organised in fish at day 7 p.i. It consists of macrophages and necrotic tissue surrounded by mixed 
inflammatory cells (lymphocytes predominantly). Large number of bacteria (red) can be seen 
trapped within these structures (c; inset). (d, e and f) Well-organised pyogranulomata are found 
surrounding the pancreas. The core of the structure, highly positive for bacterial antigens (f), is now 
well encapsulated by epithelioid cells and fibroblasts.  
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Figure 3.17 Skin lesions of fish experimentally infected with S. agalactiae ST23. (a) Well 
encapsulated granulomatous lesion as observed at the base of the fin of a fish (see Figure 6 for 
corresponding gross observation). (b) High power magnification showing mixed inflammatory cells 
including polynucleated giant cells (arrow) within the granuloma. G., granuloma; F, fin.  
G
F
A
(a)
(b)
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Figure 3.17 (continued). Skin lesions of fish experimentally infected with S. agalactiae. (c) IHC 
showing the presence of positive labelling (red) within and external to the fibrous wall of the 
granuloma. (d) Mixed inflammatory response surrounding a granuloma is infiltrating the adjacent 
muscular tissue. M., muscle.  
(c)
(d)
M
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3.5 DISCUSSION 
Fish were exposed to the pathogen by i.p. route in this study, which by-passed the 
colonisation step and therefore would possibly not corroborate exactly with the natural 
progression of the disease. However, this route enabled to develop a robust challenge model 
and direct comparisons of motalities with other studies, which mostly focused on i.p. route, 
was made possible. Moreover, lesions observed with the ST260 strain were greatly similar 
to those reported from the natural outbreak it originated from. For the ST23 strain, however, 
the i.p. route most probably resulted in a septiceamic state and development of 
histopathological changes that might not have occurred under natural conditions. 
During the passage experiments, bacteria were recovered from the brain and all other 
investigated organs independently of the strain used, suggesting that both ST260 and ST23 
may have the ability to colonise internal organs of fish. The pre-challenges however 
highlighted major differences in virulence of the 2 strains. Fish infected with ST260 
exibited numerous clinical signs that agreed with those observed in other fish studies 
(Chang et al., 1996; Evans et al., 2002), mortalities were close to 100% even at the lowest 
bacterial dose given (10
2
 cfu/fish), and bacteria were recovered from the spleen of all 
euthanized fish. In comparison, fish challenged with a high dose of ST23 did not exhibit any 
clinical signs, no mortality was attributed to the bacterium, and the bacterial recovery from 
the spleen was 30% of fish after 7 days and 0% after 16 days. These observations show that 
the ST260 isolate, which belongs by MLST to a putatively fish-adapted subgroup of S. 
agalactiae, is extremely virulent in fish. Other experimental challenge studies performed in 
tilapia using the same i.p. exposure route found mortalities as high as in our study only once 
using isolates that were non-haemolytic, similar in that regard to ST260 (Mian et al., 2009). 
This suggests that piscine non-haemolytic isolates may be more virulent in fish than the β-
haemolytic ones. The ST23 isolate, which belongs by MLST to a subgroup of S. agalactiae 
usually associated with humans or bovines and never reported from fish, was found to be 
non-virulent and cleared below detectable levels within 16 days p.i. 
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In this study, it was not known whether the ST23 used to challenge tilapia was pathogenic to 
the seal it was originally isolated from. In another study (Pereira et al., 2010), tilapias were 
challenged with another ST23, the reference strain NEM316, by i.p. injection of the same 
bacterial dose than in this study (10
7
 cfu/fish). The NEM316 reference strain, known to be 
pathogenic in murine models of infection (e.g. intra-venal infection of mice with 10
6
 cfu 
resulted in 100% mortality after 7 days; Poyart et al., 2001), was found to be non-virulent in 
tilapia. In agreement with this study, Pereira et al. (2010) successfully recovered the 
bacterial strain from the brain and kidney of fish after 48h, but no clinical signs or 
mortalities occurred and the fish were clear of bacteria after 15 days. Other studies 
evaluated the virulence in tilapia of isolates from distinct hosts of origin and/or STs. 
Experimental challenges of tilapia using S. agalactiae isolated from bovine or human hosts 
provided evidence that the majority of these isolates are not capable of sustainably infecting 
tilapia following i.p. injection (Garcia et al., 2008; Pereira et al., 2010), with the exception 
of some specific clones like the human ST7 (Evans et al., 2009). Even though S. agalactiae 
is a multi-host pathogen, in vivo studies therefore indicate niche-dependant variations in the 
virulence of specific bacterial subpopulations. 
Data generated in this study from the challenge experiment enabled for the first time an in-
depth description of the pathological changes, the bacterial loads in the organs and the 
bacterial antigen localisation during the time course of infection, using virulent (ST260) and 
non-virulent (ST23) isolates of S. agalactiae.  
The challenge study suggests that following i.p. infection, both isolates gained access to the 
bloodstream. This was demonstrated by the viable colony counts recorded from the blood 
samples and from most organs sampled at day 1 p.i., with the spleen and kidney containing 
the highest concentration of bacteria. Further examination by IHC in this study showed that 
bacteria were passively trapped within the reticulo-endothelial system of the spleen and 
kidney, which is in agreement with many other studies that consider these organs as a first 
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line of defence for the trapping and clearance of blood-borne substances (Press and 
Evensen, 1999). Following this initial trapping, however, the subsequent progression of the 
bacterial load and associated pathological changes differed markedly between the two 
strains. 
Concerning the fish infected with ST260, bacterial counts from organs revealed that 
following day 1 p.i., the bacterium had a particular tropism for the brain and the heart and, 
accordingly, these organs were the most affected as appeared grossly. Through the 
investigation of natural clinical outbreaks of tilapia, Hernandez et al. (2009) also identified 
the brain as the organ of predilection for S. agalactiae, but in their study the eye was found 
to be more frequently infected than the heart. In our study, histopathological changes 
involved mild to severe granulomatous inflammation and associated necrotic lesions in the 
pericardial cavity and in the meninges. The pericardial cavity in fish is frequently affected 
during bacterial septicaemias, which possibly results from bacterial colonisation through 
lymph drainage (Ferguson, 2006). The presence of bacteria within the brain, however, 
requires the ability to breach the blood brain barrier. In human strains of S. agalactiae, 
numerous virulence factors putatively involved in the transcellular or paracellular crossing 
of the blood brain barrier have been suggested (van Sorge et al., 2009), but it is unknown 
whether similar virulence factors are expressed by ST260. For the crossing of the blood 
brain barrier, bacteria may also use macrophages as a vehicle (the so-called Trojan horse 
mechanism) as it has been shown for S. iniae (Zlotkin et al., 2003). The ability of S. 
agalactiae to survive within fish macrophages and trigger their apoptosis has not been 
evaluated. Based on our work and other studies, fish pathogenic S. agalactiae always 
colonise the brain (Suanyuk et al., 2008; Hernandez et al., 2009; Zamri-Saad et al., 2010) 
but further work is required to understand the mechanism behind it. At the end of the 
challenge study, the pathological process evolved towards the formation of numerous 
MMC-like structures in the meninges, pericardium and choroid rete of the eye. Bacteria 
were concentrated mostly within these MMC-like structures as well as within the MMCs of 
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the spleen and kidney. However, the viable bacterial load remained high as shown by the 
colony counts, suggesting that this strain is able to survive within macrophages and/or to 
evade the immune system of the fish. Moreover, fish infected with ST260 displayed toward 
the end of the challenge numerous septic thrombi associated with severe local tissue 
infarction, notably in the liver, but also in the spleen and meninges. Numerous bacteria were 
found within these lesions, explaining the general increase of bacterial concentration 
between day 7 and day 14 in these organs. The formation of these thrombi may be due to the 
degenerative changes of endothelial cells caused by the bacterium (Zamri-Saad et al., 2010), 
and/or to the initiation of disseminated intravascular coagulation caused by bacterial toxins 
as suggested in the case of S. iniae infected fish (Ferguson et al., 1994). The development of 
these thrombi will most probably compromise widely the health status of the fish remaining 
at the end of the challenge period. 
Concerning the fish infected with ST23, the concentration of viable bacteria decreased over 
time, with almost no viable bacteria recovered from fish at day 14 p.i. In histopathology, a 
mixed inflammatory response associated with the presence of bacteria was observed in the 
choroid rete and in the pancreatic tissue; lesions evolved towards the formation of MMC-
like structures in the rete and pyo-granulomata in the pancreatic tissue. These structures, as 
well as the MMCs within the spleen and kidney, were strongly positive for bacterial 
antigens as shown by IHC.  Bacteria were restricted to these structures and possibly were 
non-viable as suggested from the colony counts data. In the case of ST23, the infection 
therefore appeared to be well-contained, suggesting that the ST23 strain does not 
successfully evade the immune system of the fish nor does it survive within macrophages, 
explaining the absence of systemic lesions with this bacterial strain. 
Numerous studies investigating the fate of antigenic and non-antigenic particulates within 
the bloodstream of fish have been published (Ellis, 1980; Secombes and Manning, 1980; 
Ferguson et al., 1976 and 1982). Some of these studies reported that following the initial 
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trapping and phagocytosis of particulates in the ellipsoidal sheaths of the spleen, phagocytic 
cells progressively migrate towards MMCs, leaving ellipsoids clear of any particulate 
matter. Ferguson (1976) however hypothesised that in the turbot (Scophthalmus maximus) 
spleen MMCs directly arose in and budded out from the ellipsoid sheaths. Interestingly, 
both processes were observed in the study presented. In the case of fish infected with 
ST260, a marked increase in the size of ellipsoids due to an accumulation of macrophages 
within and surrounding the sheaths was observed, phenomena unreported in previous 
studies but compatible with the high phagocytic activity necessary in the area. Bacteria 
trapped within ellipsoids at day 1 were phagocytosed and numerous aggregates of bacteria-
laden macrophages were then observed adjacent to the ellipsoids; this progressed towards 
the formation of MMCs. Our observations suggested that numerous MMCs arose from the 
ellipsoids in the course of infection possibly in an attempt to directly constrain the bacteria 
within encapsulated structures. In the case of fish infected with ST23, however, 
observations differed. Low numbers of bacteria were observed by IHC within ellipsoids at 
day 1, day 3 and day 7, but only at day 14 was there positive labelling of bacterial antigen 
within MMCs. Melano-macrophage centres were not present in higher numbers from the 
ST23-infected fish and such “budding” of MMCs as observed with ST260 was not 
observed. In this case it appeared that macrophages from the spleen and possibly elsewhere 
migrated to pre-existing MMCs. This might be explained by the fact that ST23 does not 
appear to survive within macrophages resulting in no urgent need to encapsulate those 
directly after phagocytosis. 
One ST260 infected fish sampled at day 14 p.i. was found to be co-infected by a bacterium 
other than S. agalactiae; this was identified as an Aeromonas species. Aeromonas species 
are a common part of intestinal microflora of fish and well recognised opportunistic 
pathogens responsible for secondary infections (Cahill, 1990; Hu et al., 2012). Among the 
other bacteria recovered and confirmed as S. agalactiae, it cannot be excluded that a distinct 
S. agalactiae was involved. In humans, S. agalactiae exists as part of the normal bacterial 
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flora in the recto-vaginal tract and it also causes neonatal disease through vertical 
transmission, suggesting adaptive changes to a new environment with up-regulation or 
activation of specific genes involved in virulence (Yang et al., 2010). Streptococcus 
agalactiae is considered therefore to be a commensal and potentially an opportunistic 
pathogen in humans. In fish, asymptomatic carriage of S. agalactiae has never been 
reported, but to our knowledge no study has ever evaluated this possibility. For this reason, 
it was important that bacteria recovered during the challenge not only were confirmed as S. 
agalactiae, but also were subjected to PFGE. The subset of isolates subjected to PFGE 
allowed a partial exclusion of secondary infection by strains of S. agalactiae other than the 
challenge strains. 
This study provided further understanding of the survival of bacteria and progression of 
associated lesions during the time course of an infection, using two distinct S. agalactiae 
strains. In all cases, the formation of granulomata or other encapsulated structures appeared 
to be a major component of the fish response. However, the virulence of the two strains 
differed strongly; unlike the ST23 strain, the ST260 appeared to evade the immune system, 
possibly survived within macrophages, and caused major lesions in all infected fish. 
Streptococcus agalactiae is a multi-host pathogen, but molecular epidemiological studies 
demonstrated that specific clones are associated with specific niches, e.g. ST260 with 
poikilothermic hosts, ST67 with cattle, ST23 with bovines and humans (Chapter 2). 
Furthermore, experimental challenge studies indicate that these associations are not only 
due to differences in exposure, but that it may correspond to niche-dependant variations in 
the virulence of strains. Comparative genomic or transcriptomic studies and identification of 
genes putatively associated with virulence and adaptation in fish are required to provide 
further understanding into the fitness of specific S. agalactiae clones in fish. 
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4 CHAPTER 4 
Comparative genomic analysis of Streptococcus agalactiae: 
evidence for niche restriction in a piscine lineage. 
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4.1 ABSTRACT 
In addition to causing local or systemic infections in humans and mastitis in bovines, S. 
agalactiae is also a major cause of systemic disease in fish. Here we provide the first 
description for the genome sequence of a non-haemolytic S. agalactiae isolated from tilapia 
(strain STIR-CD-17) and belonging by multi-locus sequence typing (MLST) to clonal 
complex (CC) 552, which corresponds to a presumptive fish-adapted subgroup of S. 
agalactiae. The genome was compared to 13 S. agalactiae genomes from human (n=7), 
bovine (n=2), fish (n=3) and unknown (n=1) origins. Phylogenetic analysis based on the 
core genome identified isolates of CC552 as the most diverged of all S. agalactiae. 
Conversely, genomes from β-haemolytic isolates of CC7 recovered from fish were found to 
cluster with human isolates of CC7, further supporting the possibility that some strains may 
represent a zoonotic or anthroponotic hazard. Comparative analysis of the accessory 
genome enabled the identification of a cluster of genes uniquely shared between CC7 and 
CC552, and encoding for proteins possibly providing enhanced fitness in specific niches. 
Other genes identified were specific to STIR-CD-17 or to CC552 based on genomic 
comparisons; however the extension of this analysis through the PCR screening of a larger 
population of S. agalactiae suggested that some of these genes may occasionally be present 
in isolates belonging to CC7. Some of these genes, occurring in clusters, exhibited typical 
signatures of mobile genetic elements, suggesting their acquisition through horizontal gene 
transfer. It is not possible to date to determine whether genes were acquired through 
intraspecies transfer or through interspecies transfer from the aquatic environment. Finally, 
general features of STIR-CD-17 highlighted a distinctive genome characterised by an 
absence of well-conserved insertion sequences, an abundance of pseudogenes, a smaller 
genomic size than observed among human or bovine S. agalactiae, and an apparent loss of 
metabolic functions considered conserved within the bacterial species, indicating that the 
fish-adapted subgroup of isolates (CC552) has undergone niche restriction. 
Keywords: Genome, Streptococcus agalactiae, tilapia, ST260 
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4.2 INTRODUCTION 
Streptococcus agalactiae has been the subject of numerous typing studies over the past 
decades, with multi-locus sequence typing (MLST) generally accepted as the standard 
typing method for global population studies (Urwin and Maiden, 2003). Isolates were found 
to cluster into well-defined clonal complexes (CCs), with some of those corresponding to 
sub-populations associated with specific host-species or clinical manifestation. Among the 
different clonal complexes identified in humans, CC17 corresponds to a very homogenous 
group exclusively adapted to humans and that is over-represented among isolates 
responsible for invasive infections in neonates (Brochet et al., 2006). Other isolates found in 
humans mostly belong to CC1, CC19 and CC23, but no strong correlation between these 
isolates and human carriage or invasion was found (Jones et al., 2006). Moreover, isolates 
belonging to CC23 are occasionally identified in other host species, including bovines, and 
an expanded MLST scheme provided evidence for two distinct clusters of CC23 exclusively 
associated with either humans or bovines (Sørensen et al., 2010). In bovines, however, the 
vast majority of mastitis-causing isolates belong to CC67, which is considered to constitute 
the bovine-adapted subpopulation of S. agalactiae (Bisharat et al., 2004), even though more 
recent work shows that other strains may be involved (Sørensen et al., 2010; Zadoks et al., 
2011). Finally, a putatively fish-adapted subpopulation (CC552) has recently been described 
(Chapter 2), whereas other isolates identified in fish belong to the human-associated CC7 
and CC283 (Chapter 2; Evans et al., 2008). 
In the past decade, seven S. agalactiae isolates from human origin and one isolate of 
uncertain origin have had their whole genome sequenced. These isolates belong to the major 
representative CCs encountered in humans (CC1, CC17, CC19 and CC23), in addition to 
the less common CC7. Comparative genomic analyses of these strains revealed a composite 
organisation with around 80% of genes shared by all strains - the core or backbone genome 
– and 20% of genes not present in all strains – the dispensable or accessory genome 
(Tettelin et al., 2005). A total of 358 genes specific to single strains were uncovered, and 
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prediction analyses further suggested that each additional S. agalactiae genome sequenced 
would reveal approximately 33 previously uncharacterised genes (Tettelin et al., 2005 and 
2008). Many of the strain-specific genes cluster within 11 to 14 large variable regions called 
genomic islands (Glaser et al., 2002; Tettelin et al., 2005; Brochet et al., 2008a), most of 
which correspond to putative integrative conjugative elements and related elements 
(Brochet et al., 2008b). Through their plasticity and potential for gene acquisition and 
transfer, these genomic islands have literally shaped the evolution of S. agalactiae through 
acquisition of genes that may enhance fitness and virulence in specific environments 
(Brochet et al., 2008a; Tettelin et al., 2008). Furthermore, some genes may well have been 
acquired from other bacterial species (Davies et al., 2009; Tettelin et al., 2005). For 
example, a region unique to one of the seven S. agalactiae genomes was found to be shared 
with S. pneumoniae, i.e. a region that contains an α-galactosidase and a system for transport 
and metabolism of sugars which may be of importance for use of the host α-galactosides 
(Tettelin et al., 2005). 
More recently, two isolates of S. agalactiae belonging to the bovine adapted sub-group 
(CC67) have had their genome sequenced. One of those genomes has been the subject of a 
comparative study against the human S. agalactiae genomes (Richards et al., 2011), which 
unveiled distinctive features with 183 genes believed to be specific to the bovine strain. 
PCR screening of a global collection of bovine and human S. agalactiae further supported 
that most of the specific genes are strongly correlated with a bovine origin. Some of those 
genes are suggested to contribute to virulence in bovines (e.g. LPXTG anchored proteins) or 
to provide metabolic advantages (e.g. lactose operon). As for the human S. agalactiae, these 
genes mostly clustered into major genomic islands, with strong support for them having 
been acquired horizontally (Richards et al., 2011). Furthermore, the authors provided 
evidence that some of these genes have been acquired by horizontal gene transfer between 
bovine S. agalactiae and other mastitis-causing Streptococcus species that are commonly 
found in cattle. Finally, the bovine S. agalactiae genome was found to contain a high 
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frequency of insertion sequences, which supports the hypothesis that an evolutionary 
bottleneck resulted in the isolation of this population (Richards et al., 2011).  
Last year, a number of genome announcements describing S. agalactiae from fish were 
published (Wang et al., 2012; Liu et al., 2012). However, the selection of these isolates 
often appeared to be arbitrary, and no in-depth genomic analyses of these isolates have been 
published so far. In the present study, for whole genome sequencing, we rationally selected 
a fish isolate based on previous in vitro (Chapter 2) and in vivo (Chapter 3) work. The 
selected strain belongs to a fish-adapted subgroup of S. agalactiae (CC552) and was 
observed to be highly virulent in Nile tilapia following experimental intra-peritoneal 
infection. In addition to describing general features of this genome, we compared it to 
existing S. agalactiae genome sequences at the level of the core and the accessory genome, 
with a particular focus on the identification of genes specific to the fish strain. We 
subsequently screened additional isolates from distinct origins for the presence/absence of 
these genes to provide preliminary evidence for their putative importance for virulence or 
adaptation in fish. 
4.3 MATERIALS & METHODS 
 4.3.1 Bacterial isolate 
The S. agalactiae strain STIR-CD-17 used in this study was isolated from the heart of a 
moribund fish during a disease outbreak affecting farmed tilapia (Oreochromis sp.) in 
Honduras in 2008. It was selected among our collection of S. agalactiae from aquatic hosts 
based on previous epidemiological, phenotypic and genotypic characterisation (Chapter 2). 
The isolate is non-haemolytic, a trait that is relatively common among isolates from fish and 
cattle but rare among human isolates (Finch & Martin, 1984; Evans et al., 2008).The isolate 
belongs to sequence type (ST) 260 and CC552, corresponding to a cluster of strains that has 
been associated exclusively with disease in aquatic poikilotherms (fish and frogs) (Chapter 
2; Lopez Sanchez et al., 2012). The strain was also subjected to standardized 3-set 
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genotyping developed for human S. agalactiae which is based on the determination of 
serotype and detection of 7 surface protein encoding genes (bca, bac, alp1, alp2, alp3, alp4 
and rib) and 7 mobile genetic elements (IS1381, IS861, IS1548, ISSa4, ISSag1, ISSag2 and 
GBSi1) using PCR (Chapter 2). STIR-CD-17 was found to be of serotype Ib but none of the 
surface protein genes or mobile genetic elements were present, further supporting the fact 
that it does not appear to be closely related to S. agalactiae of human origin. Finally, 
experimental challenge by intra-peritoneal injection showed that the isolate caused high 
morbidity and mortality in Nile tilapia (Chapter 3). 
4.3.2 Growth conditions and DNA extraction 
The bacterial isolate, which had been stored as a glycerol stock at -80˚C, was streaked onto 
5% (v/v) sheep blood agar plates (SBA; E&O Laboratories, Bonnybridge, UK) and grown 
aerobically at 28°C for 72h in order to assess purity and haemolytic properties. The isolate 
was Gram-stained and confirmed to belong to Lancefield Group B by a group B-specific 
latex agglutination test (Slidex Strepto Plus
 
B; bioMérieux, Marcy L'Étoile, France). A 
single colony was then selected and used to inoculate 5ml of Brain Heart Infusion broth 
(BHI; Oxoid, Basingstoke, United Kingdom). After overnight static incubation at 28˚C in an 
aerobic environment, genomic DNA was extracted from cells harvested from 1ml of BHI 
culture using an Epicentre MasterPure Gram-positive DNA purification kit (Epicentre, 
Madison, WI) with modifications for optimal recovery of S. agalactiae DNA. Briefly, 
bacterial culture was centrifuged, supernatant was removed and cells were re-suspended in 
150μl of TE Buffer (10 mM Tris-hydrochloride buffer, pH 7.5, containing 1.0 mM EDTA), 
6μl of mutanolysin (5U/μl; Sigma-Aldrich, Irvine, UK) and 1μl of ready to use lysozyme (as 
provided by the manufacturer), and with incubation at 37°C for 1 hour. The remainder of the 
protocol was performed according to manufacturer’s instructions, with the exception of the 
Proteinase K/Gram Positive Lysis Solution incubation time (30 min instead of 15 min) and 
the RNase incubation time (1 hr instead of 30 min). DNA concentration was quantified 
using a NanoDrop 1000 (Thermo Scientific) and the product (0.5μg) visually examined on a 
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Gel Red (Cambridge Bioscience, Cambridge, UK) stained 0.8% agarose gel (running 
conditions: 100V/cm for 1 hr) in order to assess the absence of DNA shearing. 
4.3.3 Genome sequencing, assembly and annotation  
Genome sequencing (100bp paired-end reads) was performed using an Illumina Solexa 
Genome Analyzer by the Genepool sequencing core facility (University of Edinburgh, UK). 
De novo assembly of Solexa reads was achieved by Genepool using VELVET 0.6 and 
yielded 208 contiguous sequences (Contigs). Because of time constraints, no attempt was 
made to close the genome or to organise the Contigs into a meaningful order. Following 
instructions from the National Centre for Biotechnology Information (NCBI) Prokaryotic 
Genomes Automatic Annotation Pipeline (PGAAP; http://www.ncbi.nlm.nih.gov/genom-
es/static/Pipeline), all Contigs of less than 200 nucleotides were removed and the remaining 
96 Contigs were submitted for annotation through the PGAAP. The draft genome sequence 
of S. agalactiae STIR-CD-17 has been deposited in GenBank under the accession number 
ALXB00000000. 
4.3.4 Genomic analysis for strain identity confirmation  
The molecular typing results obtained by PCR analysis of STIR-CD-17 (described in 
Chapter 2 and summarized in section 4.3.1.) were all evaluated by in-silico analysis of the 
genome. 
Firstly, the species identity was assessed by identification of the cfb gene and genes 
involved in group B carbohydrate biosynthesis within the STIR-CD-17 genome. For MLST, 
the sequence of the seven housekeeping genes described by Jones et al. (2003) were 
retrieved from the genome and submitted to the MLST database (http://pubmlst.org/) for 
locus type and ST assignment.  
The presence/absence of the 7 surface protein-encoding genes and 7 mobile genetic 
elements assessed as part of the 3-set genotyping was evaluated using BioEdit software 
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(Hall, 1999; http://www.mbio.ncsu.edu/bioedit/bioedit.html). A local nucleotide database 
file for STIR-CD-17 was created within BioEdit, thereby enabling the identification of the 
presence of known nucleotide sequences within STIR-CD-17 through the Basic Local 
Alignment Search Tool (BLASTN). Reference nucleotide sequences for the 7 surface 
protein-encoding genes and mobile elements were extracted from NCBI (GenBank 
accession numbers as provided in Chapter 2, Table 2.1) and BLAST searched against the 
STIR-CD-17 genome using BioEdit.  
The 3-set genotyping system also involves identification of the capsular serotype, for which 
the genetic basis lies within the cps genes. The cps genes from STIR-CD-17 were 
investigated through BLASTN search analysis (http://www.ncbi.n-lm.nih.gov/BLAST) to 
compare them with sequences from the GenBank database. The complete cps locus of 
STIR-CD-17 was also compared to that of H36B (serotype Ib) and A909 (serotype Ia) using 
the Artemis Comparison Tool (ACT; Carver et al., 2008) provided by the Sanger Centre 
(http://www.sanger.ac.uk/Software/ACT). This software requires genome or Contig 
information to be provided as Fasta and GeneBank format files, in addition to a comparison 
file. To generate comparison files, the DOUBLE ACT v2 web interface (http://www.hpa-
bioinfotools.org.uk/pise/double_act.html) was used using BlastN and default settings. 
Finally, the cyl operon which is the genetic basis for beta-hemolysin/cytolysin production 
(Pritzlaff et al., 2001) was analysed in order to investigate whether it would provide an 
explanation for the non-haemolytic phenotype. For this, nucleotide sequence from STIR-
CD-17 was compared to that of the non-haemolytic isolate ATCC13813 (www.atcc.org/) 
and that of the beta-haemolytic isolate A909 using ACT. 
4.3.5 General genomic analysis for prediction of sub-cellular 
localization and function of putative proteins 
In silico prediction of sub-cellular localization of proteins encoded by the genome was 
performed using the PSORTb program version 3.0.2 (http://psort.org; Yu et al., 2010), 
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employing the model built for Gram positive bacteria. PSORTb is able to categorize 
predicted proteins in one of the following localization sites: cytoplasm, cytoplasmic 
membrane (inner membrane), outer membrane, and extracellular space. However, the 
program does not necessarily lead to a specific prediction and the localization site can be 
designated as unknown.  
Functional categories of proteins were provided by the PGAAP based on the analysis of 
Clusters of Orthologous Genes (COGs) using the COGnitor program (Tatusov et al. 2001) 
(http://www.ncbi.nlm.nih.gov/COG/xognitor.html). In order to assess the putative function 
of hypothetical proteins with no associated COG, nucleotide sequences were screened for 
conserved Pfam domains (http://pfam.sanger.ac.uk/search). 
4.3.6 Comparative genomic analysis 
The complete list of annotated S. agalactiae genomes publicly available from GenBank 
(Feb. 2012) and used in this study for comparative genomic analyses is reported in Table 
4.1. It consists of seven S. agalactiae of human origin, two S. agalactiae of bovine origin 
and one S. agalactiae of unknown origin. Moreover, the genomes of three S. agalactiae of 
piscine origin that have been made available more recently (after May 2012) have been 
added to the table and included in some of the analyses. 
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Table 4.1 Origin, clonal complex (CC), sequence type (ST), serotype and accession number for genomes used in the comparative genomic studies.  
 
Strains in bold indicate those for which the complete genome is available. The STs and corresponding CCs are presented as provided in the key references. For strains 
with no ST report (ZQ0910, SA20-06 and ATCC13813), MLST was carried out in silico by extracting from the genomes the seven housekeeping genes described by 
Jones et al. (2003) and submission of those into the MLST database (http://pubmlst.org/) for locus type and ST assignment. NA, Not Available. 
Host  of origin Strain ID Source Country CC ST Serotype Accession Number Key references
Unknown NEM316 NA NA 23 23 III NC_004368 Glaser et al., 2002; Sørensen et al., 2010 
Human COH1 Blood NA 17 17 III NZ_AAJR00000000 Tettelin et al., 2005
CJB111 Blood NA 1 1 V NZ_AAJQ00000000 Tettelin et al., 2005
2603V/R NA NA 19 110 V NC_004116 Tettelin et al., 2002
18RS21 Umbilicus USA 19 19 II NZ_AAJO00000000 Tettelin et al., 2005; Lancefield et al., 1975
515 Cerebrospinal fluid NA 23 23 Ia NZ_AAJP00000000 Tettelin et al., 2005
A909 Umbilicus NA 7 7 Ia NC_007432 Tettelin et al., 2005;  Lancefield et al., 1975
H36B Umbilicus USA 7 6 Ib NZ_AAJS00000000 Tettelin et al., 2005;  Lancefield et al., 1975
Bovine FSL S3-026 Milk USA 67 67 III AEXT00000000 Richards et al., 2011
ATCC 13813 Milk NA 67 61 II AEQQ00000000 NA
ZQ0910 NA China 7 7 NA AKAP01000000 Wang et al., 2012
GD201008-001 NA China 7 7 Ia CP003810. Liu et al., 2012
SA20-06 Brain Brazil 552 553 Ib NC_019048 Mian et al., 2009; Pereira et al., 2010
STIR-CD-17 Heart Honduras 552 260 Ib ALXB00000000 Delannoy et al., 2012
Fish (Nile 
tilapia)
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4.3.6.1 Comparative genomic analysis of the core genome 
In order to automatically extract, concatenate and align nucleotide sequences from the core 
genome of S. agalactiae, we used the Panseq v.2.0. Web server (http://lfz.corefaci-
lity.ca/panseq/; Laing et al., 2010) which is a multifunctional Web-based tool designed to 
analyse closely-related genomes. For this, the “Core/Accessory Genome Analysis Function” 
was selected and genomic sequences loaded within the interface. The program was 
configured using default settings except that the core genome threshold was set to 10 so that 
any region not found in all 10 genomes was removed. The Web server only allows the 
analysis of 10 genomic sequences which were selected from those listed in Table 4.1 all S. 
agalactiae genomes from fish (n=4) and bovines (n=2), and four genomes from human 
origin (515, COH1, H36B and A909). The resulting nexus file for the core genome was then 
loaded into SEAVIEW (Gouy et al., 2010). The Gblocks program (Castresana, 2000) 
implemented within SEAVIEW was used to discard ambiguous regions and gaps, followed 
by a degree of manual refining. The final alignment of 803,614 bp-long sequences was then 
subjected to phylogenetic analysis using the TOPALi v2.5 package (Milne et al., 2004). For 
this, the model was optimised using the model selection feature in TOPALi which ensured 
the selection of the best model parameters for generating trees with our specific dataset. The 
selected model (general time reversible model [GTR] combined with the models of gamma 
distribution [G] and invariable sites [I], referred to as GTR+G+I; Rodríguez et al., 1990) 
was then used to estimate a Bayesian phylogenetic tree using the MrBayes program 
(Ronquist et al., 2003) launched from TOPALi. The MrBayes settings were 2 runs of 
625,000 generations and a burn-in period of 125,000 generations, with trees sampled every 
10 generations and inclusion of invariable sites. The consensus tree was then imported into 
DENDROSCOPE v3.2.1 (Huson et al., 2007), where visualization and editing were 
performed as required.  
A second tree was constructed in which the number of genomes representing the same CC 
was reduced in order to include other genomes; 2 S. agalactiae genomes from fish (STIR-
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CD-17 and GD201008-001), 1 genome from bovine (FSL S3-026), 4 genomes from humans 
(COH1, 18RS21, 2603V/R, 515, CJB111 and H36B) and 1 genome of unknown origin 
(NEM316) were used. The tree was generated identically as previously described, except 
that it was built on a core genome alignment of 921,707 bp-long sequences.  
4.3.6.2 Comparative genomic analysis of the accessory genome 
4.3.6.2.1 GeneRator analysis 
A comparative study was undertaken using an in-house software, developed at the Moredun 
Research Institute and called GeneRator. GeneRator is a graphical tool for comparing 
predicted proteins in annotated genomes (Figure 4.1). As an input it requires a list of 
predicted protein sequences for each genome (in Fasta format), including one reference 
genome and numerous comparison genomes. GeneRator performs a reciprocal BLAST 
comparison between each predicted protein of the reference genome against those of the 
other genomes. Moreover, for each position it then calculates if protein pairs are reciprocal 
best hits to provide an estimate of the homology between amino-acid sequences. The output 
is graphical with the predicted proteins from the reference genome displayed on the top line 
and their corresponding best BLAST hit within the comparison genomes shown below. 
Proteins are represented in blocks that are colour coded. Block colours within the reference 
genome indicate the putative general function of the predicted proteins based on COG 
classification.  Block colours within the comparison genomes indicate the level of homology 
(BLASTP score) between the predicted reference and comparison proteins, with the border 
colour indicating whether or not these sequences are reciprocal best hits. The reference 
genome used in this analysis was STIR-CD-17 and the comparison genomes were the 10 S. 
agalactiae genomes publicly available from GenBank at the time of analysis (March 2012), 
consisting of seven isolates of human origin, two isolates of bovine origin and one isolate of 
unknown origin (Table 4.1). Based on this analysis, predicted protein sequences from 
STIR-CD-17 that did not find a reciprocal best hit with a BLAST score > 80 in the other 
genomes were identified and their corresponding genes considered putatively strain-specific 
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or fish-specific. Predicted amino acid sequences from STIR-CD-17 that did find a reciprocal 
best hit with a BLAST score > 80 in genomes belonging to CC7 (A909 and H36B) only 
were also identified, and their corresponding genes considered putatively fish-associated 
because isolates belonging to CC7 occur in fish (Chapter 2).  
4.3.6.2.2 Normalised BLAST score ratio analysis  
To assess the homology between predicted proteins whilst correcting for query length to 
avoid skewed results (as would be obtained with E-values), a normalised BLAST score ratio 
(BSR) analysis was used. The BSR analysis performed here was a modification of the 
technique described by Rasko et al. (2005), which enables assessment of relatedness of 
predicted proteins using BLAST. Predicted proteins of STIR-CD-17 selected as putatively 
fish-specific or fish-associated based on GeneRator analysis (section 4.3.6.2.1) were 
BLASTP searched against the NCBI reference proteins database (http://www.ncbi.n-
lm.nih.gov/BLAST; last accessed 13 Jan. 2013). For each protein, the BLASTP bit-score for 
the alignment against itself (REF_SCORE) and for the most similar proteins within the 
database (QUE_SCORE) was obtained and normalized by dividing the QUE_SCORE by 
the REF_SCORE. Amino acid sequences with a normalized bit-score ≥ 0.8 were considered 
as homologous. Normalized bit-scores < 0.8 were an indication of divergence (0.4 < BSR < 
0.8) or uniqueness (BSR, ≤ 0.4) (Rasko et al., 2005).The BSR analysis enabled to confirm 
results obtained through GeneRator analysis. Moreover, the BSR analysis was extended to 
the whole NCBI database, including other Streptococcus species as well as the new S. 
agalactiae genomes from fish (Table 4.1) which had been lodged with GenBank after 
completion of the GeneRator analysis. 
4.3.6.2.3 ACT comparisons 
Using GeneRator and BSR analyses, genes of interest were selected based on comparative 
studies of their corresponding proteins. However it was recognised that such analyses might 
be biased by annotation discrepancies between genomes and it was therefore necessary to 
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confirm observations at the nucleotide level. For this, genome sequences were compared 
pairwise using the Artemis Comparison Tool (ACT) as previously described (section 4.3.4). 
The ACT comparison not only allowed for confirmation of presence/absence of genes 
within genomes, but it also provided insights into the genetic organisation and conservation 
of sequences flanking regions of interest. Due to time constraints, ACT comparisons were 
performed against a limited number of other genomes (minimum of 3) which were selected 
based on individual findings.  
4.3.7 Distribution of selected genes across S. agalactiae from 
different host species 
Our 3-step comparative analysis (GeneRator/BSR/ACT) led to the identification of 
candidate strain-specific genes (unique to STIR-CD-17), fish-specific genes (unique to 
isolates belonging to CC552; STIR-CD-17 and SA20-06) and fish-associated genes (unique 
to isolates belonging to CC7 and CC552; A909, H36B, ZQ0910, GD201008-001, STIR-
CD-17 and SA20-06).  
 
 
 
Figure 4.1 (next page) Example of the GeneRator software output from comparison of S. 
agalactiae genomes. Predicted proteins from the reference genome (STIR-CD-17) are displayed as 
blocks on the top line and the position of their corresponding gene within the genome is indicated 
above these blocks. These blocks are colour coded based on putative general function provided by 
the Cluster of Orthologous Groups (COG) classification. Results of the reciprocal BLASTP 
comparison between predicted proteins from the reference genome against proteins from the 
comparison genomes are provided as block in the following 10 lines. Block colours in the 
comparison genomes indicate the level of homology (BLASTP score) between the reference and 
comparison sequences whilst the border colour indicates whether these sequences are reciprocal best 
hits. The border colour can be grey or black; the reciprocal best hits are grey only. Based on this 
analysis, protein sequences from STIR-CD-17 that did not find reciprocal best hits with a BLAST 
score > 80 in the other genomes were retained and considered as putatively strain-specific or fish-
specific. An example is shown for predicted proteins of unknown function. 
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STIR-CD-17
18RS21
2603V/R
515
A909
13813
CJB111
COH1
FSL S3-026 
H36B
NEM316 
Cluster of orthologous (COG) groups of proteins
Homology groups (BlastP score)
Predicted proteins present in STIR-CD-17 that do not find
any reciprocal best hit with a BLASTP score >80 in the
comparative genomes. These predicted proteins are
therefore fulfilling our criteria of putative strain-specific
material.
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Conservation of genes of interest was assessed among a panel of S. agalactiae of bovine and 
aquatic origin. Internal primers were designed for 1 strain-specific gene, 1 fish-specific gene 
and 3 fish-associated genes using the Primer Select module of the DNAStar computer 
program from Lasergene (DNASTAR Inc., Madison, USA). A description of selected genes 
and primers is provided in Table 4.2. Although false negatives could be obtained due to 
nucleotide polymorphism at the priming sites, the relatively low level of nucleotide 
divergence observed at the intra-specific level of Streptococcus species should render this a 
rare event (Richards et al., 2011). The aquatic S. agalactiae selected for PCR screening 
corresponded to the 26 fish isolates and 6 sea mammal isolates from the collection described 
in Chapter 2 (section 2.3.1). The bovine isolates were rationally selected from a collection 
of 71 isolates based on whole genome typing by PFGE and core genome typing by MLST 
(unpublished data, R.N. Zadoks). A final panel of 19 isolates with distinct PFGE patterns 
and including 4 different STs were assessed in this study; these were all obtained from 
quarter milk samples collected from dairy cows in Denmark (Isolates provided by Y. 
Mahmod, Faculty of Health and Medical Sciences, Copenhagen University, Denmark). 
The identity of all bacterial isolates was confirmed and chromosomal DNA prepeared as 
previously described (section 2.3.1). PCR reactions were performed in a final 25μl volume 
containing 12.5μl of GoTaq Green Master Mix (Promega, Madison, USA), 0.25 μM of each 
primer and 2 μl of DNA template. The thermal cycling was conducted as follows: 
denaturation of DNA at 94°C for 5 min followed by 35 cycles of 94°C for 1 min, 49
 o
C to 
61°C for 45 sec and 72°C for 30 sec, with a final step at 72°C for 7 min. The annealing 
temperature varied between 49
o
C and 61
o
C depending on the primers used (melting 
temperatures supplied by the manufacturer - Eurofins MWG Operon, Munich, Germany). 
The PCR products for all reactions were visualized following electrophoresis through a 
1.5% (w/v) agarose gel containing Gel Red (Cambridge Bioscience, Cambridge, UK). 
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Table 4.2. Putative S. agalactiae strain-specific, fish-specific and fish-associated gene targets 
and the PCR primers used for their detection.  
 
Melting temperatures (Tm) were provided by the manufacturer (Eurofins MWG). 
 
4.4 RESULTS AND DISCUSSION 
4.4.1 Genome structure and general features 
The draft genome was composed of 96 Contigs and contained a total of 1,805,303 
nucleotide residues. Complete and draft genomes of S. agalactiae from human origin range 
from 2.09 Mb (S. agalactiae 515) to 2.3 Mb (S. agalactiae A909), whereas those from 
bovine origin range from 2.11 Mb (S. agalactiae ATCC13813) to 2.46 Mb (S. agalactiae 
FSL S3-026). The STIR-CD-17 genome is therefore of reduced size in comparison to other 
genomes, an observation which might either be real, or instead indicate its incomplete 
nature. New evidence based on complete S. agalactiae genome sequences from fish 
suggests that strains belonging to the putatively fish-adapted subgroup of S. agalactiae 
(CC552; Chapter 2), like STIR-CD-17, have a genome of reduced size. Indeed, the complete 
SA20-06 strain (ST553) is approximately 1.82 Mb, whereas the 2 other S. agalactiae 
genomes from fish, that belong to a human-related subgroup (CC7; Chapter 2) have a size 
larger than 2Mb. In STIR-CD-17, the average G+C content (35%) and the number of rRNA 
and tRNA genes (21 and 80 respectively) are lower than previous reports from other S. 
agalactiae genomes. Such observations are not supported by the complete SA20-06 
Target Locus tag Primer sequence Tm 
Strain-specific gene
71 AAATAATCCGATTGTTCCTG 91 51.2
346 ATATACTATAAATTTCCCTTCTAA 321 50.8
Fish-specific gene
 5 CTATGCCGAAGATGATTATTTG 28 54.7
491 CTTCTTGGCGTAGTTCCTCAGTA 467 60.6
Fish-associated genes
466 AAATCGGCAAGCAGACAGAAAATGAAT 494 60.4
1041 GCAATAGCACAACCGCCAAAACC 1017 62.4
663 AAGGGTGCTAGTAGTGCCGAACATAAT 691 63.4
1113 AACCAGCCATCATCCATAACAAAAAGT 1085 60.4
489 ATTGGTATTTGGAGCACTGTAGG 513 58.9
740 TCTTATTATAGGCCGGACTTGTA 716 57.1
Galactokinase
Alpha galactosidase
Sugar ABC transporter permease M3M_01182
M3M_01167
M3M_01172
 Beta-hydroxyacyl dehydratase 
FabA/FabZ
M3M_04280
Putative RecB familly exonuclease 
(cas4)
M3M_01062
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genome, suggesting that the G+C content might be biaised by the incompleteness of the 
STIR-CD-17 genome. 
Altogether a total of 1,697 protein-encoding genes were predicted automatically, with 506 
(29.8%) of the predicted products being annotated as hypothetical proteins. In addition, 102 
pseudogenes, in which frameshift and nonsense mutations introduced multiple stop codons 
throughout the gene, were identified. The 1,697 predicted genes of S. agalactiae were sorted 
with respect to COG classification (Table 4.3), which enables the allocation of general 
functions to predicted proteins, including some of those annotated as hypothetical. A total of 
352 (20.73%) genes were determined to be associated with information storage and 
processing, 268 (15.8%) with cellular processes and signaling, and 548 (32.3%) with 
metabolism. Finally, a total of 529 (31.2%) residual genes, which could not be categorized 
into COG classes, had poorly characterized functions and features. 
In addition, a report from the PGAAP revealed that genes with functions considered as 
conserved amongst the S. agalactiae species (core genome) are missing from the STIR-CD-
17 genome. This concerns genes with the following functions: 1,4 dihydroxy-2-naphthoate 
octaprenyltransferase, peptide deformylase, glutamate dehydrogenase, acid 
phosphatase/phosphotransferase, preprotein translocase subunit SecY, and fructose-6-
phosphate aldolase. Whether or not this information corresponds to a true absence would 
require further assessment (see Chaper 4 section 4.4.6 and Chapter 5 section 5.4.1.3). 
4.4.2 Strain identity confirmation 
Using genomic data, STIR-CD-17 was confirmed as S. agalactiae and belonging to 
Lancefield group B by identification of the conserved group B carbohydrate biosynthesis 
locus and the cfb gene, both of which are considered to be unique to the species S. 
agalactiae (Podbielski et al., 1994; Sutcliffe et al., 2008).  
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Table 4.3 Distribution of predicted proteins among functional categories based on COG 
classification. 
 
The strain was found to be of ST260 by PCRs and sequencing of PCR products; this result 
was further assessed using genomic data. All locus types obtained from in silico analysis 
corresponded to those of ST260 with the exception of the tkt gene. The ST260 has allele 19 
at the tkt locus, but the sequence extracted from the genome differed from allele 19 by one 
nucleotide. According to the genome sequence, STIR CD-17 is therefore not of ST260 but 
would be a single locus variant of ST260. It is unknown if this inconsistency is due to a 
sequencing error or to a point mutation that might have occurred after repeated sub-culture. 
Similar discrepancies between isolate locus type based on PCR and amplicon sequencing 
versus extraction of sequence from whole genome sequence data have also been observed 
for Streptococcus canis (R.N. Zadoks, personal communication). 
No. %
Information storage and processing 20.7
J Translation, ribosomal structure, and biogenesis 146 8.6
A RNA processing and modification 0 0.0
K Transcription 110 6.5
L Replication, recombinaison and repair 96 5.7
B Chromatin structure and dynamic 0 0.0
Cellular processes and signaling 15.8
D Cell cycle control, cell division and chromosome partitioning 17 1.0
Y Nuclear structure 0 0.0
V Defense mechanisms 43 2.5
T Signal transduction mechanisms 46 2.7
M Cellwall/membrane/envelope biogenesis 89 5.2
N Cell motility 5 0.3
Z Cytoskeleton 0 0.0
W Extracellular structures 0 0.0
U Intracellular trafficking, secretion, and vesicular transport 17 1.0
O Posttranslational modification, protein turnover, and chaperones 51 3.0
Metabolism 32.3
C Energy production and conversion 45 2.7
G Carbohydrate transport and metabolism 140 8.2
E Amino acid transport and metabolism 131 7.7
F Nucleotide transport and metabolism 65 3.8
H Coenzyme transport and metabolism 40 2.4
I Lipid transport and metabolism 40 2.4
P Inorganic ion transport and metabolism 70 4.1
Q Secondary metabolite biosynthesis, transport and catabolism 17 1.0
Poorly characterized 31.2
R General functional prediction only 178 10.5
S Function unknown 141 8.3
- Not annotated 211 12.4
Category Code Functional classification
Annotated genes
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Previous PCR-based typing of STIR-CD-17 using a standardised 3-set genotyping approach 
revealed the absence of all surface protein-encoding genes (SPGs) and mobile genetic 
elements (MGEs) analysed. BLAST analysis of those sequences against the STIR-CD-17 
genome further indicated their absence from this strain, with one exception; sequences 
homologous to the insertion sequence ISSag1 were found fragmented within multiple small 
Contigs, suggesting that this MGE or remnants of it may be present. Sequences containing 
the primer annealing sites were identified (Contig14 and Contig55). Alignment of those 
Contigs with the reference sequence AF329276 (Suanyuk et al., 2008; Table 2.1) revealed 
some level of divergence, including at the priming site for one of the primers (9 nucleotide 
differences out of 40) which might explain the negative results obtained by PCR. ISSag1 
spans from base positions 318 to 1633 within the reference sequence; Contig55 covers bases 
382 to 586, Contig14 covers bases 568 to 1010, Contig15 covers bases 960 to 1228 and 
Contig20 covers bases 1374 to 1632 of the reference sequence. Therefore, parts of the IS are 
found suggesting the presence of a single or multiple copies of ISSag1 within STIR-CD-17. 
In order to support these observation, the presence of the IS was evaluated within SA20-06 
and a single copy of the IS (SaSA20_1656) with 90% identity match with the reference 
sequence (Table 2.1 in Chapter 2) was found. 
The 3-set genotyping system also included the identification of the capsular serotype. For 
this, the cps locus was investigated by BLAST search and compared pairwise with the cps 
locus from A909 (Ia) and H36B (Ib) using ACT. Specific cps genes organisation and 
homology as previously described (Cieslewicz et al., 2005) confirmed our strain to be of 
serotype Ib, even though previously unreported gene polymorphism was observed in the 
cpsK gene (see Chapter 5, section 5.4.3.1). 
Finally, the cyl operon was analysed in order to assess whether it would provide an 
explanation for the absence of haemolysis as observed when growing the bacterium on 
blood agar plates. Genomic analysis of the only non-haemolytic strain available (the bovine 
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strain 13813) revealed that it completely lacks the cyl operon. In STIR-CD-17, genomic 
analysis showed that several of the cyl genes are either absent or partially present within the 
operon, which might explain the phenotypic observation (see Chapter 5, section 5.4.2.1).  
In summary, results of in silico MLST and 3-set genotyping are largely consistent with 
those obtained by PCR, confirming the isolate’s identity and providing new information on 
the putative presence of a divergent insertion sequence. 
4.4.3 Comparative genomic analysis of the core genome 
Bayesian phylogenetic trees were constructed based on the core genome of 10 S. agalactiae 
isolates from human, bovine and fish origins. The first tree (Figure 4.2, A) showed two 
primary isolate groups. Within each primary group, the isolates formed sub-groups which 
strongly agreed with clonal complex groupings based on MLST, with two sub-groups 
(CC552 and CC67) in group 1, and 3 sub-groups (CC23, CC17 and CC7) within group 2. A 
second tree was constructed in which the number of genomes representing CC7, CC67 and 
CC552 was reduced in order to include other genomes representing other CCs (CC1, CC19) 
or, in the case of CC23, intra-CC diversity (Figure 4.2, B). Clustering based on core 
genome continued to be consistent with grouping based on MLST, even though the latter 
only represents a small subset of the core genome. However, phylogenetic relationships 
between CCs are not always accurately reflected by MLST (Sørensen et al., 2010). For 
example, phylogenetic analysis based solely on MLST suggests a close relationship between 
the ST17 responsible of neonatal invasive disease and the bovine-adapted CC67, and 
authors have hypothesised that the hyper-invasive neonatal clone has arisen from a bovine 
ancestor (Bisharat et al., 2004). However, subsequent studies considering a larger part of the 
genome did not support this close relationship between these ST17 and CC67 (Brochet et 
al., 2006; Sørensen et al., 2010). It has been demonstrated that the un-even distribution of 
the 7 housekeeping genes used for MLST, which are located primarily in one half of the 
genome, is responsible for phylogenetic inaccuracies (Sørensen et al., 2010). Our tree based 
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on alignment of the core genome (> 0.8 Mb) does not support any close relationship 
between isolates of ST17 and CC67, further supporting the observation of others (Brochet et 
al., 2006; Sørensen et al., 2010).  
Isolates belonging to CC552 have only been recovered from fish (and a frog) and are 
believed to be fish-adapted (Chapter 2). Sequence types belonging to that CC do not share 
any single locus variants, double locus variants or triple locus variants with STs of isolates 
recovered from mammals (Chapter 2), indicating that these isolates form a largely distinct 
sub-population. In our tree, the fish isolates from CC552 formed the most divergent isolate 
group, which is in agreement with our MLST observations and results published elsewhere 
(Chapter 2; Brochet et al., 2006). However, the tree published by Brochet et al. (2006), 
which is based on comparative genomic hybridization, suggests that all mammal isolates 
form a monophyletic group separated from the fish isolates, whereas our tree suggests that 
the fish and bovine-adapted strains share a more recent common ancestor than the bovine-
adapted and human isolates. 
Isolates of ST7 have been identified in humans as a cause of invasive disease in neonates 
and adults (Jones et al., 2003) or as part of the natural vaginal microbiota (Haguenoer et al., 
2011). Despite extensive studies of S. agalactiae in cattle, ST7 has been reported only once 
as a cause of mastitis in this species (Haguenoer et al., 2011). Isolates belonging to ST7 are 
therefore considered to be mostly human-associated. However, piscine isolates have been 
subjected to MLST in recent years and isolates belonging to CC7 (ST7 and its SLV ST500) 
have been reported from outbreaks in Kuwait, China and Thailand (Evans et al., 2008; Ye et 
al., 2011; Chapter 2). Moreover, a human neonatal meningitis isolate of ST7 was found to 
be pathogenic in fish after intra-peritoneal injection (Evans et al., 2009). Comparing the 
mortalities as obtained in challenge studies by intra-peritoneal infection of tilapia, piscine 
and human strains belonging to CC7 appear to be less virulent in fish than those belonging 
to CC552 (Chapter 3; Evans et al., 2002). Our phylogenetic tree supports the observation 
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that piscine and human S. agalactiae of CC7 are closely related based on analysis of the 
core genome. This observation suggests that strains belonging to CC7 may have retained 
genes for virulence and adaptation in fish or have horizontally acquired those genes from 
isolates of CC552 or elsewhere. Comparative analysis of the accessory genome for 
identification of genes unique to isolates of CC552 or shared with CC7 may provide further 
insights into the molecular basis of virulence and adaptation of S. agalactiae in fish, which 
will be covered in the next section. 
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515 (ST23)
A909 (ST7)
H36B (ST6)
ZQ0910 (ST7)
GD201008-001(ST7)
SA20-06 (ST553)
STIR-CD-17(ST260)
ATCC13813 (ST61)
FSL  S3-026 (ST67)
COH1 (ST17)
CC7
CC17
CC23
CC67
CC552
0.001 substitution per site
Group 1
Group 2
A.
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Figure 4.2 Phylogenetic evidence for host-adaptation of S. agalactiae. The bayesian phylogenetic trees A and B were constructed based on the core genome of 10 
isolates of S. agalactiae. The host of origin for each isolate is indicated by the colour of the isolate name: blue, fish; green, bovine; red, human; orange, unknown. 
Sequence types (ST) and clonal complex (CC) of isolates included in the analysis are indicated. Posterior probabilities are shown at each node and the scale bar represents 
the substitutions per site. 
515 (ST23)
H36B (ST6)
GD201008-001 (ST7)
STIR-CD-17 (ST260)
COH1 (ST17)
CC7
CC17
CC23
CC67
CC552
0.001 substitution per site
Group 1
Group 2
FSL  S3-026 (ST67)
18RS21 (ST19)
2603V/R (ST110)
NEM316 (ST23)
CJB111 (ST1)
CC19
CC1
B.
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4.4.4 Comparative genomic analysis of the accessory genome 
A 3-step comparative genomic approach enabled the identification of putative strain-
specific, fish-specific and fish-associated genes. Some of these genes may have been lost by 
other genomes that share a common ancestor with STIR-CD-17, or they may have been 
acquired through horizontal transfer of genetic material. These genes are present in small 
clusters, called loci in this study. A total of 8 loci were identified (Table 4.4). In the 
subsequent sections, details for each locus will be presented and discussed. 
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Table 4.4 List of candidate strain-specific, fish-specific and fish-associated genes as obtained 
by GeneRator analysis and normalized BLAST score ratio (BSR).  
 
 
Locus tag Bp Putative function and COG Species and strains Product BSR
LOCUS 1 (Contig23)
M3M_05402 801 C - S. agalactiae SA20-06 hypothetical protein SaSA20_0045 1
Eremococcus coleocola ACS-139-V-Col8 oxidoreductase, NAD-binding domain protein 0.07
Tribolium castaneum hypothetical protein TcasGA2_TC008151 0.07
M3M_05407 591 C - S. agalactiae SA20-06 hypothetical protein SaSA20_004 1
S. oralis SK304 hypothetical protein HMPREF1125_1048 0.17
Campylobacter jejuni subsp. jejuni BH-01-0142 hypothetical protein CJBH_0152c 0.1
LOCUS 2 (Contig753)
M3M_01252 222 hypothetical protein C - S. agalactiae SA20-06 hypothetical protein gbs0229 1
S. agalactiae 515/NEM316 Unknown 0.62
S. agalactiae ATCC 13813 hypothetical protein HMPREF9171_2185 0.62
LOCUS 3 (Contig753)
M3M_01147 195 U S. agalactiae SA20-06 aldose 1-epimerase 1
S. agalactiae A909 hypothetical protein SAK_0542 0.99
S. agalactiae H36B aldose 1-epimerase 0.99
S. agalactiae GD201008-001/ZQ0910 hypothetical protein 0.99
Streptococcus suis ST3 galactose mutarotase-like protein 0.7
M3M_01152 564 C S. agalactiae SA20-06 aldose 1-epimerase 1
S. agalactiae A909 hypothetical protein SAK_0539 0.97
S. agalactiae H36B aldose 1-epimerase, interruption-N 0.97
S. agalactiae GD201008-001/ZQ0910 hypothetical protein 0.96
Streptococcus suis ST3 galactose mutarotase-like protein 0.61
M3M_01157 996 U S. agalactiae SA20-06 UDP-glucose 4-epimerase 1
S. agalactiae A909/H36B/GD201008-001/ZQ0910 UDP-glucose 4-epimerase 0.99
S. gallolyticus UCN34 UDP-glucose 4-epimerase 0.83
M3M_01162 1482 C S. agalactiae SA20-06 galactose-1-phosphate uridylyltransferase 1
S. agalactiae H36B galactose-1-phosphate uridylyltransferase 0.99
S. agalactiae GD201008-001 galactose-1-phosphate uridylyltransferase 0.99
S. agalactiae A909/ZQ0910 galactose-1-phosphate uridylyltransferase 0.99
S. sanguinis SK355 UTP-hexose-1-phosphate uridylyltransferase 0.69
M3M_01167 1173 C S. agalactiae H36B galactokinase 0.91
S. agalactiae SA20-06 galactokinase 0.91
S. gallolyticus subsp. gallolyticus TX20005 galactokinase 0.77
M3M_01172 2202 C S. agalactiae SA20-06 alpha-galactosidase 1
S. agalactiae A909/GD201008-001/ZQ0910/H36B alpha-galactosidase 0.99
S. canis FSL Z3-227 alpha-galactosidase 0.69
M3M_01177 828 CM S. agalactiae SA20-06 ABC transporter permease 1
S. agalactiae A909/GD201008-001/ZQ0910/H36B ABC transporter permease 1
S. canis FSL Z3-227 ABC transporter permease 0.87
M3M_01182 903 CM S. agalactiae SA20-06 binding-protein-dependent transport system  1
S. agalactiae A909/GD201008-001/ZQ0910/H36B sugar ABC transporter permease 0.93
S. canis FSL Z3-227 ABC-type sugar transport permease component 0.82
S. iniae 9117 ABC superfamily ATP binding cassette transporter 0.79
M3M_01187 1035 U Streptococcus agalactiae SA20-06 sugar ABC transporter substrate-binding protein 0.99
S. agalactiae A909/GD201008-001/ZQ0910/H36B sugar ABC transporter sugar-binding protein 0.74
Streptococcus porcinus str. Jelinkova 176 ABC transporter, solute-binding protein 0.57
M3M_01192 831 C S. agalactiae A909/GD201008-001/ZQ0910/H36B/SA20-06 AraC family transcriptional regulator 1
S. canis FSL Z3-227 transcriptional regulator 0.66
S. suis 05ZYH33 transcriptional regulator 0.65
M3M_01197 285 CM S. agalactiae SA20-06 PTS system lactose/cellobiose specific transporter  1
S. agalactiae A909/GD201008-001/ZQ0910/H36B PTS system galactitol-specific transporter subunit IIB 0.99
S. ictaluri 707-05 PTS system, Lactose/Cellobiose specific IIB subunit 0.83
S. pseudoporcinus SPIN 20026 PTS system, galactitol-specific IIB component 0.82
M3M_01202 1332 CM S. agalactiae A909/GD201008-001/ZQ0910/H36B PTS system galactitol-specific transporter subunit IIC 1
S. agalactiae SA20-06 PTS system component 0.92
Granulicatella adiacens ATCC 49175 PTS system, galactitol-specific IIC component 0.83
S. iniae 9117 PTS family galactitol (gat) porter component IIC 0.81
M3M_01207 465 C S. agalactiae SA20-06 PTS system galactitol-specific transporter subunit IIA 0.99
S. agalactiae A909/GD201008-001/ZQ0910/H36B PTS system, galactitol-specific IIA component 0.98
Granulicatella elegans ATCC 700633 PTS system IIA component 0.45
M3M_01212 831 C S. agalactiae A909/GD201008-001/ZQ0910/H36B rhamnulose-1-phosphate aldolase 1
S. agalactiae SA20-06 rhamnulose-1-phosphate aldolase 0.99
S. anginosus subsp. whileyi CCUG 39159 putative rhamnulose-1-phosphate aldolase 0.7
M3M_01217 1338 CM S. agalactiae SA20-06 PTS system sugar-specific transporter permease 1
S. agalactiae A909/GD201008-001/ZQ0910 PTS system galactitol-specific transporter subunit IIC 1
S. anginosus subsp. whileyi CCUG 39159 PTS system sugar-specific permease protein 0.9
M3M_01222 279 U S. agalactiae SA20-06 PTS system lactose/cellobiose specific transporter  1
S. agalactiae A909/GD201008-001/ZQ0910/H36B PTS system galactitol-specific transporter subunit IIB 0.98
S. anginosus subsp. whileyi CCUG 39159 PTS system, lactose/cellobiose-specific IIB subunit 0.89
Granulicatella elegans ATCC 700634 PTS system galactitol-specific transporter subunit IIB 0.86
Streptococcus ictaluri 707-05 PTS system, Lactose/Cellobiose specific IIB subunit 0.84
M3M_01227 450 C S. agalactiae A909/GD201008-001/ZQ0910/H36B/SA20-06 PTS system galactitol-specific transporter subunit IIA 1
S. porcinus str. Jelinkova 176 phosphoenolpyruvate-dependent sugar family porter 0.22
S. anginosus subsp. whileyi CCUG 39159 phosphoenolpyruvate-dependent sugar family porter 0.22
M3M_01232 2043 C S. agalactiae SA20-06 hypothetical protein SaSA20_0403 1
S. agalactiae ZQ0910 PTS system IIA domain-containing protein 1
S. agalactiae A909/GD201008-001 PTS system IIA domain-containing protein 1
S. agalactiae H36B MW0309, putative 0.99
Coprobacillus sp. 29_1 hypothetical protein HMPREF9488_00517 0.25
LOCUS 4 (Contig753)
M3M_01047 294 C - S. agalactiae SA20-06 CRISPR-associated endoribonuclease Cas2 1
S. constellatus subsp. constellatus SK53 CRISPR-associated endoribonuclease Cas2 0.95
S. mutans UA159 hypothetical protein SMU_1753c 0.94
csd1 pseudogene
M3M_01062 672 C - S. agalactiae SA20-06 CRISPR-associated protein Cas4 1
S. mutans LJ23 CRISPR-associated protein cas4 0.88
S. mutans UA159 hypothetical protein 0.86
M3M_01068 850 C - S. agalactiae SA20-06 Csd2 family CRISPR-associated protein 1
S. dysgalactiae subsp. equisimilis RE378 putative cytoplasmic protein 0.98
S. dysgalactiae subsp. equisimilis SK1251 hypothetical protein HMPREF9963_1905 0.98
M3M_01097 729 C 515 S. agalactiae SA20-06 CRISPR-associated protein Cas5 1
S. dysgalactiae subsp. equisimilis AC-2713 hypothetical protein SDSE_1670 0.96
S. canis FSL Z3-227 hypothetical protein SCAZ3_08370 0.96
A909, 
H36B
A909, 
H36B
A909, 
H36B
A909, 
H36B
H36B
A909, 
H36B
A909, 
H36B
A909, 
H36B
A909, 
H36B
PTS system, galactitol-specific IIA component; 
COG1762 Phosphotransferase system 
mannitol/fructose-specific IIA domain 
PTS system IIA domain-containing protein; 
COG3711 Transcriptional antiterminator
A909, 
H36B
A909, 
H36B
A909, 
H36B
A909, 
H36B
A909, 
H36B
A909, 
H36B
A909, 
H36B
A909, 
H36B
PTS system, galactitol-specific IIC component; 
COG3775 Phosphotransferase system, galactitol-
specific IIC component
PTS system, galactitol-specific IIA component; 
COG1762 Phosphotransferase system 
mannitol/fructose-specific IIA domain 
rhamnulose-1-phosphate aldolase; COG0235 
Ribulose-5-phosphate 4-epimerase and related 
epimerases and aldolases
PTS system, galactitol-specific IIC component; 
COG3775 Phosphotransferase system, galactitol-
specific IIC component
PTS system galactitol-specific enzyme IIB 
component; COG3414 Phosphotransferase system, 
galactitol-specific IIB component
hypothetical protein
hypothetical protein
hypothetical protein; COG1343 Uncharacterized 
protein predicted to be involved in DNA repair
putative RecB family exonuclease; COG1468 RecB 
family exonuclease
hypothetical protein;  COG3649 Uncharacterized 
protein predicted to be involved in DNA repair
hypothetical protein
aldose 1-epimerase, interruption-C (galM); 
COG2017 Galactose mutarotase and related 
enzymes
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A909, 
H36B
aldose 1-epimerase, interruption-N (galM); 
COG2017 Galactose mutarotase and related 
enzymes
UDP-glucose 4-epimerase (galE1); COG1087 UDP-
glucose 4-epimerase
galactose-1-phosphate uridylyltransferase (galT); 
COG4468 Galactose-1-phosphate uridyltransferase
galactokinase (galK); COG0153 Galactokinase
alpha-galactosidase (galA); COG3345 Alpha-
galactosidase
ABC transporter permease; COG0395 ABC-type 
sugar transport system, permease component
sugar ABC transporter permease; COG1175 ABC-
type sugar transport systems, permease 
components
sugar ABC transporter sugar-binding protein; 
COG1653 ABC-type sugar transport system, 
periplasmic component
AraC family transcriptional regulator; COG2207 
AraC-type DNA-binding domain-containing 
proteins
phosphotransferase system, galactitol-specific IIB 
component; COG3414 Phosphotransferase system, 
galactitol-specific IIB component
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Table 4.4 (Continued) 
 
The 8 clusters of selected genes are referred to here as loci. For each gene are provided: the locus tag 
within the STIR-CD-17 genome, the size of the gene (bp), the putative function and Cluster of 
Orthologous Groups classification of the corresponding protein as provided by the NCBI 
Prokaryotic Genomes Automatic Annotation Pipeline (PGAAP), and the predicted sub-cellular 
localization of the corresponding protein using the PSORTb program version 3.0.2 (http://psort.org; 
Yu et al., 2010) (C, Cytoplasm; CM, Cytoplasmic Membrane; E, Extracellular; U, Unknown). The 
presence of predicted protein sequences with a reciprocal best hit with a BLAST score > 80 in other 
S. agalactiae genomes based on GeneRator analysis is shown in the table with the name of the 
strain. The first BLASTP results for each protein are provided as well as the calculated BLAST 
score ratio (BSR). Pseudogenes are highlighted in blue, and genes later selected for PCR screening 
are highlighted in orange. 
Locus tag Bp Putative function and COG Species and strains Product BSR
M3M_01102 2424 C S. agalactiae SA20-06 CRISPR-associated helicase Cas3 1
S. dysgalactiae subsp. equisimilis SK1250 CRISPR-associated helicase Cas3 0.96
S. dysgalactiae subsp. equisimilis AC-2713 Pre-mRNA-processing ATP-dependent RNA helicase 0.95
M3M_01107 222 U 515 S. agalactiae 515 Fic protein family family 0.97
S. suis 05ZYH33 hypothetical protein SSU05_0462 0.61
S. suis ST1 hypothetical protein SSUST1_0463 0.61
LOCUS 5 Contig 751)
misc_feature    CHAP domain protein
misc_feature    resolvase family site-specific recombinase
misc_feature    resolvase family site-specific recombinase
M3M_00445 204 E - S. agalactiae SA20-06 hypothetical protein SaSA20_0545 1
S. equi subsp. zooepidemicus MGCS10565 bacteriocin BlpN-like 0.58
S. equi subsp. equi Streptococcus equi subsp. equi 404 0.57
M3M_00450 231 U - S. agalactiae SA20-06 hypothetical protein SaSA20_0544 1
S. pneumoniae SP6-BS73 bacteriocin BlpM 0.69
S. equi subsp. equi 4047 bacteriocin 0.65
misc_feature abortive infection  protein AbiGII
M3M_00465 582 C - S. agalactiae SA20-06 hypothetical protein SaSA20_0542 1
S. macedonicus ACA-DC 198 Abortive infection protein AbiGI 0.69
S. dysgalactiae subsp. dysgalactiae ATCC 27957 hypothetical protein SDD27957_04365 0.69
M3M_00470 138 U - S. agalactiae SA20-06 hypothetical protein SaSA20_0541 0.97
S. intermedius F0395 hypothetical protein HMPREF9682_00655 0.87
S. suis  D12 hypothetical protein SSUD12_0897 0.78
M3M_00475 327 C - S. agalactiae SA20-06 hypothetical protein SaSA20_0540 1
S. agalactiae NEM316 hypothetical protein 0.37
S. pneumoniae NorthCarolina6A-23 modification methylase HpaII 0.36
LOCUS 6 (Contig371)
M3M_04250 357 U - S. agalactiae SA20-06 hypothetical protein SaSA20_0928 0.99
S. pneumoniae 70585 Integrase 0.63
S. pneumoniae 2061617 phage integrase family protein 0.63
M3M_04255 189 U - S. agalactiae SA20-06 hypothetical protein SaSA20_0927 1
S. pneumoniae GA47461 hypothetical protein SPAR97_1602 0.68
S. pneumoniae GA17484 hypothetical protein SPAR47_088 0.68
M3M_04260 126 U - S. agalactiae SA20-06 hypothetical protein SaSA20_0926 1
S. pneumoniae CCRI 1974 hypothetical protein SpneC1_02124 0.68
S. pneumoniae CCRI 1974M2 hypothetical protein SpneC19_10413 0.68
M3M_04265 339 U - S. agalactiae SA20-06 hypothetical protein SaSA20_0925 0.69
Oenococcus oeni AWRIB429 hypothetical protein AWRIB429_1949 0.16
Oenococcus oeni AWRIB548 phage terminase large subunit 0.16
M3M_04270 792 U - Bacillus amyloliquefaciens DC-12 hypothetical protein BamyaD_16251 0.14
Bacillus sp. 5B6 hypothetical protein MY7_0533 0.13
Bacillus amyloliquefaciens  AS43.3 hypothetical protein B938_03325 0.13
M3M_04275 639 CM - Clostridiales bacterium OBRC5-5 hypothetical protein HMPREF1135_01905 0.4
Lachnospiraceae oral taxon 107 str. F0167 hypothetical protein HMPREF0491_01439 0.37
Staphylococcus hominis SK119 multidrug resistance protein 1 0.11
M3M_04280 369 U - Geobacillus thermoleovorans CCB_US3_UF5 putative thioester dehydrase 0.31
Coraliomargarita akajimensis DSM 45221 beta-hydroxyacyl- dehydratase FabA/FabZ 0.29
Pirellula staleyi DSM 6068 beta-hydroxyacyl- dehydratase FabA/FabZ 0.29
M3M_04285 540 C - S. agalactiae SA20-06 hypothetical protein SaSA20_0923 1
Lachnospiraceae oral taxon 107 str. F0167 hypothetical protein HMPREF0491_01453 0.26
Clostridiales bacterium OBRC5-5 hypothetical protein HMPREF1135_01904 0.25
LOCUS 7 (Contig381)
M3M_01921 618 U - S. agalactiae SA20-06 hypothetical protein SaSA20_1488 1
S. criceti HS-6 hypothetical protein STRCR_0670 0.76
S. sanguinis SK1087 ThiJ/PfpI family intracellular protease 0.61
M3M_01926 531 C - S. agalactiae SA20-06 Streptococcus agalactiae SA20-06 1
S. suis ST1 hypothetical protein SSUST1_1897 0.73
S. suis R61 hypothetical protein SSUR61_0033 0.71
LOCUS 8 Contig 751)
M3M_00390 270 U - Ashbya gossypii AAR142Cp 0.19
delta proteobacterium Response regulator receiver 0.19
Photorhabdus asymbiotica Gramicidin S synthetase 2 0.19
M3M_00395 897 C - Krokinobacter sp. hypothetical protein 0.06
- -
- -
M3M_00400 1017 C - Gloeobacter violaceus hypothetical protein 0.06
Helicobacter pylori F32 hypothetical protein HPF32_0454 0.05
- -
M3M_00405 1263 C - Fusobacterium sp. conserved hypothetical protein 0.32
Coprococcus eutactus ATCC 27759 hypothetical protein COPEUT_02118 0.29
Erysipelotrichaceae bacterium 3_1_53 hypothetical protein HMPREF0983_03234 0.25
M3M_00410 318 U - S. porcinus str. Jelinkova 176 phage integrase, N-terminal SAM domain protein 0.73
S. anginosus subsp. whileyi CCUG 39159 site-specific recombinase, phage integrase family 0.71
S. mitis bv. 2  str. SK95 phage integrase, N-terminal SAM domain protein 0.66
NCBI annotation
P
SO
R
B
Tb
 
G
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e
ra
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an
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is BlastP results based on NCBI search
515, 
COH1, FSL-
S3-026
serine hydroxymethyltransferase; COG0112 
Glycine/serine hydroxymethyltransferase
integrase; COG4974 Site-specific recombinase XerD
bacteriocin
hypothetical protein
hypothetical protein; COG1672 Predicted ATPase 
(AAA+ superfamily)
Tn5252 Orf28; COG3942 Surface antigen
hypothetical protein; COG0270 Site-specific DNA 
methylase
DJ-1/PfpI family protein; COG0693 Putative 
intracellular protease/amidase
hypothetical protein; COG3797 Uncharacterized 
protein conserved in bacteria
hypothetical protein
hypothetical protein
hypothetical protein; COG0457 FOG: TPR repeat
beta-hydroxyacyl-(acyl-carrier-protein) 
dehydratase FabA/FabZ;  COG0764 3-
hydroxymyristoyl/3-hydroxydecanoyl-
PadR family transcriptional regulator; COG1695 
Predicted transcriptional regulators
hypothetical protein
Cro/CI family transcriptional regulator
hypothetical protein
hypothetical protein
hypothetical protein; COG0477 Permeases of the 
major facilitator superfamily
ATP-dependent RNA helicase; COG1203 Predicted 
helicases
Fic protein family; COG2184 Protein involved in cell 
division
integrase;  COG0582 Integrase
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4.4.4.1 Accessory genome – Locus 1 
Locus 1 comprises two protein-encoding genes that were present in the fish-adapted 
subgroup of S. agalactiae but not in other genomes included in the analysis. Their 
corresponding proteins did not contain any known domain from which a putative function 
could be deduced and they have been predicted to have a cytoplasmic localization. The 2 
genes lay between genes that are well conserved among other streptococcal genomes, 
namely the genes purK (ATPase subunit) and purB (adenylosuccinate lyase). Conserved 
flanking regions, as identified here, can act as substrates for homologous recombination 
between strains, representing a so-called “minimal mobile element” (MME; Saunders and 
Snyder, 2002). Accordingly, the region delimited by purK and purB is a well-recognised 
MME containing variable inserts within the genome sequence of other pathogenic 
streptococci, e.g. S. pneumoniae and S. pyogenes, as demonstrated by Herbert et al. (2005). 
Selected genomes were compared using ACT in our study, which revealed that the region 
delimited by purK and purB is occupied by distinct genes between isolates of different 
lineages, e.g. STIR-CD-17 (CC552), GD201008-001 (CC7) and NEM316 (CC23), whereas 
the region is identical between isolates belonging to the same CCs. For example, the same 
putative membrane protein was identified among all S. agalactiae belonging to ST7 with no 
distinction between isolates from human or from fish origin (Figure 4.3). 
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Figure 4.3 Schematic representation of a minimal mobile element (MME) in S. agalactiae of 
distinct lineages. Different intergenic regions are depicted between purK (pale blue) and purB (pale 
purple) for S. agalactiae isolates of CC552, CC7 and CC23. Hypo, Hypothetical protein. 
 
4.4.4.2 Accessory genome – Locus 2  
Locus 2 is located on the putative pathogenicity island (PAI) IV that has been described in 
human S. agalactiae (Glaser et al., 2002; Herbert et al., 2005). It contains one single gene 
encoding for a protein uniquely found present in the fish-adapted subgroup of S. agalactiae. 
This putative protein is of unknown function and predicted to be localised in the cytoplasm. 
In this study, ACT comparison showed that this locus is absent in other S. agalactiae 
genomes from human or bovine origin, and the corresponding region occupied by a cluster 
of genes that include either the virulence genes rib or bca (Figure 4.4). The presence of rib 
and bca is mutually exclusive as only one of those is found in any isolate, which is in 
agreement with 3-set genotyping results (Kong et al., 2002; Chapter 2).  
Streptococcus agalactiae STIR-CD-17 and SA20-06 (CC552)
Streptococcus agalactiae GD201008-001, ZQ0910 and A909 (CC7)
purB
M3M_05402 M3M_05407
~1769 bp
purK Hypo Hypo
purB
SA964_0045
~1470 bp
purK Putative membrane protein
Streptococcus agalactiae NEM316 and 515 (CC23)
purB
GBS0045
~1822 bp
purK
GBS0046
Hypo Hypo
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Figure 4.4 Analysis of the genomic region comprising one of the surface protein genes rib or 
bca in S. agalactiae 2603V/R (top sequence) and A909 (bottom sequence) using ACT. The strain 
2603V/R contains the rib gene whereas A909 contains the bca gene. These genes are found to 
belong to a genomic region delimited by an AraC family transcriptional regulator (yellow arrow) 
and a site specific recombinase (purple arrow). By ACT comparison, that genomic region is found to 
be absent from STIR-CD-17 (central sequence) and replaced by ~1Kbase sequence containing a 
putative strain-specific gene (M3M_01252). The blue bars separating each genome represent 
similarity matches identified by reciprocal NBLAST analysis, with a score cutoff of 100. 
 
4.4.4.3 Accessory genome – Locus 3 
Locus 3, like locus 2, is located on the PAI IV from human S. agalactiae (Glaser et al., 
2002; Herbert et al., 2005), lying 4 genes downstream of locus 2 (Figure 4.4) and 5 genes 
upstream of locus 4. Locus 3 comprises 18 genes. The corresponding proteins are found in 
all S. agalactiae from fish, including those belonging to CC7, as well as the human S. 
agalactiae belonging to CC7. These genes are therefore considered to be “fish-associated” 
in S. agalactiae, even though some of the corresponding proteins are also found to be well 
conserved in other Streptococcus spp, e.g. S. ictaluri and S. canis, or in other bacterial 
species, e.g. Granulicatella elegans. All those genes encode for proteins involved in 
carbohydrate transport and metabolism with the exception of 1 transcriptional regulator. 
Among these genes, one codes for an α-galactosidase (galA), an enzyme that catalyzes the 
hydrolysis of galactose-containing oligosaccharides. It also contains genes for all the 
rib
bca
rib
2603V/R
STIR-CD-17
A909
M3M_012522
LOCUS 2 LOCUS 3
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enzymes of the Leloir pathway (galK, galE, galM and galT) involved in the transport and 
degradation of galactose. These genes have been well characterised in lactic acid bacteria 
(Grossiord et al., 1998). Galactose is present in dairy products but also in fish tissues like the 
brain, where it forms part of glycolipids and glycoproteins (Tocher, 2003). The presence of 
these genes in meningo-encephalitis causing bacteria may therefore provide some metabolic 
advantages. In S. thermophilus, it is strongly suggested that the primary role for Leloir 
pathway enzymes is to produce precursor sugars for assembly of exopolysaccharides (EPS; 
Levander and Rådström, 2001). EPS are secreted externally, and differ from the capsular 
polysaccharides (CPS) that are tightly associated with the cell surface (Levander and 
Rådström, 2001). The production of EPS in bacteria leads to a loose “fluffy” pellet 
phenotype following centrifugation (Forde and Fitzgerald, 2002); interestingly, a similar 
phenotypic observation was also made with STIR-CD-17 (Chapter 3, section 3.3.1.3). Yet, 
to our knowledge no EPS has been described in S. agalactiae. However, despite being 
responsible for distinct end products, some of the eps genes responsible for EPS production 
in S. thermophilus are known to be organised in the same manner and to share very high 
homology with cps genes responsible for capsule polysaccharide production in S. agalactiae 
(Stingele et al., 1996), suggesting a common origin of these genes. Consequently, whether 
some strains of S. agalactiae have the ability to produce EPS and if so the mechanism 
behind it remains to be investigated further. The S. agalactiae capsule is composed of 
numerous polysaccharides that include glucose, galactose and rhamnose (Cieslewicz et al., 
2005); the enzymes encoded by Locus 8 may therefore also play a role in the production of 
precursors involved in capsule formation. 
4.4.4.4 Accessory genome – Locus 4 
The genetic composition and organisation of locus 4 corresponds to a CRISPR-cas module 
(clustered regularly interspaced short palindromic repeats-CRISPR-associated proteins) of 
subtype IC (Makarova et al., 2011). CRISPR modules are carried within the genomes of 
many bacteria and constitute an adaptative immunity system that acts against mobile genetic 
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elements (Horvath et al., 2010). Based on this comparative analysis, this locus is unique to 
the fish-adapted isolates but remnants of it are present in 3 other S. agalactiae genomes 
(515, COH1, FST S3-026) and in other Streptococcus spp. (Table 4.4). This locus, with the 
very same sequence as in STIR-CD-17, was also recently reported from an ST260 isolate 
recovered from a frog (Lopez-Sanchez et al., 2012). Two of the genes in this locus are 
mutated (pseudogenes) and the system is therefore probably inactive in our strain, as also 
suggested for the frog isolate (Lopez-Sanchez et al., 2012). 
4.4.4.5 Accessory genome – Locus 5 
Locus 5 is composed of 5 genes and 4 pseudogenes that were only detected in the fish-
adapted subgroup of S. agalactiae. This locus is located on the PAI VI reported from human 
S. agalactiae (Herbert et al., 2005) and contains three protein-encoding genes and one 
pseudogene with defence mechanism functions. One of the genes encodes a hypothetical 
protein that has a conserved cytosine-DNA methylase domain (PF00145) and might 
therefore play a role in protection against bacteriophages (Kumar et al., 1994). Indeed, it has 
been shown that restriction endonucleases discriminate between endogenous and foreign 
DNA by their methylation patterns and therefore lead to the cleavage of DNA not protected 
by methylation (Briggs et al., 1994). Two other genes that are adjacent to each other encode 
proteins with domains corresponding to those found in bacteriocins. Bacteriocins are 
proteinaceous toxins produced by bacteria to inhibit the growth of similar or closely-related 
strains. Typically, production of bacteriocin is co-ordinated by an operon carrying up to 6 
genes including those encoding a two-component regulatory system, a small peptide 
pheromone, and a dedicated ABC transporter, as well as an immunity protein (Dawid et al., 
2007). Such an operon was not found in our strain and it is therefore unlikely that the 
proteins would be expressed and localised extracellularly in STIR-CD-17. Finally, the 
identified pseudogene would, if expressed, encode an abortive infection protein AbiGII 
which is considered to confer protection against bacteriophages by blocking their 
multiplication (Chopin et al., 2005). 
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Locus 5 also contains a gene that encodes a protein suspected to be a surface antigen (COG 
classification) and containing a CHAP domain (pfam05257). The CHAP domain is 
associated with amidase functions, and is usually found in proteins involved in bacterial cell 
wall metabolism of bacteria (Bateman and Rawlings, 2003). Sub-cellular localisation 
prediction further supports that this protein, if produced, is extracellularly located. The exact 
role of this protein in piscine S. agalactiae deserves further exploration as it is possibly 
involved in interaction with the host or in the formation of capsule. Finally, locus 5 also 
contains 1 gene coding for a hypothetical protein containing a domain of unknown function 
(InteProScann; DUF4095) and 2 pseudogenes encoding resolvases. In this study, ACT 
comparison analyses revealed that the locus is delimited by direct repeats of 159bp and that 
the corresponding region for Locus 5 in other genomes is occupied by the same, single 159 
bp sequence (Figure 4.5). This observation suggests that it might have been a mobile 
element (Sadowski, 1986) that has lost its mobility through inactivation (by mutation) of the 
resolvases.
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Figure 4.5 (A) Genetic structure of the Locus 5 which carries genes (full arrows) and pseudogenes (dashed arrows). Locus 5 integrated into and disrupted a 
conserved gene encoding a putative outer-membrane protein. Direct repeats (DR) flank the extremities of the locus and a single example of the corresponding region is 
also found in other genomes not containing Locus 2. Hypo, Hypothetical protein. (B) Alignment of the DR and equivalent region in A909, with annotation 
numbering referring to (A). For the alignment, sequences were extracted from the ACT comparison file, aligned using the MAFFT multiple sequence alignment web 
service implemented in JALVIEW 2.4 (Clamp et al., 2004). Shading levels are set using Genedoc software with the grey colour highlighting single nucleotide differences.  
  
SAK0782
Streptococcus agalactiae STIR-CD-17 and SA20-06
Streptococcus agalactiae A909
~5015bp
SAK0783
DR DR
A 1
2 3
B
ResolvasesDNA methylase BacteriocinHypoHypo Abi
Surface
antigen
          
          
1/1-159 : 
2/1-160 : 
3/1-159 : 
          
                                                                                                                                                                
         *        20         *        40         *        60         *        80         *       100         *       120         *       140         *       160
GTAGGGTTACTACAACGAAACAAAGAGTAAAAATCCGTTATTTTAAGCATTTCTTCAAGCATTTTGTCTTTGTTGAAGAAGGTGA-TTTGACACCAAAAAGGTATTAAAAAACATATTGACGTGACCGTTTGTTTTGAAGTGGCTTGCGTAGACAAAAAA
GTAGCGTTGCTACAACGAAGCAAAGGGTAAAAATCCTTTATTTTAAGCACTTTTTCAAGCATTTTGTCTTTATTGAAAAGAGTGATTTTAACATAAAAAAGGTATTAAAAAACATATTGACGTGACCGTTTGTTTTGAAGTGGCTTGCGTAGACAAAAAA
GTAGGGTTACTACAACGAAACAAAGAG-AAAAATCCTGCATTTTAAGTAGTTTTACAAGCATTTTGTCTTTGTTGAAGAAGGTGAATTTGACACCAAAAAGGTATCAAAAAACATATTGAAGTGACCGTTTGTTTAGATGTTGATTGCGTAGACAAAAAG
                                                                                                                                                                
      
      
 : 159
 : 160
 : 159
      
1
2
3
Comparative genomic analysis  
4-144 
4.4.4.6 Accessory genome – Locus 6 
Locus 6 is composed of 8 protein encoding genes, from which 3 are unique to STIR-CD-17 
while the remaining 5 are unique to the fish-adapted subgroup of S. agalactiae (homologues 
in SA20-06 only). ACT comparative analysis revealed that a 6-phospho-beta-glucosidase 
coding gene present in other genomes is disrupted in STIR-CD-17 by the insertion of Locus 
6, suggesting that genes from that locus are part of a mobile genetic element (Figure 4.6). 
Among the genes present are a putative integrase, two transcriptional regulators and three 
hypothetical proteins with no domain of known function. Also found are one beta-
hydroxyacyl dehydratase involved in fatty acid biosynthesis (M3M_04280; PF07977) and 
one major facilitator family transporter (M3M_04275; PF07690). The latter protein, 
predicted to be localised in the cytoplasmic membrane, is known to transport small solutes 
in response to chemiosmotic ion gradient (Pao et al., 1998). 
 
Figure 4.6 Genetic structure of Locus 6, which carries genes encoding an integrase (red), a 
beta-hydroxyacyl dehydratase (yellow), a putative permease (orange), hypothetical proteins 
(white), and transcriptional regulators (blue). Locus 5 integrated into and disrupted the gene 
encoding a 6-phospho-beta-glucosidase. 
4.4.4.7 Accessory genome – Locus 7 
Locus 7 comprises two genes that thus far have only been found in the fish-adapted 
subgroup of S. agalactiae (homologues identified within SA20-06 only). One of the genes 
encodes a hypothetical protein that contains a conserved domain of unknown function 
6-phospho-beta-glucosidase
Streptococcus agalactiae STIR-CD-17 and SA20-06
Streptococcus agalactiae A909
Absent from: 
Streptococcus agalactiae SA20-06
~4160bp
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(PF08002) and is predicted to be cytoplasmic. The other gene encodes a DJ-1/PfpI family 
protein (COG0693/PF01965), which includes proteins with intracellular protease function 
or transcriptional regulators (Halio et al., 1996; Ohnishi et al., 2005). These genes are 
inserted between 2 genes that are well conserved among streptococci: ksgA (16S ribosomal 
RNA methyltransferase KsgA/Dim1 family protein) and rnmV (primase-like protein). In 
other S. agalactiae, a distinct insert between these flanking genes has been identified by 
ACT comparisons in this study, hence fulfilling the criteria for an MME as described in 
section 4.4.4.1.1. Comparative analysis using ACT was performed, as for locus 1, using 
isolates belonging to CC552, CC7 and CC23. Unlike Locus 1, less diversity was observed 
as the isolates belonging to CC7 and CC23 all contained a homologous region between 
rnmV and ksgA (Figure 4.7). 
Figure 4.7 Schematic representation of a minimal mobile element (MME) in S. agalactiae of 
distinct lineages. Different intergenic regions are depicted between rnmV (pale blue) and ksgA (pale 
purple) between S. agalactiae isolates of CC552 and isolates of CC7/CC23. Hypo, Hypothetical 
protein. 
 
4.4.4.8 Accessory genome – Locus 8 
Locus 8 is part of a putative PAI (PAI VI; Herbert et al., 2005) that has been described in S. 
agalactiae NEM316 and 2603V/R. This PAI also contains the cyl operon, located 4 genes 
downstream from Locus 8. In our dataset, Locus 8 is however unique to STIR-CD-17 and 
contains genes encoding 3 hypothetical proteins with no domains of known function, 1 
Streptococcus agalactiae STIR-CD-17 and SA20-06 (CC552)
Streptococcus agalactiae GD201008-001 and ZQ0910 (CC7), plus A909, NEM316 and 515 (CC23)
M3M_05402 M3M_05407
~1162 bp
rnmV ksgAPutative protease Hypo
ksgA
A964_1700
~481 bp
rnmV Histidine triad nucleotide-binding protein
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serine hydroxymethyltransferase (SHMT) and 1 integrase. The SHMT is an enzyme that 
catalyzes the reversible cleavage of serine to form glycine and monocarbonic groups, 
essential in several biosynthetic pathways. In a recent study, it was shown that the SHMT of 
halotolerant bacteria is up-regulated under conditions of high salinity, resulting in an 
increased salinity tolerance due to an accumulation of glycine betaine within the cell 
(Waditee-Sirisattha et al., 2012). It is unknown whether this enzyme plays a similar role in 
our strain, but such a mechanism may be important considering that S. agalactiae can infect 
fresh water and salt water host species (Bowater et al., 2012). The presence of an integrase 
encoding gene suggests that this locus may be a mobile genetic element, a hypothesis 
further supported by the ACT comparison (Figure 4.8). Indeed, the ACT comparison 
reveals that the locus was integrated into and disrupted a gene conserved among other S. 
agalactiae (as confirmed by BLASTN search). 
 
Figure 4.8 Genetic structure of Locus 8 which carries genes encoding an integrase (red), a 
serine hydroxymethyltransferase (black) and three hypothetical proteins (white). Locus 8 was 
integrated into and disrupted a conserved gene encoding a hypothetical protein. 
4.4.5 Distribution of selected genes across S. agalactiae from 
different host species 
The 3-step comparative analysis (GeneRator/BSR/ACT) of a limited number of available 
genomes enabled the identification of candidate strain-specific genes (SSG; unique to STIR-
SAK0785
Streptococcus agalactiae STIR-CD-17 
Streptococcus agalactiae A909
~6472bp
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CD-17), fish-specific genes (FSG; unique to isolates belonging to the fish adapted CC552; 
STIR-CD-17 and SA20-06) and fish-associated genes (FAG; unique to isolates belonging to 
CC7 and CC552; A909, H36B, ZQ0910, GD201008-001, STIR-CD-17 and SA20-06). As a 
proof of concept, a collection of bovine, sea mammal and piscine S. agalactiae isolates was 
screened by PCR for identification of presence/absence of 1 SSG (M3M_04280), 1 FSG 
(M3M_01062) and 3 FAGs (M3M_01167, M3M_01172 and M3M_01182), belonging to 
the previously described Loci 6, 4 and 3 respectively (Table 4.4.). These results, combined 
with results obtained from in silico analyses (Table 4.4.) of genomes of bovine, human, fish 
and unknown origins are provided in Table 4.5.  
Six different profiles of presence/absence were obtained. Piscine isolates of ST260 were 
positive for the 5 genes (profile 6), whereas the genes were completely absent from 100% of 
the seal isolates, 95% of the bovine isolates and 72% of the human isolates (profile 1). 
Piscine isolates of ST261 all had profile 5, which differs from profile 6 in the absence of 
M3M_01062, whereas isolates from CC7 showed a range of profiles. All piscine isolates 
were positive for a minimum of 3 genes (profiles 2, 3, 4 and 5). There was therefore a strong 
correlation between the carriage of the genes and the host of origin being fish, with however 
some exceptions.  
The 3 FAGs were expected to be present in isolates of CC552 and CC7. Accordingly, all 
fish isolates of CC552 and most isolates of CC7 were positive for these genes, including 1 
dolphin isolate and 2 human isolates. However, 2 fish isolates of CC7 (STIR-CD-23 and 
STIR-CD-24) only had 2 of the 3 FAGs, whereas 1 bovine isolate of CC1 (MRI Z1-198) 
had all 3 FAGs. 
The FSG was expected to be present in all fish isolates of CC552, however such association 
was not fully supported by the PCRs as it was not found within the fish isolates of ST261 
(STIR-CD-29 to 32). Moreover the FSG was found within fish isolates belonging to human-
Comparative genomic analysis  
4-148 
associated CCs (CC283 and CC7) and the dolphin isolate (profile 4), showing that they are 
FAG rather than FSG. 
Finally, the SSG, which was expected to be present within fish isolates of ST260 only, was 
found within other fish isolates, including isolates of ST7 and ST261, and should therefore 
also be classified as FAG. 
In conclusion, a strong correlation was found between the carriage of these genes and the 
host of origin being fish. However the characterisation of SSG, FSG and FAG was not fully 
supported by the PCRs. All of these genes will therefore be considered “putatively fish-
associated” in the remainder of this chapter.  
 
 
 
 
 
 
 
 
Table 4.5 (next page) Distribution of putative strain-specific, fish-specific and fish-associated 
genes among a population of S. agalactiae of bovine (green), human (red), sea mammal (black), 
fish (blue) and unknown (orange) origin. The 6 profiles obtained are the result of PCR screening 
(in vitro analysis; IV) or bioinformatics analysis based on available genomes (in silico analysis; IS). 
In silico analysis is based on complete genomes (isolate name in bold) as well as incomplete 
genomes for which the absence of a gene cannot be guaranteed. Strain name, origin, clonal complex 
(CC) and sequence type (ST) are provided. The multiple piscine isolates originating from a single 
country in Kuwait, Honduras, or Colombia are epidemiologically related. 
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Isolate ID Host Country CC ST Source of data
M
3M
_0
42
80
 
M
3M
_0
10
62
 
M
3M
_0
11
67
 
M
3M
_0
11
72
 
M
3M
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11
82
 
P
R
O
FI
LE
NEM316 NA NA 23 23 IS - - - - -
515 Human NA 23 23 IS - - - - -
2603V/R Human NA 19 110 IS - - - - -
18RS21 Human USA 19 19 IS - - - - -
COH1 Human NA 17 17 IS - - - - -
CJB111 Human NA 1 1 IS - - - - -
MRI Z1-654 Bovine Denmark 1 1 IV - - - - -
MRI Z1-658 Bovine Denmark 1 1 IV - - - - -
MRI Z1-660 Bovine Denmark 1 1 IV - - - - -
MRI Z1-651 Bovine Denmark 1 458 IV - - - - -
FSL S3-026 Bovine USA 67 67 IS - - - - -
ATCC 13813 Bovine NA 67 61 IS - - - - -
MRI Z1-618 Bovine Denmark 19 19 IV - - - - -
MRI Z1-620 Bovine Denmark 19 19 IV - - - - -
MRI Z1-621 Bovine Denmark 19 19 IV - - - - -
MRI Z1-624 Bovine Denmark 19 19 IV - - - - -
MRI Z1-625 Bovine Denmark 19 19 IV - - - - -
MRI Z1-629 Bovine Denmark 19 19 IV - - - - -
MRI Z1-630 Bovine Denmark 19 19 IV - - - - -
MRI Z1-633 Bovine Denmark 19 19 IV - - - - -
MRI Z1-635 Bovine Denmark 19 19 IV - - - - -
MRI Z1-638 Bovine Denmark 19 19 IV - - - - -
MRI Z1-639 Bovine Denmark 19 19 IV - - - - -
MRI Z1-619 Bovine Denmark 19 44 IV - - - - -
MRI Z1-656 Bovine Denmark 23 199 IV - - - - -
MRI Z1-643 Bovine Denmark 23 23 IV - - - - -
MRI Z1-199 Phocine UK 23 23 IV - - - - -
MRI Z1-200 Phocine UK 23 23 IV - - - - -
MRI Z1-201 Phocine UK 23 23 IV - - - - -
MRI Z1-202 Phocine UK 23 23 IV - - - - -
MRI Z1-208 Phocine UK 23 23 IV - - - - -
STIR-CD-23 Piscine Thailand 7 7 IV - + + - +
STIR-CD-24 Piscine Thailand 7 7 IV - + + - +
MRI Z1-684 Bovine Denmark 1 1 IV - - + + +
H36B Human USA 7 6 IS - - + + +
A909 Human NA 7 7 IS - - + + +
ZQ0910 Piscine China 7 7 IS - - + + +
GD201008-001 Piscine China 7 7 IS - - + + +
STIR-CD-26 Piscine Thailand 7 500 IV - - + + +
STIR-CD-28 Piscine Thailand 7 500 IV - - + + +
STIR-CD-27 Piscine Thailand 7 7 IV - - + + +
MRI Z1-198 Delphine UK 7 399 IV - + + + +
STIR-CD-21 Piscine Thailand 7 7 IV - + + + +
STIR-CD-14 Piscine Vietnam 283 491 IV - + + + +
STIR-CD-25 Piscine Thailand 283 283 IV - + + + +
SA20-06 Piscine Brazil 552 553 IS - + + + +
STIR-CD-01 Piscine Kuwait 7 7 IV + - + + +
STIR-CD-02 Piscine Kuwait 7 7 IV + - + + +
STIR-CD-03 Piscine Kuwait 7 7 IV + - + + +
STIR-CD-04 Piscine Kuwait 7 7 IV + - + + +
STIR-CD-05 Piscine Kuwait 7 7 IV + - + + +
STIR-CD-29 Piscine Belgium 552 261 IV + - + + +
STIR-CD-30 Piscine Australia 552 261 IV + - + + +
STIR-CD-31 Piscine Australia 552 261 IV + - + + +
STIR-CD-32 Piscine Australia 552 261 IV + - + + +
STIR-CD-09 Piscine Colombia 552 260 IV + + + + +
STIR-CD-10 Piscine Colombia 552 260 IV + + + + +
STIR-CD-11 Piscine Colombia 552 260 IV + + + + +
STIR-CD-12 Piscine Colombia 552 260 IV + + + + +
STIR-CD-13 Piscine Costa Rica 552 260 IV + + + + +
STIR-CD-17 Piscine Honduras 552 260 IV and IS + + + + +
STIR-CD-18 Piscine Honduras 552 260 IV + + + + +
STIR-CD-19 Piscine Honduras 552 260 IV + + + + +
STIR-CD-07 Piscine Honduras 552 260 IV + + + + +
1
4
6
2
3
5
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4.4.6 Evidence for niche restriction  
The two piscine isolates belonging to the fish-adapted sub-group of S. agalactiae (STIR-
CD-17 and SA20-06) were found to be very similar based on their core genome as well as 
their accessory genome. Because the STIR-CD-17 genome is incomplete, the genome of 
SA20-06 was used as a representative of the fish-adapted sub-group for whole genome 
comparison using ACT (Figure 4.9.). This analysis showed that the SA20-06 genome is of 
reduced size compared to other S. agalactiae genomes due to the absence of large DNA 
fragments. Most of the missing DNA fragments correspond to regions that have been well 
defined in S. agalactiae NEM316 and referred to as putative pathogenicity islands (PAI) 
because they exhibit a mixture of genetic signatures of different mobile elements and are 
usually found next to tRNA genes (Glaser et al., 2002). These islands are known regions of 
genomic plasticity that shaped the evolution of S. agalactiae through the acquisition of traits 
for virulence and adaptation (Tettelin et al., 2005; Glaser et al., 2002; Brochet et al., 2008a). 
Accordingly, the fish-associated genes from Loci 2, 3 and 5 were found within islands IV or 
VI (Figure 4.9). However the complete or partial absence of most putative PAI (as well as 
other regions) is uncommon and has never been reported in previous studies of S. agalactiae 
of human origin.  
In recent years, genome sequences of long-established and recent host-restricted bacteria 
have provided insights into the evolutionary forces driven by this lifestyle. The transition to 
host-pathogen or symbiotic restriction has been associated with a sharp increase of mobile 
elements (mostly insertion sequences) followed by genomic rearrangements and deletions of 
varying size (Moran and Plague, 2004). The accumulation of mobile elements is believed to 
be the consequence of a reduced effective population size that lowers the efficiency by 
which purifying selection maintains genes, thereby providing opportunities for insertions 
(Parkhill et al., 2003). The proliferation of mobile elements has consequences, both 
beneficial and deleterious: (1) transposition often leads to the inactivation of genes; (2) 
mobile elements may carry or activate genes involved in virulence or adaptation; (3) 
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repeated transposition of elements results in homologous regions scattered in the genome, 
which yields the basis for rearrangements and deletion of large fragments (Al Safadi et al., 
2010; Moran and Plague, 2004). Another hallmark during or following host-restriction is the 
abundance of pseudogenes, which are putatively inactivated coding sequences due to 
mutations (Ochman and Davalos, 2006). The abundance of pseudogenes is likely due to a 
combination of factors including genetic drift associated with population bottleneck, but 
also the result of a constant and rich environment provided by the host that renders some 
genes useless and eliminated (Moran and Plague, 2004). Therefore, if proliferation of 
mobile elements is expected in the short term, inactivation and loss of large genetic 
elements are expected in the longer run. Genomic characteristics of long-term host 
dependence include genome size reduction, deletion or mutation of mobile elements beyond 
recognition, and reduced metabolic capacities (Moran and Plague, 2004). 
The recently described bovine S. agalactiae genome was found to be of much larger size 
than S. agalactiae genomes from human source due to large acquisitions of genetic material 
by horizontal gene transfer including material from other mastitis-causing streptococci 
(Richards et al., 2011). More importantly, a distinctive feature of the bovine S. agalactiae 
genome was the high frequency of recently acquired insertion sequences (IS) (97 IS in the 
bovine strain as compared to 30 or less in the human strains); the authors hypothesised a 
possible evolutionary bottleneck, which is in agreement with other studies showing a more 
limited genomic diversity in the bovine-associated population compared to the human 
(Bisharat et al., 2004). The bovine S. agalactiae genome therefore presents features of niche 
adaptation and possible transit towards a more restricted niche. 
The fish-adapted S. agalactiae subgroup exhibits a limited genomic diversity (Chapter 2), 
but it contrasts with the bovine-adapted S. agalactiae genome at numerous levels. Molecular 
epidemiological studies failed to identify any of the frequently encountered IS (Chapter 2) 
and, accordingly, no well conserved IS was identified in the STIR-CD-17 genome. 
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Moreover, the genome is of reduced size due to absence or deletion of large genomic 
fragments and it contains a high number of pseudogenes (102 pseudogenes in STIR-CD-17 
in contrast to 1 in 2603V/R, 32 in A909 and 40 in NEM316). Finally, among all the strains 
investigated during this project, isolates belonging to the fish-adapted subgroup were the 
most laborious, and it is indeed not without reason that these strains have been misclassified 
in the past as a new species, S. difficile, characterised by: (1) an absence of growth at 37°C, 
(2) slow growth on BHI agar plates at 30°C (1mm colonies after 48h incubation), (3) 
absence of β-haemolysis on sheep blood agar plates, and (3) a restricted metabolic 
capability, as assessed by biochemical tests (Eldar et al., 1994). Metabolic pathways were 
not investigated in this genomic study; however and as mentioned in section 4.3.1., genes 
considered to be conserved among the S. agalactiae species were reported absent from 
STIR-CD-17 by the PGAAP, including numerous genes encoding for proteins with 
metabolic functions like the fructose-6-phosphate aldolase, a 1,4 dihydroxy-2-naphthoate 
octaprenyltransferase, or a glutamate dehydrogenase. BLASTN searches failed in 
identifying these enzyme-coding genes within SA20-06, whereas it was present in other S. 
agalactiae genomes. This observation highlights the putative loss of metabolic pathways, 
but further investigation is required. In conclusion, genomic features of the fish-adapted 
subgroup of S. agalactiae suggest that, unlike bovine S. agalactiae, it has undergone full 
niche restriction. 
 
 
Figure 4.9 (next page) Pairwise comparison of the genomic sequences of SA20-06 (middle) 
against NEM316 (top) and 2603V/R (bottom) using ACT (Carver et al., 2005). The sequences 
have been aligned from the predicted replication origins (oriC; right). The red bars separating each 
genome represent similarity matches identified by reciprocal BLASTN analysis, with a score cutoff 
of 300. The position of putative pathogenicity islands (Herbert et al., 2005) is highlighted in the 
NEM316 genome, whereas the position of putative fish-associated loci is highlighted in SA20-06. 
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4.5 CONCLUSIONS  
The non-haemolytic S. agalactiae of CC552 have a distinctive genome characterised by a 
limited number of IS, an abundance of pseudogenes, a small genomic size, and an apparent 
loss of metabolic functions considered conserved within the species, indicating that this 
fish-adapted subgroup of isolates has undergone niche restriction. Accordingly, these 
isolates are the most divergent of all S. agalactiae based on phylogenetic analysis of the 
core genome, which corroborate, at the genomic level, previous work showing that non-
haemolytic S. agalactiae recovered from fish exhibit limited genomic diversity and are 
distinct from human or bovine isolates (Chapter 2). Conversely, β-haemolytic isolates 
recovered from fish and belonging to the human-associated CC7 were found to cluster with 
human isolates of CC7, further supporting the possibility that some strains may represent a 
zoonotic or anthroponotic hazard (Evans et al., 2008 and 2009; Chapter 2). Comparative 
analysis of the accessory genome enabled the identification of a cluster of genes uniquely 
shared between CC552 and CC7 among the S. agalactiae species (Locus 3) and encoding 
for proteins involved in carbohydrate transport and metabolism, possibly necessary in 
providing precursors for EPS formation, CPS formation, or metabolic advantages required 
for their fitness as fish pathogens. Other loci identified were specific to strain STIR-CD-17 
or to CC552 based on limited genomic comparisons; however the extension of this analysis 
through the PCR screening of a larger population of S. agalactiae suggested that some of 
these genes may be present in isolates of CC7. In the future, a larger and more diverse 
bacterial population should be screened and more putative fish-associated genes 
incorporated in the study to confirm these preliminary results. Some of the loci identified 
corresponded either to MME (Locus 1 and 7) or showed a mixture of genetic “signatures” of 
MGE (Locus 5, 6 and 8), suggesting the acquisition of these through horizontal gene 
transfer. It is not possible at present to identify whether these genes were acquired through 
intraspecies transfers or interspecies transfers from the aquatic environment. These putative 
MGEs are however unlikely to have been acquired recently as major components of these 
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have lost their function (e.g. resolvases appeared as pseudogenes in Locus 5). Among the 
genes identified within the putative MGEs, some may encode for proteins involved in 
adaptation to the aquatic environment (e.g. SHMT, Locus 8) or virulence (e.g. surface 
antigen, Locus 5); however numerous fish-associated genes identified were found to encode 
hypothetical proteins predicted to be localised in the cytoplasm. Finding predicted 
cytoplasmic proteins as genuine components of the extracellular proteome (‘moonlighting’ 
proteins) is a recognized phenomenon that has been the focus of recent discussion 
(Henderson and Martin, 2011; Copley, 2012), suggesting that these genes may still play a 
role in virulence. The STIR-CD-17 genome was mostly characterised by genetic material 
loss, with limited additional genetic material. Therefore, it may be hypothesised that the 
virulence of this strain in fish does not fully result from the acquisition of new genes but 
from the expression of virulence genes well defined in human isolates. 
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5.1 ABSTRACT 
Streptococcus agalactiae is a pathogen of multiple host species. Numerous genes encoding 
virulence determinants have been well-characterised in S. agalactiae isolated from humans, 
but the presence of these genes and the function of their encoded proteins have not been 
thoroughly investigated in S. agalactiae of fish origin. In the present study, genes encoding 
recognised virulence factors in human S. agalactiae were selected and their presence 
evaluated within the genome of STIR-CD-17, an isolate belonging to a fish-adapted 
subpopulation of S. agalactiae. A literature review of those genes found in STIR-CD-17 is 
presented, accompanied by the results of bioinformatic analysis to assess structural 
homologies between human and piscine S. agalactiae. Numerous genes were completely 
absent in STIR-CD-17, while the cyl operon responsible for the β-haemolysin production 
was found to be only partially present, indicating that their encoded proteins are not 
important contributors to pathogenicity of S. agalactiae in fish. The gene encoding an 
immunogenic bacterial adhesin in certain S. agalactiae from humans (gbs2018) was 
identified as a distinct variant, unique to fish isolates, which possibly reflects differences or 
adaptations in the function of the protein. Finally, a set of genes were found to be well-
conserved in STIR-CD-17 and included fbsA, pavA, srr1, cfb, hylB, ponA and sodA. The 
cspA gene was also found to be well conserved, but a deletion responsible for a frameshift 
suggested that, if the gene is expressed, the protein would be secreted and not cell-wall 
anchored. Moreover, the cps genes were also found to be well-conserved, with the exception 
of cpsK, but whether the variations in cpsK affect the biosynthesis of the capsule is 
unknown. This work provides a basis for further post-genomic studies in vitro and in vivo.  
Keywords: Virulence, genome, Streptococcus agalactiae, ST260 
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5.2 INTRODUCTION 
In the late 19
th
 century, Robert Koch formulated guidelines that laid the foundation for 
establishing the link between pathogens and disease. For over 100 years, his postulate was 
gold standards to define microbial virulence, despite the fact that it was not possible to 
establish the link between pathogen and disease for a number of microorganisms that do not 
grow in vitro, only cause the disease in partnership with other organisms, or require specific 
environmental factors or host predispositions. In order to overcome some of these 
limitations, later studies provided revisions of the Koch postulate which encompassed 
immunological and/or epidemiological proofs of disease causation (reviewed by Fredricks 
and Relmans, 1996).  
With the advent of molecular microbiology in the late twentieth century, studies then 
focused on specific genes and the importance of their corresponding protein to virulence.  In 
order to define a virulence factor, Stanley Falkow devised a molecular version of Koch’s 
postulate that consist of 3 criteria: (1) the phenotype or trait under investigation should be 
associated with pathogenic strains and absent from the non-pathogenic ones, (2) the specific 
inactivation of the gene(s) encoding for the suspected virulence trait should lead to a 
measurable loss of pathogenicity in an appropriate animal model, (3) the subsequent 
reintroduction of the mutated gene(s) should restore the pathogenicity in the same animal 
model (Falkow, 1988). However, this postulate also has limitations since it suggests a clear 
distinction between pathogens and non-pathogens, which is not always the case. For 
example, S. agalactiae is carried as part of the commensal vaginal flora in woman and 
causes neonatal disease through vertical transmission, suggesting adaptive changes to a new 
environment with up-regulation or activation of specific genes involved in virulence (Yang 
et al., 2010). 
In the last decade, the search for virulence genes has been revolutionized by the exponential 
increase in the number of available genome sequences and the development of comparative 
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genomic methodologies (Raskin et al., 2006). For example, genome analysis of S. 
agalactiae enabled the discovery of genes encoding an immunoprotective protein later 
found to be involved in pilus formation (Lauer et al., 2005). Purely in silico approaches 
based on identifying virulence genes by comparing sequence similarity with known 
virulence genes have been developed (Lin et al., 2011). These approaches have led to an era 
where the term “putativism” is legion. Indeed, genes may have niche-adapted functions and 
identification of genetic conservation can therefore only lead to an assumption of virulence 
that needs to be tested in an adapted experimental model to demonstrate functional 
conservation (Wassenaar and Gaastra, 2001). In human S. agalactiae, a computational 
approach has led to the identification of a myriad of putative virulence genes which have not 
undergone in vitro or in vivo studies thus-far (Lin et al., 2011). 
However, numerous virulence genes have been well characterised in human S. agalactiae 
(Maisey et al., 2008). Those genes do not always fulfil Falkow’s postulates, e.g. the cps 
operon considered to encode a virulence factor, the polysaccharide capsule, is present in 
both pathogenic and non pathogenic bacteria possibly as part of the core genome 
(Cieslewicz et al., 2005). Other virulence genes, however, have been shown to be part of 
mobile genetic elements (e.g. the scpB and lmb genes, encoding fibronectin-binding and 
laminin-binding surface proteins, are part of a composite transposon; Herbert et al., 2005) 
and their acquisition may enhance the virulence of specific strains in specific niches. 
Accordingly, evidence from molecular epidemiological studies using multi-locus sequence 
typing (MLST) suggest that specific strains are associated with specific niche, e.g. sequence 
type (ST) 17 with neonates, ST67 with cows, and ST260 with fish (Bisharat et al., 2004; 
Brochet et al., 2006; Chapter 2). Moreover, further evidence indicate that this association is 
not only due to differences in exposure, but to true differences in virulence as shown in 
experimental infection studies of tilapia comparing the virulence of S. agalactiae strains of 
distinct ST and/or host of origin (Garcia et al., 2008; Pereira et al., 2010; Chapter 3). 
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Comparative genomic analysis (Chapter 4) enabled the identification of genetic elements 
that are uniquely or predominantly associated with fish strains, but virulence elements that 
may be shared across host-species were not considered. In the present study, genes encoding 
recognised virulence factors in human S. agalactiae were selected and their presence 
assessed in the piscine S. agalactiae STIR-CD-17. A literature review of those genes found 
in STIR-CD-17 is presented, accompanied by bioinformatic analysis to assess structural 
homologies between human and piscine S. agalactiae. This approach enabled the 
identification of a set of genes which are potential candidates for further in vitro and in vivo 
studies in order to evaluate their putative role in virulence in the specific context of fish 
infections. 
5.3 MATERIALS & METHODS 
5.3.1 Virulence gene selection and identification  
A review of the literature was performed in order to identify factors for which a role in 
virulence is supported by in vitro and/or in vivo studies of S. agalactiae from humans. Based 
upon their apparent primary function, these factors were classified into three major 
categories (Doran and Nizet, 2004): (1) adhesins, or factors responsible for the adherence 
and colonization to host epithelia, endothelia, or extracellular matrix, (2) invasins, or factors 
responsible for the invasion of host cells or the dissemination of bacteria across the 
extracellular matrix, and (3) immune evasins, or factors involved in the evasion of the host 
immune system. The systematic names (Locus tag) of the selected virulence factors in the 
three complete reference genomes available at the time of analysis (NEM316, A909 and 
2603V/R; Feb 2012) were further retrieved from the literature (Lin et al., 2011) or through 
key words and/or BLAST searches into the NCBI website (http://www.ncbi.nlm.nih.gov/). 
Finally, the presence/absence of these virulence coding genes was evaluated in the piscine 
STIR-CD-17 genome. For this, BLASTN searches of the nucleotide sequences from the 
three complete genomes were performed against the STIR-CD-17 genome using the BioEdit 
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software (Hall, 1999; http://www.mbio.ncsu.edu/bioedit/bioedit.html) and as previously 
described (Chapter 4). When a partial or complete match was obtained using BioEdit, the 
Contig containing the matching sequence in STIR-CD-17 was used in pairwise comparisons 
against the three complete genomes using ACT (Chapter 4), which allow assessment of 
homology and determination of conservation of position within the genomes. Because the 
STIR-CD-17 genome is incomplete (Chapter 4), the apparent absence of a gene may 
represent a true negative result (the gene is missing from the Contig) or a false negative 
result (the relevant Contig is missing). In order to provide further confidance of missing 
genes, the Contigs in STIR-CD-17 that would contain genes neighbouring a putatively 
missing gene were retrieved and ACT comparisons were performed. The selected virulence 
factors, their categorization and their systematic names in genomes are listed in Table 5.1. 
For the genes found to be well conserved among genomes, the homology of their encoded 
proteins was further evaluated using normalised BLAST score ratio analyses as previously 
described (Chapter 4). For genes found to be only partially conserved and for which 
multiple BLAST hits were obtained due to variable repeat segments or non homologous 
regions within the sequence, homology was evaluated through nucleotide and amino acid 
alignments using the MAFFT multiple sequence alignment web service implemented in 
JalView 2.4 (Clamp et al., 2004). 
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Table 5.1 List of known virulence genes with systematic gene names in the 3 complete reference genomes of human S. agalactiae and in the draft genome 
sequence of the piscine strain STIR-CD-17. 
 
°The Contig number is provided when genes are not annotated but found to be partially present. 
NEM316 A909 2603 STIR-CD-17°
Adhesins
fbsA Fibrinogen-binding protein FbsA GBS1087 SAK1142 SAG1052 M3M_07935
fbsB Fibrinogen-binding protein FbsB GBS0850 SAK0955 SAG0832 -
pavA Fibronectin-binding protein GBS1263 SAK1277 SAG1190 M3M_03075
srr 1 Serine-rich repeat protein 1 GBS1529 SAK1493 SAG1462 M3M_05192
srr 2 Serine-rich repeat protein 2 - - - -
bibA Immunogenic bacterial adhesin GBS2018 SAK1999/2002 SAG2063 M3M_09338
PI-1 Pilus island 1 GBS1474-1478 - SAG0645-0649 -
PI-2a Pilus island 2a - - SAG1404-1408 -
PI-2b Pilus island 2b - SAK1437-1442 - M3M_06269-06299
lmb Laminin-binding protein GBS1307 SAK1319 SAG1234 -
Invasins
cyl β-hemolysin/cytolysin GBS0644-55 SAK0790-0801 SAG0662-73 M3M_00345-00355
cfb CAMP factor GBS2000 SAK1983 SAG2043 M3M_09048
hylB Hyaluronate lyase GBS1270 SAK1284 SAG1197 M3M_03035
rib Surface protein rib GBS0470 - SAG0433 -
bca C-α protein - SAK0517 - -
Immune evasins
cps Cps gene cluster GBS1237-47 SAK1251-1262 SAG1162-75 M3M_08948-09003
neu neu  gene cluster GBS1233-36 SAK1247-1250 SAG1158-61 M3M_09008-09023
pbp1A/ponA Penicillin-binding protein 1A GBS0288 SAK0370 SAG0298 M3M_06939
soda Superoxide dismutase GBS0808 SAK_0913 SAG0788 M3M_06204
cspA Serine protease cspA GBS2008 SAK1991 SAG2053 Contig31
scpB C5a peptidase GBS1308 SAK1320 SAG1236 -
bac C-β protein - SAK0186 - -
Systematic name/locus in genomes
Gene/island Function/annotationCategory
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5.3.2 Structural and phylogenetic analysis of gbs2018  
A total of 38 complete gbs2018 nucleotide sequences for which MLST results are known 
were retrieved from the NCBI website. These comprise the gbs2018 from all published S. 
agalactiae genomes available at the time of analysis, plus sequences deposited in GenBank 
by Lamy et al. (2006) and Brochet et al. (2006).  
The gbs2018 gene is known to display sequence diversity: 3 major allelic variants have been 
described in isolates from human sources (Lamy et al., 2006). Even though all gbs2018 
genes display homologous regions, structural diversity is revealed by the acquisition or loss 
of nucleotide segments and a total of 11 distinct segments have been reported thus far 
(Lamy et al., 2006). Work by Lamy et al. (2006) thereby served as a reference for 
deciphering the structure of new variants encountered. In the current bioinformatic analysis,  
gbs2018 sequences were aligned and compared using the MAFFT multiple sequence 
alignment web service implemented in JALVIEW 2.4. Distinct gbs2018 variants identified 
were then compared pairwise using dot-plots (DOTTUP program with default setting with 
the exception of the word size of 12; http://mobyle.pasteur.fr), which allowed to determine 
the segments shared between different variants and the boundaries of these segments.  
Phylogenetic analysis was then performed based on the concatenation of segments   
previously aligned independently. For this aim, specific segments identified within the 
gbs2018 variants were manually extracted and aligned independently using MAFFT. Files 
were created and comprised a specific segment type with aligned sequences from all strains 
comprising that segment type. These files were then loaded in SEAVIEW (Gouy et al., 
2010) and concatenated. Finally the output file was loaded once more into TOPALi v2.5 for 
phylogenetic tree construction. Tree construction was optimised using the model selection 
feature. The selected model (HKY model of Hasegawa, Kishino, and Yano; Hasegawa et 
al., 1985) was then used to estimate a Bayesian phylogenetic tree using the MrBayes 
program (Ronquist et al., 2003) launched from TOPALi v2.5. The MrBayes settings were 2 
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runs of 625,000 generations and a burn-in period of 125,000 generations, with trees sampled 
every 10 generations. The consensus tree was imported into DENDROSCOPE v3.2.1 
(Huson et al., 2007), where visualization and editing were performed as required.  
5.3.3 Phenotypic test: CAMP reaction 
The Christie/Atkins/Munch-Petersen (CAMP) test (Wilkinson, 1977) was carried out to 
evaluate the CAMP activity of all the aquatic S. agalactiae collection of fish and sea 
mammals’ origin (Chapter 2, section 2.3.1). Isolates were streaked on 5% (v/v) sheep blood 
agar plates (E&C Laboratories, Scotland, UK) at right angles to a β-haemolysin-producing 
strain of Staphylococcus aureus (ID No: NCTC7428) in duplicate, and incubated 
aerobically at 28°C for up to 48h. Also included were 2 Streptococcus canis isolates (Isolate 
FSL Z3-022; FSL-Z3-023) as CAMP- positive controls, and a Streptococcus dysagalactiae 
subsp. dysagalactiae (Isolate QMP Z3-580) as a CAMP-negative control. 
5.4 RESULTS AND DISCUSSION 
5.4.1 Adhesins 
Among the putative adhesins investigated, 5 were detected within the piscine STIR-CD-17 
genome (Table 5.1). These comprised genes encoding the fibronectin-binding protein PavA 
and sortase-processed surface proteins such as the fibrinogen-binding protein FbsA, the 
pilus type 2 (variant PI-2b), the immunogenic bacterial adhesin BibA and the serine-rich 
repeat protein Srr1. 
5.4.1.1 Fibrinogen-binding protein  
The ability to bind fibrinogen is an important characteristic of strains belonging to the 
hyper-virulent ST17 clone responsible for neonatal infectious disease in humans (Rosenau 
et al., 2007). Two proteins with an ability to bind both soluble and immobilized human 
fibrinogen have been identified and referred to as FbsA and FbsB/Fgag (Schubert et al., 
2002; Jacobsson et al., 2003). Both proteins are not found in all S. agalactiae strains 
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(Rosenau et al., 2007) but they are usually found conjointly in the hyper-virulent ST17 
clone (Brochet et al., 2006). In STIR-CD-17, only fbsA was detected. 
In vitro and in vivo studies of S. agalactiae of human origin have confirmed the role of 
FbsA as an important virulence factor. In vitro, an fbsA knock-out mutant resulted in loss of 
fibrinogen-binding abilities and impaired growth in human blood, suggesting that the 
protein may also contribute to phagocytosis resistance (Schubert et al., 2002). Moreover, 
assessment of an fbsA knock-out mutant in a mouse model of infection resulted in 
significant reduction of mortalities, less pronounced weight loss, and less severe arthritis 
(Jonsson et al., 2005).  
FbsA has typical features of a cell-surface located protein with an N-terminal signal peptide 
sequence and a C-terminal wall anchoring region preceded by an LPXTG motif. Its inner 
structure contains variable 16-amino acid long repetitive units that have been described to 
interact with human fibrinogen and to promote adhesion to human epithelial and endothelial 
cells (Schubert et al., 2002 and 2004; Tenenbaum et al., 2005). The number of  repeats of 
this unit, which is composed of consensus sequence G-N/S/T-V-L-A/E/M/Q-R-R-X-
K/R/W-A/D/E/N/Q-A/F/I/L/V/Y-X-X-K/R-X-X, varies between 2 and 30 amongst different 
strains (Rosenau et al., 2007; Shubert et al., 2002), but a single repeat binds fibrinogen, as 
demonstrated using synthetic peptides (Shubert et al., 2002). 
The predicted fibrinogen binding region in STIR-CD-17 is composed of 2 repeat sequences 
of G-N-V-L-E-R-R-Q-R/H-D-V-D/E-N-K-S-Q (Figure 5.1). It is not known if the repeat 
segment binds piscine fibrinogen, as all previous experiments have focused on human 
fibrinogen. However, the high degree of conservation of the gene sequence and of the repeat 
segments suggests that FbsA might play a role in STIR-CD-17 pathogenesis in fish, 
although further studies using piscine S. agalactiae and/or fish models of infection are 
required.  
Virulence genes 
5-172 
 
Figure 5.1 Sequence alignment of predicted FbsA amino acid sequences from STIR CD-17, 
reference strain A909 and reference strain NEM316. The fibrinogen-binding site, composed of 
repetitive units of 16 bases, extends from consensus positions 40 to 316 (the first and last repeat 
units from the consensus sequence are framed in red). For the reference strains, a total of 13 (A909) 
and 17 (NEM316) repeat units are found, whereas STIR-CD-17 has only 2 of these repeat segments. 
For all sequences, the N-terminal region comprises the secretion signal peptide sequence and the C-
terminal region comprises the cell-wall anchoring region preceded by an LPXTG motif (framed in 
blue). Shading levels were set using Genedoc software (http://www.psc.edu/biome-d/genedoc/), with 
the grey colour highlighting single nucleotide differences. Dots correspond to missing nucleotides. 
The consensus sequence is represented in the bottomline of each block. 
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5.4.1.2 Fibronectin-binding protein 
PavA was first identified in S. pneumoniae but homologues are found in a variety of Gram-
positive bacteria, including S. agalactiae (Glaser et al., 2002; Henderson et al., 2011). 
Despite its lack of an N-terminal signal peptidase cleavage site and a C-terminal wall 
anchoring signature, it was shown by immune-electron microscopy that PavA is located on 
the outer cell surface of S. pneumoniae (Holmes et al., 2001). Pneumococcal PavA binds 
fibronectin, which is a major glycoprotein of the host extracellular matrix (Holmes et al., 
2001). Experiments using knock-out mutants showed that PavA affects pneumococcal 
adherence and invasion of epithelial and endothelial cells in vitro, whereas in vivo 
experiments in mouse models revealed a severe decrease in the virulence of the 
corresponding mutants (Holmes et al., 2001; Pracht et al., 2005). 
PavA is well conserved among S. agalactiae, including STIR-CD-17, with a calculated BSR 
> 0.99 between the protein in STIR-CD-17 and the proteins in NEM316, A909 or 2603V/R. 
However there are no reports on the role of the pavA gene in S. agalactiae and the 
expression, cellular location and role of the corresponding protein in human and piscine S. 
agalactiae requires further investigation.  
5.4.1.3 Serine-rich repeat protein 
Two variants of the serine-rich repeat protein Srr have been described in the literature, with 
the second variant (Srr2) mostly associated with strains from the hypervirulent ST17 clone 
(Brochet et al., 2006; Seifert et al., 2006). However, in STIR-CD-17 it is the variant Srr1 
that is found. 
In vitro and in vivo experiments using knock-out mutants of S. agalactiae of human origin 
revealed that Srr1 has an important role in the binding of S. agalactiae to human keratin 4 
and fibrinogen (Samen et al., 2007; Seo et al., 2012), that it contributes to vaginal 
colonisation through host-cell attachment (Sheen et al., 2011), and that it facilitates 
penetration of the blood-brain-barrier (van Sorge et al., 2009; Seo et al., 2012). In a neonatal 
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sepsis model of infection in mice, strains possessing Srr1 were, however, found to be less 
virulent than those with Srr2 (Seifert et al., 2006). 
Defining features of the protein Srr include an N-terminal signal peptide, one or two unique 
non repeat regions (NR domain), two serine-repeat regions (SRR1 and SRR2) of which one 
comprises the majority of the protein (SRR2), and a C-terminal LPXTG cell-wall anchoring 
motif (Seifert et al., 2006). The NR region mediates adhesion whereas the SRR2 domain has 
no adhesive properties and appears to be highly variable in size (Pyburn et al., 2011). It has 
been hypothesised that the SRR2 domain has evolved in order to extend the NR domain 
beyond the cell-wall and other surface components to facilitate attachment of the NR 
domain (Pyburn et al., 2011). The amino acids that alternate with the serine in the SRR 
regions of Srr1 are alanine, threonine and methionine (Seifert et al., 2006). In S. agalactiae 
A909, Srr1 is 1258 amino acids long with 280 repeats of the amino acid sequence S-A/T/M. 
In contrast, Srr1 in STIR-CD-17 is much smaller in size (730 amino acids; Figure 5.2) with 
an SRR2 domain containing only 16 S-A/T/M repeats. This observation suggests that cell-
wall components may be thinner in STIR-CD-17 than in other S. agalactiae strains or that 
Srr1 is of limited functional relevance in STIR-CD-17. 
Homologues of the gene exist in several streptococcal species (Lizcano et al., 2012) and the 
genes encoding for Srr1 or Srr2 are part of the so-called secY2/A2 locus. This locus 
includes 2 glycosyltransferases (GtfA and GtfB) involved in Srr protein glycosylation, 
which is required for protein stability, and 5 genes (secY2, asp1-3, secA2) encoding 
components of the secY2/A2 complex necessary for Srr transport (Mistou et al., 2009; 
Seifert et al., 2006). Species and strain-specific structural variations occur and can include 
additional glycosyltransferases (for example a total of 8 glycosyltransferases are observed in 
S. agalactiae A909; Figure 2). In STIR-CD-17, secY2 is absent, suggesting that Srr1 might 
not be exported extracellularly. Disruption of secY2 in strains of S. gordonii resulted in 
accumulation of the protein within the cytoplasm (Bensing and Sullam, 2002), but in 
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Mycobacterium smegmatis, Mycobacterium tuberculosis and Listeria monocytogenes, 
SecA2-only systems have been identified and reported to be functional through an as-yet 
undefined mechanism (Rigel and Braunstein, 2008). However, secA2 appears as a 
pseudogene in STIR-CD-17 and it is therefore unlikely that the Srr1 protein is present on the 
surface of STIR-CD-17. 
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Figure 5.2 Characterisation of the secY2/A2 locus in STIR-CD-17 by linear comparison between S. agalactiae A909 (top sequence) and Contig 622 from STIR 
CD-17 (bottom sequence), created using the Artemis Comparison Tool. A homologous block of genomic sequence (BLASTN matches) is indicated by blue bars 
between the sequences. In S. agalactiae A909, this locus includes 1 gene (srr1) encoding a serine-rich cell-wall anchored protein, 8 glycosyltransferases (GtfA to GtfH) 
involved in the Srr protein glycosylation, which is required for protein stability, and 5 genes (secY2, asp1-3, secA2) encoding components of the secY2/A2 complex and 
necessary for Srr1 transport. In comparison, in S. agalactiae STIR-CD-17, the locus lacks a 6,805 bp region comprising the genes gtfE-gtfH plus secY2; secA2 appears as 
a pseudogene (green) due to potential frameshift, and the srr1 gene (M3M_05192) is of reduced size at its C-terminal region. 
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5.4.1.4 Peptidoglycan anchored protein  
Brochet et al. (2006) first described the presence of a putative peptidoglycan-anchored 
protein referred to as gbs2018 and sag2063 based on their locus tag in the published 
genomes of strains NEM316 and 2603V/R respectively. Through the exploration of the gene 
structure in a global collection of S. agalactiae of human and animal origin, a total of 7 
allelic variants (gbs2018-1 to -6, plus sag2063) were reported. Gbs2018-4 and -6 
correspond to variants only identified in S. agalactiae from cattle and fish respectively, 
whereas other variants have been identified in S. agalactiae from humans and other host 
species (Brochet et al., 2006). A strong correlation exists between chimeric variants and the 
STs of the strains, with for example gbs2018-3 found exclusively among the hypervirulent 
ST17 clone (Brochet et al., 2006; Santi et al, 2007; Lamy et al., 2006). 
The gbs2018 variants are present at the same genetic locus in all S. agalactiae (Santi et al, 
2007). The resulting protein may either be surface anchored or truly extracellular, but not all 
strains demonstrate expression of the protein in vitro possibly due to regulatory differences 
(Santi et al., 2007 and 2009). Using deletion mutants of the reference strain 2603V/R 
(containing the sag2063 variant), an in vitro study demonstrated the protein to have 
adhesive and antiphagocytic properties (Santi et al., 2007). Moreover, vaccination of mice 
with a recombinant derivative of sag2063 conferred protection against bacteria expressing 
either the same variant or the gbs2018-1 variant. However, evidence suggests that there is 
no cross protection between all variants found among human isolates (Santi et al., 2007). 
Work on gbs2018-3 highlighted this variant to be essential for the hyper-virulence of ST17 
clone as it is required for adhesion and translocation across the intestinal barrier and the 
blood brain barrier (Tazi et al., 2010). No work has been published on other variants. 
Structurally, these proteins display similar N-terminal (secretion signal peptide) and C-
terminal (LPXTG cell-wall anchoring motif) regions but diverge at their central domains. 
The structure of allelic variants found among human isolates has been described by different 
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research teams; each of those teams, however, attributed a different name to similar 
chimeric variants, therefore rendering the nomenclature somewhat confusing (Table 5.2). 
Based on multiple alignments, Lamy et al. (2006) defined the presence of 11 segments (S1 
to S11). In that study, the boundaries of most segments were defined by blocks displaying 
identical nucleotide sequences, whereas the basis of identification for segments S5 and S7 
relied on the fact that the segment encodes variable KPXX repeats. The structure of 
chimeric variants as reported by Lamy et al. (2006) exclusively focused on sag2063 and 
gbs2018-1 to -3; in the current study, the structural analysis is extended to include the 
variants identified by Brochet et al (2006) and the one identified in STIR-CD-17, consisting 
of gbs2018-4 (strain 549.12 isolated from a cow and of ST247), gbs2018-5 (CCH30 isolated 
from a human and of ST1) and gbs2018-6 (strain 2.22 isolated from a fish and of ST246; 
STIR-CD-17 isolated from a fish and of ST260) (Figure 5.3). This was achieved using 
multiple alignments and dot plot analyses as described in Figure 5.4. The gbs2018-5 
variant, as deposited in GenBank by Brochet et al. (2006), was found to be only partially 
complete as analysis of this sequence revealed that it only comprises the 3’ segments 
corresponding to S7 and S8, from which we cannot deduce whether it actually corresponds 
to a new variant. In the current study, a total of four new segments are reported among the 
gbs2018 variants. As shown in Figure 5.3, each gbs2018 variant contains at least one 
distinctive segment (S3 for gbs2018-1, S9 for gbs2018-2, S10 for gbs2018-3, S15 for 
gbs2018-4 and S14 for gbs2018-6). Both sequences from fish (2.22 and STIR-CD-17) are 
identical (gbs2018-6) with the exception of S7 (3 repeats of KPXX for STIR-CD-17 and 2 
repeats for 2.22). For this variant, most of the inner part of the protein is unique (S14), but 
interestingly one of its segments (S11) is also shared with the variant found among 
hypervirulent strains of ST17 (Figure 5.3). 
The putative gbs2018 encoding proteins each have a highly conserved region at their N and 
C termini: whilst this allows sequences from diverse strains to be aligned, the resulting 
phylogenetic tree as generated by Lamy et al. (2006) would not accurately reflect the 
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heterogeneity found among the different segments as these would not be aligned correctly. 
In our study, segments were extracted and aligned independently prior to concatenation and 
phylogenetic tree construction. Major clustering was therefore based on segments shared 
between all variants (S1 and S8), whereas other segments enabled the tree to be refined 
within the major clusters. Furthermore S7/S5 were removed from the analysis as the number 
of repeats appeared to correspond to an adaptive evolution specific for each isolate, not 
reflecting the overall picture. It is possible that S7/S5 have evolved in order to extend the N-
terminal sequence beyond the cell-wall, as hypothesised for the repeat domain of the Srr1 
protein (section 5.4.1.3). In the tree (Figure 5.5), each major cluster corresponds to a 
specific variant, whereas sub-clusters denote variations within a specific variant. Most 
importantly the analysis reveals that the gbs2018-6 from fish and gbs2018-4 from bovine 
are clustering with the gbs2018-3 variant found among ST17 hypervirulent human strains. 
The variant found among fish pathogenic strains possibly has an important role in virulence 
and could be an interesting target for further studies. 
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Table 5.2 Names attributed by different research teams to chimeric variants of the gene encoding a peptidoglycan-anchored protein originally called 
gbs2018/sag2063. 
 
The host range and sequence type (ST) of strains found to carry each of the specific variant is provided. A reference strain and accession number is also provided for each 
variant. NA, Non Available, H. Human, B., Bovine, C., Canine, F., Feline, R. Rodent, P., Piscine; HvgA, Hypervirulent GBS adhesin; BibA, Group B 
Streptococcus immunogenic bacterial adhesin. 
Name Accession N° Brochet et al., 2006 Lamy et al., 2006 Santi et al., 2007 Tazi et al., 2010
2603V/R AE009948 SAG2063 Gbs2018 cluster A BibA variant I BibA H, F 19, 110, 28
NEM316 NC_004368.1 Gbs2018-1 Gbs2018 cluster A BibA variant II BibA H, B, C, F 23, 249, 253
NEM1010 AM183361 Gbs2018-2 Gbs2018 cluster B BibA variant III NA H, B, C, F, R 1, 2, 3, 6, 7, 8, 9,  10, 12, 41, 50, 103, 196, 226, 248, 251
BM110 AM051291 Gbs2018-3 Gbs2018 cluster C BibA variant IV HvgA H 17, 252
549.12 AM51292 Gbs2018-4 NA NA NA B 61, 247
CCH330 AM051293 Gbs2018-5 NA NA NA H, B 1, 8
2.22 AM051294 Gbs2018-6 NA NA NA P 246
Reference strains Nomenclature in different publications
STs Hosts
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Figure 5.3 Mosaic structure of the gene encoding the 5 chimeric gbs2018 variants  encountered 
in S. agalactiae from humans (variants gbs2018-1 to -3; after Lamy et al., 2006), bovines 
(variant gbs2018-4; mentioned by Brochet et al., 2006) and fish (variant gbs2018-6 from 
genome STIR-CD-17 and mentioned by Brochet et al., 2006). The 5’-terminal segment S1 
encodes for the secretion signal peptide whereas the 3’-terminal segment S8 contains the cell-wall 
anchor signature. The segments S5 and S7 contain variable numbers of KPXX repeats. Other 
segments are found in 1 to 4 of the gbs2018 variants. Distinction between gbs2018-1 and sag2063 is 
based on the presence or absence of S6. For variants gbs2018-1 to -3, the segments are named as in 
Lamy et al. (2006) with adaptation: S10 as referred in Lamy et al. (2006) has been subdivided and 
referred to as S10 and S12 in the present figure. Structure of variants gbs2018-4 and -6 is based on 
analysis from the present study. The segment S11’ identified in this study is identical to S11 with the 
exception of an internal deletion. Segments S12, S13, S14 and S15 were newly identified in the 
current study.  
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Figure 5.4 Pairwise comparisons of gbs2018 from STIR-CD-17 against representatives of 
previously described gbs2018 variants using dot-plots. Abscissas and ordinates indicate the size 
(bp) of the genes compared and lines indicate matching regions. The structure of the variants 
compared is presented along with the graphs, with matching segments represented by blocks framed 
with continuous lines, whereas non-matching segments are represented by block with dashed lines. 
Comparison of STIR-CD-17 with NEM1010 and NEM316 showed that all variants share the 
conserved N-terminal signal peptide region S1 (shown in red) and the conserved C-terminal regions 
S7 and S8 (shown in green and navy, respectively). Comparison with BM110 identifies homology of 
the S11 region, which is present with 2 copies in BM110 and a single copy with internal deletion in 
STIR-CD-17 (shown in pink). Finally, comparison with 549.12 shows homology of the S13 element 
(shown in light blue). The central segment of STIR-CD-17 did not show homology with any known 
sequence and is named S14. 
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Figure 5.5 Bayesian phylogenetic tree of the gbs2018 gene. Names of strains and corresponding sequence types (STs) are provided within the figure. Symbols adjacent 
to the strain information indicate the origin of the strain being fish (blue circles) or bovine (green triangle), whereas the absence of symbol indicates a human or unknown 
origin (NEM316). Major clusters are in agreement with the different variants reported in Figure 5.3. Posterior probabilities are shown at each node and the scale bar 
represents the substitutions per site. 
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5.4.1.5 Pili 
Pili were unrecognized in decades of studies of S. agalactiae until comparative genomics 
enabled the identification of genes responsible for expression of these cell surface 
appendages (Lauer et al., 2005). Two distinct loci called PI-1 and PI-2 are responsible for 
the biosynthesis of pili in S. agalactiae, with PI-2 existing as 2 chimeric variants known as 
PI-2a and PI-2b (Rosini et al., 2006; review by Telford et al., 2006). 
Both loci have a similar genetic organization; they are composed of 2 sortase C (SrtC) 
encoding-genes implicated in the assembly and polymerization of the pilus components, 
plus 3 structural protein encoding-genes with cell-wall anchoring motifs, namely the 
backbone protein (BP) and 2 ancillary proteins (AP1 and AP2). Cell-wall anchoring of pili 
is mediated by another sortase not encoded within the PI locus, the sortase A (SrtA) which 
covalently attaches pili to the cell-wall utilizing one of the AP as the anchor protein (Nobbs 
et al., 2008). Analysis of the distribution of pili within a collection of 289 human clinical 
isolates revealed that all strains carried at least one of these 2 loci and up to 94% of the 
strains expressed pili on their surface (Margarit et al., 2009). 
Most studies to-date have focused on deciphering the role of pilus type 2a in pathogenesis. 
The AP1-2a (ancillary protein AP1 of pilus type 2a), has adhesion properties and the pilus 
type 2a variant has been implicated in mediating attachment to human respiratory epithelial 
cells (Dramsi et al., 2006, Konto-Ghioghi et al., 2009), human vaginal and cervical 
epithelial cells (Sheen et al., 2011) and to brain microvascular endothelial cells (Maisey et 
al., 2007). Pili are involved in biofilm formation (Konto-Ghioghi et al., 2009) and it was 
recently demonstrated that the biofilm-forming biotype is strictly conferred by pilus type 2a 
and not by pili of types 1 or 2b (Rinaudo et al., 2010). However conflicting results have 
been published concerning resistance to phagocytosis and resistance to intracellular killing 
by macrophages for pilus type 2a (Maisey et al., 2008; Papasergi et al., 2011), which 
suggests that not only pilus type but also level of expression and host or environmental 
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factors may influence pilus functions. Finally, in vivo challenges of 6 weeks old and 
newborn mice revealed that PI-2a is an important virulence factor but in the neonatal 
context only (Papasergi et al., 2011).  
Studies on pilus type 1 and 2a suggested that these variants promote survival of S. 
agalactiae within macrophages (Jiang et al., 2012) and invasion of epithelial cells 
(Adderson et al., 2003; Krishnan et al., 2007). Conflicting results in terms of adhesion have, 
however, been obtained for the pilus type 1: using recombinant AP2-1 proteins, one study 
revealed that it acts as a ligand to specific tissue receptors, thereby promoting adherence to 
pulmonary epithelial cells (Krishnan et al., 2007), whereas another study using deletion 
mutants could not demonstrate that PI-1 pili mediate adhesion to respiratory epithelial, 
cervical or vaginal cells (Jiang et al., 2012). 
Only one study evaluated the role of the pilus type 2b, which is the pilus type present in 
STIR-CD-17, and this in vitro study used knock out mutants to demonstrate that this variant 
promotes phagocytosis and survival of the bacteria within macrophages (Chattopadhyay et 
al., 2011). 
STIR-CD-17 lacks the PI-1 locus. Strains with PI-2b but lacking PI-1 have been rarely 
reported in human S. agalactiae; of a collection of 289 isolates, only 1% was PI-2b positive 
and PI-1 negative (Margarit et al., 2009). In that study, the structure of the pilus islands was 
investigated and it was shown that PI-2b has a good degree of conservation for BP and AP2, 
whereas AP1 clusters into 2 allelic variants (1 variant represented by the reference strain 
COH1 and the other by A909). With STIR-CD-17, a third API-1 allele, closer to that of 
COH1 (ST17), was identified in this study (Figure 5.6). Moreover BP-2b is truncated and a 
sortase appears as a pseudogene due to potential frameshift causing the introduction of stop 
codons. Delta-BP knock-out mutants completely eliminate pilus polymerisation (Nobbs et 
al., 2008; Rosini et al., 2006), suggesting that BP is essential. Therefore no pili might be 
present on the surface of STIR-CD-17. 
Virulence genes 
5-186 
 
 
Figure 5.6 Streptococcus agalactiae pilus type 2b. Panel A: schematic representation of the 
genetic structure encoding for the pilus type 2b, which is composed of genes encoding a backbone 
protein (BP), 2 ancillary proteins (AP1 and AP2) and 2 sortases (grey arrows). Panel B: pairwise 
comparison of S. agalactiae STIR-CD-17 (middle sequence) with A909 (top sequence) or COH1 
(bottom sequence) using the Artemis Comparison Tool. A homologous block of genomic sequence 
is indicated by blue or red bars between the sequences. The AP1 from STIR-CD-17 shows a region 
with non-homology with the AP1 from A909 or COH1, suggesting it is a new variant. In STIR-CD-
17, the BP is truncated and one of the sortases is shown as a pseudoprotein (green), further 
suggesting that no pilus in expressed by STIR-CD-17. 
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5.4.2 Invasins 
Among the 5 invasion genes investigated, 3 were found to be fully or partially present in the 
genome of STIR-CD-17. These include genes encoding β-haemolysin, CAMP factor and 
hyaluronate lyase HylB. 
 5.4.2.1 Beta-haemolysin/cytolysin 
A hallmark phenotype for most human S. agalactiae is the appearance of a clearing zone 
surrounding colonies grown on blood agar, also called β-haemolysis. This phenotypic 
characteristic is due to a surface-associated toxin referred to as beta-hemolysin/cytolysin 
(βH/C) and capable of forming pores in red blood cell membranes (Marchlewicz and 
Duncan, 1981). The toxin is responsible for cytolytic and/or apoptotic injuries in a broad 
range of eukaryotic cells, including pneumocytes (Nizet et al., 1996), cardiomyocytes 
(Hensler et al., 2008), hepatocytes (Ring et al., 2002), neuronal cells (Reiß et al., 2011), 
brain and lung micro-vascular endothelial cells (Nizet et al., 1997; Gibson et al., 1999) and 
macrophages (Liu et al., 2004). In vivo, the βH/C was found to contribute to virulence in 
rabbit or murine models of arthritis (Puliti et al., 2000), pneumonia (Hensler et al., 2005), 
sepsis (Ring et al., 2002) and meningitis (Doran et al., 2003).  
The toxin has not been purified to-date and there is therefore little information about its 
chemical structure. However, the genetic basis of the βH/C production has been identified to 
lie within the so called cyl operon (Spellerberg et al., 1999; Pritzlaff et al., 2001). This 
discovery enabled the generation of isogenic deficient mutants for investigation of the toxin 
function using in vitro and in vivo models. Within the operon, cylE represents the structural 
gene for the toxin as the gene alone is able to confer the haemolytic capacity to E. coli 
(Pritzlaff et al., 2001); however, evidence suggests that other genes within the operon (cylJ 
and cylK) are necessary for the full expression of the phenotype (Forquin et al., 2007). 
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The diagnosis of S. agalactiae  infection in humans often includes observation of β-
haemolysis as a phenotypic tool (Jones et al., 2003), and cylB has recently been suggested 
as a real time PCR target for detection of S. agalactiae in clinical samples (de Zoysa et al., 
2012). Non-haemolytic isolates, however, exist and their prevalence among carriage isolates 
is estimated between 5 to 8 %, although this value may be underestimated as most studies 
use β-haemolysis as diagnostic criterion for identification of S. agalactiae (Nickmans et al., 
2012). Non-haemolytic isolates have been reported not only in humans, but also in bovines, 
mice, amphibians, shrimp and fish (Elliot et al., 1990; Duarte et al., 2004; Hasson et al., 
2009). In fish, non-haemolytic S. agalactiae isolates are a frequent finding during outbreaks 
(Bowater et al., 2012; Mian et al., 2009; Chapter 2) and these isolates have previously been 
erroneously classified as a new bacterial species called Streptococcus difficile (Vandamme 
et al., 1997). The piscine STIR-CD-17 is also non-haemolytic, as are all of the isolates 
belonging to the fish-adapted CC552 (Chapter 2). Genomic analysis of the only non-piscine, 
non-haemolytic strain available (the bovine strain ATCC13813) revealed that the complete 
cyl operon is missing. In STIR-CD-17, the cylA and incomplete cylB plus cylE are present, 
whereas other genes from the operon are absent, explaining the non-haemolytic phenotype 
(Figure 5.7). The partial or complete loss of these genes in STIR-CD-17 and the absence of 
haemolysis in numerous fish pathogenic S. agalactiae demonstrate that the toxin is not an 
important contributor to pathgenicity in this host. 
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Figure 5.7 Linear comparison of the cyl operon (and adjacent genes) between the β-heamolytic S. agalactiae A909 (top sequence) and the non-heamolytic S. 
agalactiae STIR CD-17 (bottom sequence), created using the Artemis Comparison Tool. A homologous block of genomic sequence (BLASTN matches) is indicated 
by blue bars between the sequences. All genes from the cyl operon are present within S. agalactiae A909 (cylX to cylK), whereas most corresponding genes are absent 
from the S. agalactiae STIR CD-17, with the exception of cylB (M3M_00350; complete sequence) and partial sequences for cylA (M3M_00355) and cylE (M3M 
_00345). 
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 5.4.2.2 CAMP-factor  
Christie et al. (1944) first described a phenotypic reaction consisting of the lysis of red 
blood cells due to the synergystic interaction between an undetermined agent produced by S. 
agalactiae and the Staphylococcus aureus sphingomyelinase C (beta-toxin). The reaction 
and the S. agalactiae secreted agent are now commonly known as CAMP reaction and 
CAMP-factor respectively, after the discoverers initials (Christie, Atkins & Munch-
Petersen). Evidence that the CAMP factor is an important virulent factor is based on two in 
vivo studies, one indicating that purified CAMP factor is lethal to mice and rabbits (Skalka 
and Smola, 1981), and the other revealing that sub-lethal doses of S. agalactiae injected 
along with the purified toxin induces fatal septicaemia in mice (Jürgens et al., 1987). It was 
also found that the CAMP factor binds to glycosylphosphotidylinosito-anchored proteins, 
suggesting that binding of the toxin to a cell receptor is necessary for its cell pore-forming 
action (Lang et al., 2007). More recently, the virulence properties of a CAMP-deficient 
mutant was evaluated and, based on an in vivo experiment, it was concluded that the mutant 
retains full virulence (Hensler et al., 2008). This new study is in contradiction with previous 
observations and suggests that the CAMP factor might therefore be nonessential for 
systemic virulence of S. agalactiae. 
The complete 226 amino acid sequence of the CAMP factor was identified manually from 
peptide fragments in 1988 (Rühlmann et al., 1988), which enabled subsequent identification 
in 1994 of the corresponding gene named cfb (Podbielski et al., 1994). Homologues of this 
gene have been identified in other streptococcal species such as S. pyogenes (Gase et al., 
1999), S. uberis (Jiang et al., 1996) and S. canis (Gürtük and Lämmler, 1990). The CAMP 
reaction and cfb-targeted PCRs have found their use as a diagnostic tool for S. agalactiae 
identification (Bae and Bottone, 1980; Ke et al., 2000), but strains that are phenotypically 
and/or PCR CAMP-negative have been reported on rare occasions in human and bovine 
isolates, suggesting that cfb is not always expressed and could be present in a mutant form 
or be absent from some strains (Hassan et al., 2000 and 2002; Kong et al., 2002; Podbielski 
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et al., 1994). Moreover non-haemolytic fish pathogenic isolates are commonly reported as 
phenotypically CAMP-negative (Bowater et al., 2012, Evans et al., 2008).  
Along with many other reports of S. agalactiae from fish (Evans et al., 2007; Bowater et al., 
2012), all piscine S. agalactiae belonging to the fish-adapted subgroup from our study were 
found to be CAMP-negative, including STIR-CD-17 (data not shown). However, the gene 
was found to be present within the STIR-CD-17 genome and it is well-conserved in 
comparison with the reference genomes (BSR > 0.97). The presence of the gene suggests 
that it is not expressed either due to in vitro conditions, possibly due to a repressor 
activation, or due to a gene defect along the pathway of expression. In order to investigate 
the latter hypothesis, the CovSR operon (Contig581, M3M03940 to M3M_03965) 
responsible for expression regulation of the CAMP gene was further investigated and 
compared to other sequences using ACT. The operon appeared to be well conserved. Within 
that operon, the covR gene is of particular interest, as covR deletion mutants are deficient for 
CAMP factor expression (Lamy et al., 2004). In STIR-CD-17, covR (M3M_03940) only 
shows 3 non-synonymous bp differences with the corresponding gene from NEM316 
(gbs1672). This suggests that expression of the CAMP factor might not be due to a gene 
defect but to an undetermined repression under laboratory conditions used when growing 
the bacterium on blood agar. However, preliminary RT-PCR results suggest that expression 
in STIR-CD-17 takes place in vitro after a overnight growth in brain and heart infusion (data 
not shown). The overall good conservation of the gene within S. agalaciae species suggests 
that, from an evolutionary point of view, the toxin is beneficial to bacterial fitness in 
specific niches or for pathogenesis in hosts including fish. However, the actual function 
performed remains to be determined. 
 5.4.2.3 Hyaluronate lyase  
Hyaluronate lyase is a secreted protease encoded by hylB that cleaves one of the major 
components of the extracellular matrix referred to as hyaluronan (Baker and Pritchard, 
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2000). Because of its enzymatic property, hylB is thought to be an important virulence 
factor contributing to host tissue invasion. Consistent with this hypothesis, higher levels of 
hyaluronate lyase production have been associated with strains causing invasive infections 
in humans (Milligan et al., 1978; Musser et al., 1989). However, the role of hylB in the 
course of infection has not been defined. Moreover, conflicting results were obtained when 
another study (Granlund et al., 1998) identified a group of invasive S. agalactiae strains 
with no hyaluronidase activity due to integration of IS1548 within the hylB gene. The role 
of this gene in S. agalactiae pathogenesis is therefore still under debate. 
Structurally, hylB contains a promoter region, a ribosome binding site and a secretion signal 
peptide-encoding sequence (Gase et al., 1998). In STIR-CD-17, the gene is globally well 
conserved in comparison to the reference genomes (BSR > 0.9) and it does not contain any 
insertion sequence, suggesting that it could be expressed.  
5.4.3 Immune evasins 
Among the 7 putative evasins investigated, 4 were found to be fully or partially present in 
the genome of STIR-CD-17 (Table 5.1). These include genes encoding the enzymes 
responsible for production of the polysaccharide capsule, the serine protease CspA, the 
penicillin-binding protein 1A and superoxide dismutase.  
5.4.3.1 Polysaccharide capsule 
Virtually all S. agalactiae are considered to be encapsulated, even though a recent study 
revealed that some strains lack the capsular locus (Creti et al., 2012). The capsule is a major 
virulence factor formed by different arrangements of polysaccharides (including glucose, 
galactose and N-acetylneuraminic acid) organised in repeat unit structures (Cieslewicz et al., 
2005). The coating of encapsulated bacteria by N-acetylneuraminic acid is considered to be 
an adaptative evolutionary feature of molecular mimicry, since the bacterial N-
acetylneuraminic acid is identical to predominant sialic acids found on glycans of vertebrate 
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cells, thereby preventing the host from recognising the bacteria as non-self (Angata and 
Varki, 2002; Carlin et al., 2007; Severi et al., 2007). Consequently, mutants lacking sialic 
acid demonstrated a loss of virulence in a neonatal model of mice infection (Wessels et al., 
1989).  
Genes responsible for polysaccharide production and transportation are clustered in the so-
called cps operon (cpsA to cpsL). Structural diversity of capsule architecture is determined 
by polymorphism of the cps operon leading to variation in serotypes (Cieslewicz et al., 
2005). To date, ten capsular serotypes have been identified: Ia, Ib and II to IX (Slotved et 
al., 2007). In humans, ST17 is predominantly associated with serotype III, but this serotype 
has been identified in other STs and other host species, including ST283 in fish (Chapter 2) 
and ST23 in cattle (Sørensen et al., 2010). In cattle, many strains are non-typeable (Dogan et 
al., 2005). In fish, 3 distinct serotypes have been described: Ia, Ib and III (Evans et al., 2008, 
Suanyuk et al., 2008; Chapter 2).  
In this study, STIR-CD-17 was found to be of serotype Ib by PCR (Chapter 2). In order to 
confirm this result with the genomic information, the cps locus was investigated and 
compared with the only 2 cpsIb sequences available from the NCBI website (accession 
numbers NZ_AAJS010 and AB050723). Specific cps gene organisations and homologies as 
described (Cieslewicz et al., 2005) confirmed STIR-CD-17 to be of serotype Ib, even 
though previously unreported gene polymorphisms were observed. Indeed, sequence 
comparison of cps loci revealed the presence of numerous single nucleotide differences 
specific for STIR-CD-17 as well as a non-homologous region of 218bp within the cpsK 
gene (Figure 5.8). The predicted CpsK from STIR-CD-17 and other isolates of serotype Ib 
however shows homology (BSR = 0.81), whereas the comparison with the predicted CpsK 
from the reference genomes shows divergence (BSC < 0.54), as expected, due to different 
serotypes. Whether the non-homologous region affects the biosynthesis of the capsule in 
serotype Ib remains to be investigated. 
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Figure 5.8 Sequence alignment of cpsIbJ and cpsIbK genes using sequence from isolate STIR 
CD-17 and sequences with accession number NZ_AAJS010 (H36B isolate) and AB050723 
(undefined isolate). Specific primers annealing sites for Ib serotyping from Poyart et al. (2007) are 
shown in the figure (Ib-F, Ib-R). Stop codons are framed in red and start codons are indicated with 
arrows. Nucleotide position refers to the sequence with Genbank accession number AB050723. Dots 
indicate nucleotide sequences identical to that of the consensus sequence. Two shading levels are set 
using Genedoc software: black for 100% homology between the 3 sequences and grey for 2 
sequences being homologous out of the 3. 
  
             
             
STIR-CD-17 : 
NZ_AAJS010 : 
AB050723.1 : 
             
                                                                                                                          
       *      5020         *      5040         *      5060         *      5080         *      5100         *      5120    
-----..........................C..........................................................................................
-----.....................................................................................................................
..........................................................................................................................
     ATGAATTATAGTATCATTATGTCGGTaTATAATGAGCCTTTAAATTATGTGAGAGATTCAGTAGAATCTATATTAAATCAAACGCTTACTGATTTTGAGTTCATAATTGTCATTGAT
       
       
 :  117
 :  117
 : 5124
       
             
             
STIR-CD-17 : 
NZ_AAJS010 : 
AB050723.1 : 
             
                                                                                                                          
     *      5140         *      5160         *      5180         *      5200         *      5220         *      5240      
..........................................................................................................................
..........................................................................................................................
..........................................................................................................................
AATCCAAGTAGAGGTGATTTAAAGCAATTCTTAACAGAATATTCAGTTGTAGATAATAGAATAAAAATCTTGCTTAATGAAGAAAATATTGGTTTAGCATCAAGTTTGAACAAAGCGGTGAA
       
       
 :  239
 :  239
 : 5246
       
             
             
STIR-CD-17 : 
NZ_AAJS010 : 
AB050723.1 : 
             
                                                                                                                          
   *      5260         *      5280         *      5300         *      5320         *      5340         *      5360        
..........................................................................................................................
..........................................................................................................................
..........................................................................................................................
AATTTCTAAGGGAGAATATATTTTTAGAATGGATGCTGATGATATTTCATATCCAAGTAGATTTGATAAGCAAATTCGTTTTATGGAGGAAAATTCATTGGATTTCTCAGCAACTCTAATAG
       
       
 :  361
 :  361
 : 5368
       
             
             
STIR-CD-17 : 
NZ_AAJS010 : 
AB050723.1 : 
             
                                                                                                                          
 *      5380         *      5400         *      5420         *      5440         *      5460         *      5480         *
..........................................................................................................................
..........................................................................................................................
..........................................................................................................................
AATTGATAGACCAAAAAGGAAATTTAGTATATAAACAACGAGAAAGTAATAAAATATACTTAACTAATGATATACGGAAGATGTTATTGAATAGATCTATACTTGCCCACCCAACGTGGTGC
       
       
 :  483
 :  483
 : 5490
       
             
             
STIR-CD-17 : 
NZ_AAJS010 : 
AB050723.1 : 
             
                                                                                                                          
      5500         *      5520         *      5540         *      5560         *      5580         *      5600         *  
..........................................................................................................................
..........................................................................................................................
..........................................................................................................................
GTAAAAAAGAAAGTTTTCGATAAGTTAATGGGATATAGAGATTTAGTACCTGTTGAAGATTATGATTTTGCAATAAGAGGAGCTCTGGCTGATTTCAAAATCGGCTTACTCAATAAAGTACT
       
       
 :  605
 :  605
 : 5612
       
             
             
STIR-CD-17 : 
NZ_AAJS010 : 
AB050723.1 : 
             
                                                                                                                          
    5620         *      5640         *      5660         *      5680         *      5700         *      5720         *    
..........................................................................................................................
..........................................................................................................................
..........................................................................................................................
TTTACAGTATAGATTAAACGAGAATGGAATATCACAAACCAATAAGTTTAAGCAATATATTTACTCAGCTATTTTACAAGATTTTTATAAAGAAAAATCTTATATTGATATCACAAAAATTA
       
       
 :  727
 :  727
 : 5734
       
             
             
STIR-CD-17 : 
NZ_AAJS010 : 
AB050723.1 : 
             
                                                                                                                          
  5740         *      5760         *      5780         *      5800         *      5820         *      5840         *      
..........................................................................................................................
..........................................................................................................................
..........................................................................................................................
CTAATTACTTTCAAGAGTATGTGATAAAGAAACGCTATACTCAGCAAGAGCTCTCTAAATATTTTGAGCTAAAATCTACCCCTAGTATTACTATTAGAAAACTATATATTTGTTTATATTTA
       
       
 :  849
 :  849
 : 5856
       
             
             
STIR-CD-17 : 
NZ_AAJS010 : 
AB050723.1 : 
             
                                                                                                                          
5860         *      5880         *      5900         *      5920         *      5940         *      5960         *      59
.......................A..................................................................................................
..........................................................................................................................
..........................................................................................................................
TACTTTAAGTCTCCCTTGGTTAGgAGGTTATTAATAAATGATATTAATATTTTAGTACTGAAATTGTTTGGAGGAGAGAAACAAAGTGACTAATAGAAAAATTTATGTATGTCATACTCTTT
       
       
 :  971
 :  971
 : 5978
       
             
             
STIR-CD-17 : 
NZ_AAJS010 : 
AB050723.1 : 
             
                                                                                                                          
80         *      6000         *      6020         *      6040         *      6060         *      6080         *      6100
....................................................C.....................................................................
..........................................................................................................................
..........................................................................................................................
ATCATTTATTGATTTGTTTATATAAAGAAGAGATATATTCAAATTTAGAAATtATTCTCTCTTCTTCTATTCCTGATGTTGATAATTTAGAGAAAAAATTAAAATCAAAAACAATAAATATA
       
       
 : 1093
 : 1093
 : 6100
       
Ib-F
cpsIbJ
cpsIbK
             
             
STIR-CD-17 : 
NZ_AAJS010 : 
AB050723.1 : 
             
                                                                                                                          
         *      6120         *      6140         *      6160         *      6180         *      6200         *      6220  
...................................G......................................C...............................................
..........................................................................................................................
..........................................................................................................................
CATATTTTAGAAGAATCTAGTGGTGAAAGTGAAGAaTTATTATCAGTACTTAAAGATGCTGGTCTAAGTTATAGtAAGTTTGATAGTAATTGTTTTATTTTTAATGATGCAACGCCTATTGG
       
       
 : 1215
 : 1215
 : 6222
       
             
             
STIR-CD-17 : 
NZ_AAJS010 : 
AB050723.1 : 
             
                                                                                                                          
       *      6240         *      6260         *      6280         *      6300         *      6320         *      6340    
.........................................................C................................................................
..........................................................................................................................
..........................................................................................................................
GAGGACACTAATAAAGCATGGTATTTATTATAATCTAATTGAAGATGGTTTAAATTGtTTTACTTACTCTATATTTAGTCAAAAACTTTGGAAGTATTATGTAAAAAAATATATTCTTCACA
       
       
 : 1337
 : 1337
 : 6344
       
             
             
STIR-CD-17 : 
NZ_AAJS010 : 
AB050723.1 : 
             
                                                                                                                          
     *      6360         *      6380         *      6400         *      6420         *      6440         *      6460      
G.....................C.............................................................................T.....A.G.AC.........T
..........................................................................................................................
..........................................................................................................................
aAATTCAGCCACATGGATTTTCaCGATATTGTTTAGGGATTGAAGTTAATTCATTAGTTAATTTGCCAAAGGATCCGCGTTATAAAAAATTTATTGAAGTcCCTAGgAaAgaACTTTTTGAc
       
       
 : 1459
 : 1459
 : 6466
       
             
             
STIR-CD-17 : 
NZ_AAJS010 : 
AB050723.1 : 
             
                                                                                                                          
   *      6480         *      6500         *      6520         *      6540         *      6560         *      6580        
...TC..ATTC.........T..T..C.TG...G..A.........TTAACC....G.T.G.......T..AG....TT..A....G..A..A..AT..G.GTAT.....TTG..A..AA.C
..........................................................................................................................
..........................................................................................................................
AATgtAAcagaATATCAAAAaGAaATgGcaATAaATcTTTTTGGAGcagtaaGAGTtAgTaTTAAATCaCCttCAGTacTAgTATTaACgCAgCCtcTAtCtataGATAAagaGTtTAtgAg
       
       
 : 1581
 : 1581
 : 6588
       
             
             
STIR-CD-17 : 
NZ_AAJS010 : 
AB050723.1 : 
             
                                                                                                                          
 *      6600         *      6620         *      6640         *      6660         *      6680         *      6700         *
ACCG.CAG.G.G.T.TC...GTATTC....G....ACG...A..T.G.CGAT..T...C.G.......G..CATT.....................................A....G....
..........................................................................................................................
..........................................................................................................................
ttatAacaAtAaGaTagAAAcgtccgAAGAaCAATttaATTtTTaTaAatcaATaGTCaAtGAATATAtAAataaAGGGTACAATGTTTATTTAAAAGTTCATCCTAGAGATgTAGTaGATT
       
       
 : 1703
 : 1703
 : 6710
       
             
             
STIR-CD-17 : 
NZ_AAJS010 : 
AB050723.1 : 
             
                                                                                                                          
      6720         *      6740         *      6760         *      6780         *      6800         *      6820         *  
....................T..............A.C............................T..............T.......................T................
..........................................................................................................................
..........................................................................................................................
ATTCCAAATTGCCGGTAGAGcTATTACCATCAAATgTtCCTATGGAAATTATAGAGTTGATGTTAAcAGGTCGGTTCGAATgTGGGATAACACATTCGTCCACTGcGCTGGATTTTTTAACT
       
       
 : 1825
 : 1825
 : 6832
       
             
             
STIR-CD-17 : 
NZ_AAJS010 : 
AB050723.1 : 
             
                                                                                                                          
    6840         *      6860         *      6880         *      6900         *      6920         *      6940         *    
................................................--------------------------------------------------------------------------
................................................--------------------------------------------------------------------------
..........................................................................................................................
TGTGTTGATAAAAAAATAACTTTAGTAGATCTGAAGGATATTAAATGA                                                                          
       
       
 : 1873
 : 1873
 : 6954
       
Ib-R
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Immediately downstream of the cps operon is the neu gene cluster (neu A to D) responsible 
for terminal sialysation of the polysaccharide capsule. This region is well conserved within 
STIR-CD-17 as compared with the reference genomes. 
5.4.3.2 Penicillin-binding protein 1A  
Since their discovery as targets of beta-lactam antimicrobials, the penicillin binding proteins 
(PBPs) have been the subject of intense research and have been identified as enzyme 
families involved in peptidoglycan biosynthesis (Georgopapadakou et al., 1980; Zapun et 
al., 2008). Bacterial species can express numerous PBPs with different and potentially 
redundant functions (Denome et al., 1999). One of those proteins, referred to as PBP1a and 
encoded by ponA, was shown to be required for virulence in a neonatal sepsis model of 
infection in rats using signature-tagged mutagenesis (Jones et al., 2000). Subsequently, it 
was found that ponA mutants were more susceptible to phagocytic killing and were cleared 
more rapidly after lung exposure in an in vivo aerosol model of rat pups infection (Jones et 
al., 2003 and 2007). One of the mechanisms by which PonA may act as an immune evasin 
was revealed when the protein was linked with increased resistance to the human 
antimicrobial peptides (AMPs) that are released by phagocytes for the killing of engulfed 
microorganisms (Hamilton et al., 2006). Other proteins have been described to confer AMP 
resistance through changes in surface charges (Peschel, 2002), but ponA mutants do not 
demonstrate any alteration of charge at their surface (Hamilton et al., 2006). It is therefore 
not known how the PBP1a protein confers resistance to AMPs. 
In fish, AMPs constitute the first line of defense against pathogens and have been identified 
in tissues such as mucosal surfaces and skin (Cole et al. 1997), and in immune cells such as 
phagocytic granulocytes (Mulero et al., 2008) and eosinophilic granule cells (Silphaduang 
and Noga, 2001). Furthermore, the expression of an AMP with demonstrated antimicrobial 
properties has been shown to be up-regulated in the gill and spleen of S. agalactiae-infected 
tilapia (Peng et al., 2012). Antimicrobial peptides are thereby considered an important 
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component of the innate immune system and phagocytic killing in fish (Gómez & Balcázar, 
2008). The ponA gene was identified in STIR-CD-17 and its corresponding protein is well 
conserved in comparison to reference genomes (BSR > 0.99). Thus, the ability of the 
bacterium to resist the action of piscine AMPs through ponA expression deserves further 
investigation.  
5.4.3.3 Superoxide dismutase 
The manganese-dependant superoxide dismutase (Mn-SodA or SodA) is a 202 aa long 
periplasmic enzyme that converts superoxide anions (O2
-
) into molecular oxygen (O2) and 
hydrogen peroxide (H2O2), which in turn is further detoxified by catalases or peroxidases 
(Poyart et al., 2001). Superoxide anions are toxic compounds released by activated 
phagocytes intra- and extra-cellularly during the respiratory burst. Intraphagosomal release 
of O2
-
 is regarded as a component in the killing of bacteria, whereas extracellular release of 
O2
-
 is seen as a defence mechanism that kills foreign cells without phagocytosis and 
mediates the inflammatory process (Bannister et al., 1987). Consequently, SodA may 
constitute an important immune evasin for pathogenic bacteria. Using a mouse infection 
model, survival of a sodA knock-out mutant was severely impaired in the bloodstream and 
the brain but unchanged in the liver or the spleen (Poyart et al., 2001), suggesting that SodA 
confers survival benefits in specific host niches.  
Fish macrophages and neutrophils are known to produce bactericidal superoxide anions 
during the respiratory burst (Gómez & Balcázar, 2008). In STIR-CD-17, the predicted SodA 
is well conserved in comparison with the reference genomes (BSR > 0.99), shedding light 
on a putative immune evasin of importance in fish infections. 
5.4.3.4 Serine proteinase 
The cell-surface associated protein A (CspA), encoded by the cspA gene, was initially 
described by Harris et al. (2003) as a putative cell-wall serine protease capable of cleaving 
human fibrinogen into fibrin-like compounds. Coating of Streptococcus agalactiae by 
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fibrin-like substances might then prevent recognition of the bacterium by the host immune 
system. In accordance with this assumption, inactivation of cspA decreased S. agalactiae 
virulence and resistance to opsonophagocytic killing by neutrophils in a neonatal rat model 
of sepsis (Harris et al., 2003). CspA also has the ability to cleave and inactivate numerous 
chemokines that act on neutrophil activation (Bryan and Shelver, 2009). 
Structurally, CspA is composed of an N-terminal secretion signal peptide, a protease 
domain, a domain A, and a C-terminal LPXTG cell-wall anchoring motif. In STIR-CD-17, 
no gene corresponding to cspA has been annotated through the NCBI pipeline but it is 
mentioned as a pseudogene due to a potential frameshift. Sequence comparison using ACT 
revealed a deletion sequence of 352 bases within CspA in STIR-CD-17, which is 
responsible for the frameshift. However, two open reading frames (ORFs) can still be 
detected:  ORF-A contains the signal peptide encoding domain, the protease domain and the 
domain A of CspA, whereas ORF-B contains the cell wall anchor domain (Figure 5.9).  In 
the event that ORF-A is expressed, which has yet to be determined, these observations 
suggest that CspA cannot be a cell-wall anchored protein but instead would be a secreted 
protein in STIR-CD-17. This possibility is further supported by examples from the 
literature. In the case of another streptococcal species which has undergone genome 
reduction, namely Streptococcus equi, frameshift mutations that truncated cell-wall proteins 
have also been described and the secreted products found to remain active (Holden et al., 
2009). 
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Figure 5.9 Investigation of the CspA locus by linear comparison between S. agalactiae A909 (top) and STIR-CD-17 (bottom) using the Artemis Comparison 
Tool. The 3 reading frames and gene positions for both reverse and forward sequences are presented. Bars within reading frames denote stop codons. A homologous 
block of genomic sequence (BLASTN matches) is indicated by red bars between the sequences. This shows that the gene has been annotated as a pseudogene due to a 
deletion responsible for a frameshift. However 2 open reading frames (ORFA and ORFB) can be distinguished. The ORFA comprises most of the gene, including the 
signal peptide encoding motif, suggesting that it could be expressed as a secreted protein.  
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5.4.4 Virulence genes absent from STIR-CD-17 
Numerous virulence genes present in other S. agalactiae were absent from the STIR-CD-17 
genome and are therefore non essential for pathogenesis in fish.  
In the case of the fibrinogen binding protein FbsB, encoded by the fbsB gene, most of the 
corresponding sequence in STIR-CD-17 has been replaced by a non-homologous sequence 
with no conclusive blastN hit within the GenBank repository (Figure 5.10). In other cases, 
the genes are part of putative pathogenicity islands or mobile genetic elements found to be 
absent from the STIR-CD-17 genome: this includes the pilus type 1, the alpha-like proteins 
encoding genes rib and bca, the laminin binding protein encoding gene lmb, the C5a-
peptidase encoding gene scpB, and the bac gene encoding for the β-C protein (Figure 5.11).  
 In some of these cases, the corresponding region is occupied by putative fish-associated 
genes: Locus 5 (Chapter 4, section 4.4.4.5) is found in the place of the PI-1 coding genes, 
whereas Locus 2 (Chapter 4, section 4.4.4.2) is found in the place of rib and bca. 
 
Figure 5.10 Investigation of the fbsB gene by linear comparison between S. agalactiae A909 
(top sequence) and Contig 531 from STIR CD-17 (bottom sequence) created using the Artemis 
Comparison Tool. The 3 reading frames and gene positions for both reverse and forward sequences 
are represented. Bars within reading frames denote stop codons. A homologous block of genomic 
sequence (BLASTN matches) is indicated by red bars between the sequences. The fbsB gene within 
S. agalactiae A909 is annotated as SAK_0955. The fbsB gene within STIR-CD-17 is absent with the 
corresponding region mostly replaced by a non-homologous sequence that shows no significant 
blastN hit within the NCBI website. 
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Figure 5.11 Analysis of the genomic region comprising and flanking bac. Panel A: in A909, bac is part of a putative composite transposon of 9kB flanked by the 
insertion sequences ISSag3 and IS1381. Panel B: based on ACT comparison, the corresponding region appears to be absent from STIR-CD-17 and 2603V/R. H. 
Hypothetical protein, ICMT. isoprenylcysteine carboxyl methyltransferase, His. histidine kinase, DBP. DNA binding response regulator. 
STIR-CD-17
A909
2603V/R
BacHISSag3 DBPHisICMT IS1381
A
B
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5.5 CONCLUSIONS 
Numerous genes encoding recognised virulence factors in S. agalactiae from humans were 
absent in STIR-CD-17, including genes encoding putative adhesins (pilus type 1, fibrinogen 
binding protein FbsB, laminin-binding protein), invasins (surface protein Rib, C-α protein), 
or evasins (C5a peptidase, C-β protein). Moreover, a cluster of genes encoding a virulence 
determinant important for pathogenicity in humans S. agalactiae was found to be only 
partially present, i.e. the cyl operon responsible for β-haemolysin production. Genes 
encoding the β-haemolysin therefore appear to have originally been present within the 
STIR-CD-17 genome, but their function has been lost, possibly during the niche-reduction 
process (Chapter 4). The complete or partial absence of all these genes indicates that their 
encoded virulence determinants are non-essential to the fish-adapted subpopulation of S. 
agalactiae.  
Virulence factors may be present as different variants among distinct S. agalactiae strains, 
as described for the pilus type 2 (variants 2a and 2b), the gbs2018 (variants 1 to 6), and the 
serine-rich repeat protein Srr (variant 1 and 2). In STIR-CD-17, genes encoding the serine-
rich repeat protein 1, the pilus type 2b and the gbs2018 variant 6 were identified. Genomic 
evidence, however, suggested that no pilus might be present on the surface of STIR-CD-17 
due to frameshifts. Srr1 is also found in S. agalactiae from humans, but the gbs2018-6 
variant identified in STIR-CD-17 has uniquely been identified among isolates belonging to 
the fish-adapted subpopulation. The existence of distinct variants among different bacterial 
clones suggests differences or adaptations in the function of the protein. Based on the 
importance of the gbs2018 variants studied in S. agalactiae from humans (Tazi et al., 2010), 
it can be hypothesised that gbs2018-6 enhances the fitness of isolates in fish, but further 
work is required to investigate expression and function of this variant. Furthermore, a set of 
genes encoding recognised virulence factors in S. agalactiae from humans were found to be 
well-conserved in STIR-CD-17, including fbsA, pavA, srr1, cfb, hylB, ponA and sodA. The 
cspA gene, encoding a serine protease, was also found to be well-conserved, but a deletion 
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responsible for a frameshift suggested that, if the gene is expressed, the protein would be 
secreted and not cell-wall anchored. The cps genes were also found to be well-conserved, 
with the exception of cpsK, but whether the variations in cpsK affect the biosynthesis of the 
capsule is unknown at the present time. 
Two complete genomes of S. agalactiae of piscine origin have been recently deposited in 
GenBank (after May 2012) and include the SA20-06 isolate belonging to the fish-adapted 
subgroup of S. agalactiae (CC552), and the GD201008-001 isolate belonging to the human-
associated subpopulation (CC7). Because of time constraints, the analysis presented here 
was not updated with these genomes. However, preliminary analyses revealed that all 
observations of absence, presence or variations of genes as made for STIR-CD-17 are 
consistently found in SA20-06, indicating that these observations are conserved among the 
fish-adapted subgroup of S. agalactiae. This work provides a basis for further post-genomic 
studies that may include, for example, expression studies and immunogold labelling for 
assessment of capsular localisation. Generation of knockout mutants and in vivo studies are, 
however, required to further confirm the implication of the corresponding proteins in 
virulence according to the tenet of the molecular version of Koch’s postulate (Falkow, 
1988). 
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General discussion 
6.1 Context of this study 
The objective of this study was to enhance our understanding of the molecular 
epidemiology, host-adaptation and pathogenicity of S. agalactiae in aquatic species, with 
particular emphasis on tilapia. Streptococcus agalactiae is a multi-host pathogen and 
numerous typing methods have been used in an attempt to decipher the population structure 
and relatedness of isolates of bovine and human origin (Brochet et al., 2006; Sørensen et al., 
2010). Concerning S. agalactiae from aquatic origins, scientific information on this 
important threat for the aquaculture industry had mainly focused on case reporting 
(Hernández et al., 2009) and/or experimental challenges (Mian et al., 2009), with limited 
information in terms of pathogenesis, virulence determinants and genotypes of the strains 
involved. However, two studies published shortly before the work described in this thesis 
commenced provided the first insights into the population structure of S. agalactiae from 
aquatic animals. Evans et al. (2008) and Suanyuk et al. (2008) used standardized typing 
systems, covering either the core genome or the accessory genome, to compare genotypes of 
S. agalactiae between aquatic species, humans and bovines. Based on comparison with 
equivalent S. agalactiae typing information already existing in public databases, their results 
revealed that genetically distinct subpopulations of S. agalactiae do occur in fish, with some 
being apparently unique to isolates occurring in fish and others more similar to isolates 
occurring in humans. Furthermore, experimental infections of tilapia using bovine mastitis-
causing isolates revealed that these bacteria could not infect tilapia, suggesting that S. 
agalactiae from cattle and from fish belong to distinct subpopulations. When this thesis 
project was initiated, no information regarding the genome content of S. agalactiae 
recovered from clinically affected fish was available. Therefore, in order to expand the 
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available knowledge, the present study was designed to provide a sequential and 
multidisciplinary approach. Starting with a global collection of aquatic S. agalactiae 
isolates, the population structure and relatedness of these isolates with those from human or 
bovine origins was evaluated using a combination of molecular typing methods. Specific 
strains were then studied further, in vivo, using an experimental tilapia challenge model, 
which allowed an assessment of the virulence of strains representing specific S. agalactiae 
subpopulations and the associated disease pathology. Based on these results, a single strain 
identified as fish-adapted and extremely virulent in tilapia was selected for whole genome 
sequencing. This study provided the first comparative genomic study to include S. 
agalactiae from fish, with the aim of identifying genes with a putative role in virulence or 
host adaptation. 
6.2 Streptococcus agalactiae and host-adapted subpopulations  
Streptococcus agalactiae has been the subject of numerous typing studies in the past 
decades, with multi-locus sequence typing (MLST) generally accepted as the standard 
typing method for global population studies (Urwin and Maiden, 2003). Whole genome 
sequencing may replace MLST in the future, but MLST remains an important tool for 
molecular epidemiology because the MLST database includes more isolates than have been 
characterized based on whole genome sequencing (Spratt, 2011), thus providing a less 
detailed but broader frame of reference than offered by whole genome sequences. MLST is 
an unambiguous method based on sequencing of the internal portion of selected 
housekeeping genes (Jones et al., 2003). It is used to define sequence types (STs) and clonal 
complexes (CCs). Studies have identified that some STs or CCs correspond to 
subpopulations associated with specific host-species (Figure 6.1).  
Among the different CCs identified, CC17 corresponds to a very homogenous group that is 
adapted to humans and which is over-represented among isolates responsible for invasive 
infections in neonates (Brochet et al., 2006), while CC67 corresponds to a specific cluster of 
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strains pathogenic for cattle. Phylogenetic analysis based solely on MLST suggests a close 
relationship between CC17 and CC67, and authors have hypothesised that the hyper-
invasive neonatal clone arose from a bovine ancestor (Bisharat et al., 2004). However, 
subsequent studies considering a larger part of the genome or the whole core genome did 
not support this close relationship between CC17 and CC67 (Brochet et al., 2006; Sørensen 
et al., et al., 2010; Chapter 4). In bovines, more recent work showed that other strains are 
commonly involved in mastitis (Sørensen et al., 2010; Zadoks et al., 2011), including those 
belonging to ST103. Phylogenetic analysis based on the core genome of S. agalactiae, 
including the genome of a ST103 strain recently made publicly available in GenBank, 
indicated that these non-haemolytic isolates are very distinct from others found in cattle or 
humans (Figure 6.2) and that they are most closely related to the non-haemolytic CC552 
that is associated with fish and other poikilotherms (Chapter 2). The adaptation of CC552 to 
poikilotherms is based on a reductive evolutionary process and seems to have occurred 
anciently (Chapter 4). 
In contrast, some CCs are shared between host species (Figure 6.1), suggesting that cross-
species transmissions may occur. For example, CC23 is frequently identified among human 
carriage strains (Jones et al., 2003) and it has also been reported in numerous other host-
species but never in fish (Chapter 2). Another example is CC7; isolates belonging to that CC 
are considered to be human-associated and are genetically very distant from CC552 
(Chapter 2 and 4), yet it has been frequently reported in fish. This suggests that host 
adaptation is not only reflected at the level of the core genome (for CC552) but may also be 
driven by genes present in the accessory genome (for CC7). 
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Figure 6.1 Venn diagram illustrating S. agalactiae genotypes predominantly identified in a 
single host or shared between humans, bovines or fish. Clonal complexes (CCs) or sequence 
types (STs) as obtained by multi-locus sequence typing are displayed.*clusters of non-haemolytic 
isolates. 
 
 
Figure 6.2 Bayesian phylogenetic tree constructed based on the core genome of 10 S. agalactiae 
isolates corresponding to sequence types (STs) belonging to clonal complexes (CCs) mentioned 
in Figure 6.1. The host of origin for each isolate is indicated by the colour of the isolate name: blue, 
fish; green, bovine; red, human; purple, sea mammal; orange, unknown. Posterior probabilities are 
shown at each node and the scale bar represents the substitutions per site. 
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6.3 Possible routes of exposure in aquatic animals  
The fact that the same STs have been found in fish, other aquatic species and humans 
suggests that interspecies transmission may occur. 
In fish, isolates belonging to CC7 (ST7 and ST500) or CC283 (ST283 and ST491) have 
been reported from clinical outbreaks in Kuwait (Chapter2; Evans et al., 2008), China (Ye et 
al., 2011), Thailand (Chapter 2) and Vietnam (Chapter 2). ST500 and ST491 have only been 
reported in fish thus far, but CC7 and CC283 are part of a large group of predominantly 
human-associated CCs (Chapter 2). ST7 has been associated with infection in humans in 
numerous countries, including countries in Asia (Evans et al., 2008), whereas the ST283 has 
been associated with invasive disease in human adults predominantly in Asia (Ip et al., 
2006). ST7 also occurs as a carriage strain in humans, where S. agalactiae may be part of 
the natural flora of the gastro-intestinal and genito-urinary tracts (Dillon et al., 1982; Jones 
et al., 2003).  
To our knowledge the STs of human-colonizing S. agalactiae strains have not been 
investigated among Asian populations. A Danish study further identified that S. agalactiae 
from human origin may survive up to 4 weeks in water (Jensen and Berg, 1982). These 
studies are not directly related to aquaculture but combination of this information suggests 
that human S. agalactiae may be present in aquaculture systems through effluents. In China 
and other Asian countries, where the bulk of worldwide tilapia production is concentrated, 
there is a long history of administering wastewater and human excreta to fish ponds. In 
extensive and semi-intensive aquaculture practise, latrines are often placed over the ponds to 
allow human excreta to enter the system (Lima dos Santos and Howgate, 2011), while 
wastewaters are used as a source of water for aquaculture, but also as a source of nutrients 
to support the growth of both fish and the organisms the fish feeds on (Little and Edwards, 
1999). Moreover, in some rural regions, the use of untreated effluent in aquaculture ponds 
remains the only available method for wastewater treatment (World Health Organization, 
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2006a,b). These cultural practises enable high fish yields to be obtained with little or no 
additional feeding (Petersen and Dalsgaard, 2003). However, there are evident drawbacks in 
terms of food safety and disease transmission. Available evidence suggests that products 
from such systems will be contaminated by enteric pathogens on the skin and the gut, and 
that in some circumstances the organisms may invade tissues including muscles (Buras et 
al., 1987). Epidemiological evidence for transmission of pathogens between human and fish 
due to use of sewage water is, however, limited except when it comes to the transmission of 
certain trematode diseases, mainly those caused by Clonorchis (oriental liver fluke) and 
Fasciolopsis (giant intestinal fluke) (Lima dos Santos and Howgate, 2011). There is only 
one epidemiological study providing evidence for transmission of S. agalactiae between 
human and fish through wastewaters: a strain of S. agalactiae isolated from mullet during a 
massive fish kill in Kuwait Bay was found to have the same RAPD pattern as a S. 
agalactiae strain isolated from sewage outfalls adjacent to the infected site (Jafar et al., 
2008). Challenge experiments have confirmed that some human-derived strains of S. 
agalactiae are pathogenic to fish. Using an ST7 from human origin, intra-peritoneal 
challenge of tilapia successfully induced disease and death in fish (Evans et al., 2009), while 
Pereira et al. (2010) demonstrated that out of the 8 S. agalactiae from human origin 
assessed, one induced clinical signs and mortality in both injection and immersion trials. In 
conclusion, the presence of human-associated STs affecting fish in Asian farms may be 
linked to aquaculture practise leading to contacts between S. agalactiae of human origin and 
fish through the water (Figure 6.3).  
Other isolates identified in fish belong to CC552 (Chapter 2) and have been isolated from 
fish in North America, South America, Eurasia and Australia, suggesting a global spread of 
this clone (Chapter 2, Evans et al., 2008, Lusiastuti et al., 2012). Isolates belonging to 
CC552 are hypervirulent in fish and present characteristics of host-restricted bacteria 
(Chapter 3 and 4). Accordingly, isolates belonging to this CC have never been reported in 
mammals. It is therefore unlikely that these clones have been introduced through interaction 
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with humans or other hosts. It is unknown how these strains are introduced in aquaculture 
systems and it may be possible that fish carry the bacterium asymptomatically (Figure 6.3), 
as described in humans and bovines; however this possibility has never been investigated. 
Over the last years, recurrent epizootics of S. agalactiae in wild giant groupers and other 
wild fish have been reported in Australia (Bowater et al., 2012). The strain involved 
presents typical characteristics of the fish-adapted subgroup of S. agalactiae, i.e. non-
haemolytic, thermosensitive and CAMP negative isolates. The origin or source of these 
infections is unknown but it may be suggested that a reservoir in the biotic or abiotic aquatic 
environment exists. No outbreak of S. agalactiae in fish had been reported prior the report 
from Bowater et al (2012). It is unknown how S. agalactiae was introduced in the wild 
population in Australia, but streptococcal disease may have been introduced through global 
trade of aquarium fish (Wittington and Chong, 2007). In chapter 2, we reported for the first 
time S. agalactiae CC552 from aquarium fish in Australia but originally imported from 
South-East Asia, indicating that the release of imported aquarium fish into the wild is a 
plausible source of introduction of the pathogen. 
To date, it is unclear if or how the transmission of S. agalactiae between fish occurs for all 
S. agalactiae clones identified in fish. Using an ST283 recovered from a natural outbreak of 
streptococcosis in tilapia in Vietnam, a study was not successful in inducing the disease by 
immersion exposure (Wongsathein, 2012). There are no other reports of cohabitation or 
immersion challenges that used human-associated ST recovered from clinical infections in 
fish. It may be possible that high and sustained bacterial loads in the water, such as those 
likely to be achieved through aquaculture practices using wastewater, are required, possibly 
in combination with predisposing environmental or management factors such as high 
temperatures, low dissolved oxygen or high stocking density (Wongsathein, 2012). Mian et 
al. (2009) performed experimental cohabitation challenge studies using non-haemolytic 
Brazilian isolates likely to belong to CC552 and successfully reproduced the disease, 
indicating that horizontal transfer can occur with this clone under experimental conditions. 
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However numerous questions remain. It is has not been evaluated whether the bacterium is 
shed by infected fish and this could easily be done as for S. iniae (Baum et al., 2013). 
Moreover, the survival of fish-pathogenic S. agalactiae in seawater or freshwater 
microcosms has not been tested, unlike with other fish pathogens (Avendaño-Herrera et al. 
2006; Duodu and Colquhoun, 2010). Similar experiments using isolates of CC7, CC283 and 
CC552 would help determine whether the water and currents may be an important factor for 
the survival of the bacterium and the transmission of the pathogen. Finally, the natural 
portal(s) of entry of this pathogen in fish have not been adequately investigated thus far and 
warrant further attention. 
Streptococcus agalactiae has also been detected in aquatic or semi aquatic animals 
including seals, dolphins and crocodiles (Chapter 2, Bishop et al., 2007, Evans et al., 2006). 
S. agalactiae recovered from grey seals and crocodiles all belonged to ST23 (Bishop et al., 
2007; Chapter 2). Within ST23, molecular serotypes Ia and III predominate, with serotype 
Ia linked to humans and serotype III primarily found in dairy cattle (Brochet et al., 2006; 
Sørensen et al., 2010). All seal and crocodile isolates had serotype Ia, suggesting a human 
origin. In humans, ST23 is a commonly recto-vaginal carried strain in adults although it 
may also cause neonatal invasive disease (Jones et al, 2003). Given the predominant niche 
of ST23 in humans, it is conceivable that its presence in these hosts is due to microbial 
contamination of surface water (Figure 6.3). S. agalactiae isolated from dolphins in 
Scotland and Kuwait in this study and elsewhere (Chapter2; Evans et al., 2006) were part of 
CC7 (ST7 and ST399). During the natural outbreak in Kuwait bay, ST7 was cultured from 
fish and a bottlenose dolphin (Tursiops truncates). Authors hypothesised that the dolphin 
may have been infected through ingestion of infected fish (Evans et al., 2006), but it is 
equally likely that the dolphin became infected in the same manner as fish, i.e. due to 
immersion in or ingestion of sewage contaminated water (Evans et al., 2006; Figure 6.3). 
Transmission from fish to humans has not been reported but may theoretically occur 
(Figure 6.3). Consumption of fish has been associated with an increased risk of S. 
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agalactiae serotype Ia and Ib colonization in people (Foxman et al., 2007). In the case of S. 
iniae, it has been shown that people manipulating infected fish with wounds in their hands 
may be infected (Weinstein et al., 1997). It is possible that the emergence of ST283 in Asia 
has been driven by handling or consumption of fish, but molecular and epidemio-
surveillance studies are required to investigate this possibility. Recently, isolates belonging 
to CC552 were identified from doctor fish used in spas in the UK and it was suggested that 
repeated contacts with humans may result in virulence of these strains in humans. In view of 
the genome reduction of this clone (Chapter 4), this seems unlikely, because it would 
probably require acquisition of large genomic fragments from human associated strains. 
 
Figure 6.3 Possible routes of inter- and intra-species transmissions of Streptococcus agalactiae 
in humans and aquatic host species. Full arrows indicate proven routes, dashed arrows are 
hypothetical, references for routes of transmission are provided when available. Full boxes have 
been observed/described in the literature, dashed boxes are hypothetical. 
 
Fish - symptomatic
Fish - asymptomatic
Human - symptomatic
Human - asymptomatic
Environment 
(water)
Manning et 
al., 2010
Wildlife 
asymptomatic or 
symptomatic
Jensen & Berg, 
1982; Jafar et 
al., 2008
Evans et al., 
2006
Delannoy 
et al., 
2013
Manning et 
al., 2010
Mian et al., 
2010
Foxman et 
al., 2007
General discussion 
6-222 
6.4 Streptococcus agalactiae virulence and pathogenesis in fish 
In this study, the clinical signs, the in vivo distribution of viable bacteria and bacterial 
antigens, and the gross and histopathological lesions that develop during the time course of 
S. agalactiae infection were investigated for the first time (Chapter 3). Moreover, 2 strains 
were evaluated, one belonging to a fish adapted subpopulation (ST260) and one belonging 
to a subpopulation never reported in fish (ST23). The ST260 strain was highly virulent with 
mortalities close to 100% with the lower dose (10
2
 cfu per fish). Typical clinical signs 
including ataxia were induced, whereas no major clinical signs or mortalities occurred in the 
fish challenged with the ST23. After injection, both strains gained access to the bloodstream 
and viable bacteria were recovered from all organs under investigation. After 7 days post-
challenge and for both strains, the formation of granulomata or other encapsulated structures 
and containment of bacteria within these structures appeared to be a major component of the 
fish response, which is in agreement with studies of natural outbreaks (Hernández et al., 
2009). However, the load of viable bacteria remained high within organs and associated 
lesions were important in fish infected with ST260, suggesting that, unlike ST23, this strain 
is able to survive within macrophages and/or to evade the immune system. In chapter 3, it 
was demonstrated that the lack of report of ST23 strains in fish is probably not due to lack 
of exposure, but rather to a lack of virulence in fish, which provided an excellent basis to 
investigate genomic differences underlying these subpopulations. 
In experimental challenges of tilapia using ST7 or ST283, a 50% mortality rate was 
obtained after intra-peritoneal injection of around 10
3.3 
and 10
7
 colony forming units per fish 
respectively (Evans et al., 2002; Wongsathein, 2012), which correspond to doses that would 
induce about 100% mortalities with isolates belonging to the fish-adapted subpopulation 
(Chapter 3). Our challenge study therefore indicated that the fish-adapted ST260 is 
hypervirulent in fish, even though comparison of virulence of strains using standardised 
challenge models are required to confirm this. Based on the examples of comparative 
genomic studies of enterobacteria, staphylococci or even S. agalactiae from bovine origin, it 
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has been shown that gain in pathogenicity in bacteria may be driven by acquisition of genes 
through horizontal gene transfer (Fraser-Liggett, 2005; Raskin et al., 2006; Richards et al., 
2011). However recent work has shed light on a much wider spectrum of virulence 
acquisition mechanisms in bacteria: it was shown that virulence in bacterial species like 
Rickettsia is not correlated with acquisition of foreign DNA but may result from regulatory 
changes of expression of virulence determinants due to genome decay (Fournier et al., 
2009). In our study, the genome of the hypervirulent ST260 strain was sequenced and one of 
the most remarkable features of this genome was the massive genomic reduction resulting in 
the loss of almost all genomic islands described in S. agalactiae from human origin 
(Chapter 4). Comparative genomic analysis revealed the conserved presence of a limited 
number of genes encoding well-recognised virulence determinants in S. agalactiae from 
humans and including adhesins (fbsA, pavA, srr1), invasins (cfb, hylB) and immune evasins 
(ponA, sodA, cps) (Chapter 5). Comparison with the reference strain NEM316, which is of 
ST23 and known not to be virulent in tilapia (Pereira et al., 2010), similarly to the ST23 
isolate used in our challenge study (Chapter 3), highlighted that these virulence genes were 
also present in ST23. This observation suggests that it is not the presence but the expression 
of these genes that may explain the ability of ST260 to cause disease in fish and this 
possibility requires further assessment. One important distinction between ST23 and ST260 
was however identified and consisted of the presence of a distinct variant of the 
glycoprotein anchored protein gbs2018 in the fish-adapted group (Chapter 5). In view of the 
importance of gbs2018 to virulence in humans (Santi et al., 2007), it may be hypothesised 
that the existence of a specific variant among the fish-adapted clones reflects an adaptive 
evolution for virulence in fish. Finally, comparative genomic analysis enabled the 
identification of several genes that have possibly been acquired through horizontal gene 
transfer and apparently associated with strains occurring in fish (Chapter 4). With some 
exceptions, the majority of these genes were found to encode hypothetical proteins of 
unknown function and their role in virulence is unknown.  
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Numerous S. agalactiae genomes have been made publicly available over the end course of 
this project, including the genome of the ST23 isolate used in the challenge study (MRI Z1-
201) and the non-haemolytic ST103 isolate used to construct Figure 6.2. Extension of the 
comparative genomic analysis performed in this study with these genomes would provide 
further insights into the genes possibly unique to piscine S. agalactiae. Furthermore, the 
approaches of the “OMICS” era have yet to be fully applied to piscine S. agalactiae. Further 
work including proteomic analyses and transcriptomic analyses to evaluate gene expression 
profile over the course of challenge studies would enable the identification of proteins of 
importance for pathogenesis in fish and could provide viable targets for vaccine 
development. Biological validation of the role of these genes in pathogenesis and virulence 
would necessitate the generation of mutants deficient or altered in the target genes, followed 
by in vivo studies to evaluate variations in virulence and/or in vitro studies to evaluate 
variations in adherence and invasion of cell lines, as well as survival within macrophages. 
Most studies of this sort in streptococci have been conducted using temperature-sensitive 
suicide plasmids such as pG
+
host9 to generate knock-out mutants (Yamaoto et al., 2005). 
However, S. agalactiae strains belonging to the fish-adapted subgroup do not grow well at 
37˚C or higher temperatures and other approaches will therefore have to be considered. An 
alternative for iditentification of genes important for virulence in fish may for example be 
achieved using a new method called TraDIS and standing for transposon directed insertion-
site sequencing (Langridge et al., 2009). 
6.5 Concluding remarks and future directions 
The multidisciplinary approach used in this study has been successful in providing scientific 
information regarding the population structure, pathogenesis and virulence of S. agalactiae 
in fish. The major information researchers should take in account is that very distinct 
lineages of S. agalactiae occur in fish, with one hypervirulent lineage strictly adapted to 
poikilotherms through reductive evolution, and other lineages that are human-associated and 
apparently less virulent to fish. These lineages differ in term of transmission, pathogenesis 
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and virulence. This thesis laid a firm foundation for further studies; these should address the 
questions of epidemio-surveillance for assessment of transmission of S. agalactiae between 
human and fish and evaluation of the role of putative virulence determinants, with a view to 
effective control of the disease in fish through prevention or vaccine development. 
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Appendix: Bacterial collection 
A collection of 33 S. agalactiae from distinct geographical regions and host of origin was 
assembled with the help and generosity of a number of researchers worldwide. A list of the 
bacterial isolates used in this study is provided herby (NA, Non available).  
 
Code № Reference Country Date Species Organ Additionnal information Provided by
STIR-CD-01 K0101 Kuwait Sep-01 Liza klunzingeri 
(mullet)
Brain Natural outbreak in 
Kuwait bay
STIR-CD-02 K0102 Kuwait Sep-01 Liza klunzingeri 
(mullet)
Brain Natural outbreak in 
Kuwait bay
STIR-CD-03 K0103 Kuwait Sep-01 Liza klunzingeri 
(mullet)
Brain Natural outbreak in 
Kuwait bay
STIR-CD-04 K0104 Kuwait Sep-01 Liza klunzingeri 
(mullet)
Brain Natural outbreak in 
Kuwait bay
STIR-CD-05 K0105 Kuwait Sep-01 Liza klunzingeri 
(mullet)
Brain Natural outbreak in 
Kuwait bay
STIR-CD-09 B09032 Sa Ti Be 
08-18b
Colombia Aug-08 Oreochromis  sp. 
(ti lapia)
Kidney Cage farm in Lake 
Betania
STIR-CD-10 B09032 Sa Ti Be 
08-21a
Colombia Nov-08 Oreochromis  sp. 
(ti lapia)
Kidney Cage farm in Lake 
Betania
STIR-CD-11 B09032 Sa Ti Be 
21b
Colombia Nov-08 Oreochromis  sp. 
(ti lapia)
Kidney Cage farm in Lake 
Betania
STIR-CD-12 B09032 Sa Ti Be 
08-18 a
Colombia Aug-08 Oreochromis  sp. 
(ti lapia)
Kidney Cage farm in Lake 
Betania
STIR-CD-13 B09032 Sa Ti Cr 
08-14b
Costa 
Rica
Jun-08 Oreochromis  sp. 
(ti lapia)
Eye Farm CR1
STIR-CD-07 B08059 E52 
HEART
Honduras Aug-08 Oreochromis  sp. 
(ti lapia)
Heart Farm H1
STIR-CD-17 B08059 E28 
heart
Honduras Aug-08 Oreochromis  sp. 
(ti lapia)
Heart Farm H1
STIR-CD-18 B08059 E52 
spleen
Honduras Aug-08 Oreochromis  sp. 
(ti lapia)
Spleen Farm H1
STIR-CD-19 B08059 PE45 
spleen
Honduras Aug-08 Oreochromis  sp. 
(ti lapia)
Spleen Farm H1
STIR-CD-14 May 06 Vietnam May-06 Oreochromis  sp. 
(ti lapia)
NA NA Margaret Crumlish (University 
of Stirl ing, UK)
STIR-CD-21 09011056/1L Thailand May-09
Oreochromis  sp. 
(ti lapia)
Liver Saraburi Province
STIR-CD-22 09011088/2L Thailand Oct-09 Oreochromis  sp. 
(ti lapia)
Liver Nakhon Sawan Province
STIR-CD-23 GQ338316 Thailand NA Oreochromis  sp. 
(ti lapia)
Kidney Nakhon Pathom Province
STIR-CD-24 GQ338317 Thailand NA Oreochromis  sp. 
(ti lapia)
Kidney Kanchanaburi Province
STIR-CD-25 GQ338318 Thailand NA Oreochromis  sp. 
(ti lapia)
Kidney Chachoengsao Province
STIR-CD-26 GQ169772 Thailand NA Oreochromis  sp. 
(ti lapia)
Kidney Mukdahan Province
STIR-CD-27 GQ169773 Thailand NA Oreochromis  sp. 
(ti lapia)
Kidney Nakhon Phanom 
Province
STIR-CD-28 GQ169774 Thailand NA Oreochromis  sp. 
(ti lapia)
Kidney Phetchaburi Province
STIR-CD-29 / Belgium Aug-07 Oreochromis  sp. 
(ti lapia)
Kidney
/brain
Tilapia recirculating 
farm
Francois Lieffrig (Centre d' 
Economie Rurale Groupe, 
Belgium)
STIR-CD-30 TCFB 1876 Australia 2004 Puntius conchonius 
(rosy barb)
Kidney Aquarium fish Dr Jeremy Carson (University of 
Tasmania, Australia)
STIR-CD-31 TCFB2983, 
originally P97-
1103(FD1631)
Australia 1997 NA Heart Aquarium fish, l ikely to 
have been imported from 
South-East Asia
STIR-CD-32 TCFB 2984, 
originally P96-
1986(FD1616)
Australia 1996 Mikrogeophagus 
ramirez i  (golden 
ram)
Liver Aquarium fish imported 
from Indonesia
MRI Z1-198 / UK 1995 Tursiops truncatus 
(bottlenose dolphin)
Lungs Animal stranded around 
the coast of Scotland
MRI Z1-199 / UK Dec-02 Halichoerus grypus 
(grey seal)
Lungs Animal stranded around 
the coast of Scotland
MRI Z1-200 / UK Dec-02 Halichoerus grypus 
(grey seal)
Lungs Animal stranded around 
the coast of Scotland
MRI Z1-201 / UK Feb-03 Halichoerus grypus 
(grey seal)
Lungs Animal stranded around 
the coast of Scotland
MRI Z1-202 / UK Mar-03 Halichoerus grypus 
(grey seal)
Lungs Animal stranded around 
the coast of Scotland
MRI Z1-208 / UK 2010 Halichoerus grypus 
(grey seal)
Lungs Animal stranded around 
the coast of Scotland
Dr Kim Thomson (University of 
Stirl ing, UK) and Dr Terutoyo 
Yoshida (University of 
Miyazaki, Japan) 
Prof Carlos Iregui (Universidad 
Nacional de Colombia, Bogotá, 
Colombia)
Prof Hugh W Ferguson (St. 
George’s University, Grenada, 
W. Indies)
Dr Janenuj Wongtavatchai 
(Chulalongkorn University, 
Thailand)
Dr Nicky Buller, Department of 
Agriculture and Food Western 
Australia, Australia)
Dr Geoff Foster (SAC Veterinary 
Services, UK) and Dr Mark 
Dagleish (MRI, UK)
Dr Temdoung Somsiri 
(Kasetsart University Campus, 
Thailand)
